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ABSTRACT OF THE DISSERTATION 
 
DISSECTING THE MOLECULAR MECHANISMS UNDERLYING SYNAPSE 
DEVELOPMENT AND NEURONAL FUNCTIONS IN CAENORHABDITIS 
ELEGANS 
by 
Shuo Luo 
Doctor of Philosophy in Biology and Biomedical Sciences  
(Neuroscience) 
Washington University in St. Louis, 2009 
Dr. Michael L. Nonet, Chairperson 
 
The development and function of the nervous system is under delicate regulation 
of diverse tissue-derived signals in multi-cellular organisms.  In Dr. Nonet’s lab, I am 
using the model organism Caenorhabditis elegans to ask two basic questions: 1) How do 
different tissues in an organism coordinate to regulate neural functions and behaviors?  2) 
What controls the development of synapse, the basic unit of the nervous system?  These 
questions divide my dissertation into three parts, with the first two parts related to the 
first question and the third part to the second question. 
In the first part of this dissertation, I present work that demonstrates the role of the 
C. elegans intestine as an endocrine organ in regulating the rhythmic defecation behavior 
(Chapter 2).  The C. elegans defecation behavior consists of three well-coordinated 
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muscle contractions that enable the nematode to expel intestinal contents out to the 
environment.  Genetic and cell biology analyses showed that the early and late muscle 
contractions involve activities in the intestine and GABAergic neurons (AVL and DVB), 
respectively, while it remains unclear how the intestinal event is coordinated with later 
activation of GABAergic neurons.  Using molecular genetics and cell biology 
approaches, we demonstrate that the exocytic protein AEX-4 and proprotein convertase 
AEX-5 function in the worm intestine to control the defecation motor program.  When 
expressed in the intestine, AEX-5 is secreted into the pseudocoelom, and this secretion is 
blocked by AEX-4 disruption.  Moreover, we show that the G-protein coupled receptor 
(GPCR) AEX-2 functions in GABAergic neurons to regulate defecation behavior, and it 
is genetically downstream of intestinal AEX-4 and AEX-5 signals.  We also demonstrate 
that the stimulatory G! pathway relays the AEX-2 signal in GABAergic neurons.  
Together, our results provide evidence that the C. elegans intestine is able to modulate 
neuronal function by secretory signals. 
In the second part of this dissertation, I present work that demonstrates the role of 
the C. elegans intestine in modulating the cholinergic neurotransmission (Chapter 3).  C. 
elegans  utilizes acetyl choline as a neurotransmitter at its neuromuscular junctions 
(NMJs) to control muscle contractions and locomotion related behaviors.  Using 
molecular genetics, pharmacological, and physiological approaches, we show that the 
proprotein convertase AEX-5 is required in the intestine to maintain normal cholinergic 
transmission in the nematode.  In addition, we find that the GPCR AEX-2 functions in 
the GABAergic neurons to maintain cholinergic transmission level, and the stimulatory 
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G! pathway is genetically downstream of AEX-2.  Interestingly, we find that although 
both the defecation motor program and the cholinergic transmission modulation involve 
intestinal signals and neuronal G-protein pathways, they depend on different downstream 
molecules: while the defecation requires GABA to activate the enteric muscle contraction 
in the last step of the defecation, the modulation of cholinergic transmission depends on 
neuropeptide processing enzymes EGL-3 and EGL-21.  As GABAergic neurons do not 
directly synapse on cholinergic neurons in C. elegans, we speculate that the peptide 
signals act in a paracrine manner on cholinergic neurons.  This suggests the C. elegans 
intestine could function as an endocrine organ to modulate multiple aspects of neuronal 
functions. 
In the last part of this dissertation, I focus on the early neural development of C. 
elegans and I present the preliminary work on the focal adhesion complex molecule 
ZYX-1 for its role in mechanosensory synapse development (Chapter 4).  We cloned the 
zyx-1 allele from the genetic screen that looked for worms defective in PLM synaptic 
patch formation.  Using time course imaging analysis of fluorescence labeled PLM 
neurons, we show that zyx-1 mutants are able to form synapses during early development, 
while they fail to maintain the synapse to adulthood.  In addition, we demonstrate that 
ZYX-1 acts cell-autonomously in mechanosensory neurons to regulate PLM synapse 
maintenance.  We are currently working to dissect the molecular mechanisms that 
underlie ZYX-1’s function in synapse maintenance.  I expect the study will shed light on 
our understanding of the molecular mechanisms underlying neural development. 
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Chapter 1 
 
Introduction to the Defecation Behavior in C. elegans And the 
Modulation of Neuronal Functions 
 2 
1. The C. elegans Defecation Behavior 
 
1.1. C. elegans As A Model Organism to Study Behaviors 
C. elegans is a ~1mm long, free-living soil nematode that was first isolated and 
settled as a genetic model organism by Sydney Brenner in 1960’s (Wood, 1988).  With as 
few as 959 somatic cells, C. elegans exhibits surprisingly diversified behaviors from 
feeding, locomotion, chemotaxis, to more complex behaviors such as mating and egg-
laying, making this small animal a desirable model to dissect the cellular and molecular 
mechanisms underlying behaviors (Riddle et al., 1997).  In addition, with the completion 
of the 302-cell nervous system circuitry that discloses the complete connecting patterns 
of all neurons in a single adult hermaphrodite (White et al., 1988; White, 1986), people 
started looking forward to understanding how different tissues (including neurons) in a 
single animal coordinate to regulate complex behaviors. 
 
1.2. Defecation Motor Program (DMP) 
Among various behaviors observed in C. elegans, the defecation behavior attracts 
our attentions because it is rhythmic and it involves the communication among different 
tissues including neuronal and non-neuronal cells (which will be discussed in more 
details in following sections).  The C. elegans defecation motor program (DMP) consists 
of three well-coordinated muscle contractions that happen about every 45 seconds in 
healthy, feeding animals (Fig 1A) (Thomas, 1990).  This program first starts with a 
posterior body-wall muscle contraction (pBoc), which squeezes and pushes intestinal 
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contents forward.  The posterior body-wall muscles then relax.  About 1-2 seconds later, 
the anterior body-wall muscles contract (aBoc), pressurizing intestinal contents around 
the anus.  Almost at the same time, the set of enteric muscles that wrap the posterior 
intestine and the anus of the animal contract, opening the anus and expulsing the 
intestinal contents out to the environment (Exp) (Fig 1A) (Thomas, 1990).  This 
completes the defecation cycle and the whole program repeats itself in precision about 45 
seconds later.  As this behavior is highly invariant in wild type animals, and as the 
disruption of the defecation motor program leads to phenotypes that are easily observable 
under dissecting microscopes (such as constipation), people adopted a variety of 
molecular genetics and cell biology strategies to identify the cells and genes that are 
involved in defecation regulation. 
 
1.3. GABAergic Neurons in the Defecation Regulation 
The first immediate speculation on the identity of the cells that are involved in 
controlling the serial muscle contractions during the defecation cycle involved neurons.  
Indeed, in a systematic study of the GABAergic nervous system in the nematode, people 
found that two GABAergic neurons, AVL and DVB, are required for the execution of 
aBoc and Exp steps in the defecation motor program (McIntire et al., 1993a; McIntire et 
al., 1993b).  The C. elegans GABAergic nervous system consists of 26 GABAergic 
neurons, with 19 type-D motor neurons that synapse on body wall muscles, 4 RME motor 
neurons that control worm foraging behaviors, one RIS interneuron with unknown 
functions, and AVL and DVB motor neurons (Fig 1B) (McIntire et al., 1993b).  Serial 
 4 
electron microscopy analysis shows that DVB (and likely AVL) forms a neuromuscular 
synapse on the anal depressor, an enteric muscle that regulates anus opening during the 
expulsion (Fig 1B) (White, 1986).  Interestingly, when AVL and DVB neurons are killed 
with a laser microbeam, the worm exhibits strong expulsion defects and becomes 
constipated (McIntire et al., 1993b), suggesting the two GABAergic neurons are involved 
in direct enteric muscle activations.  In support of this observation, in mutant animals that 
lack the functional GABA synthase UNC-25 (the worm homologue of the glutamic acid 
decarboxylase, GAD), most of the expulsion step of the defecation cycle is absent and the 
animal becomes constipated (McIntire et al., 1993a; Thomas, 1990).  These data strongly 
suggest that GABAergic neurons AVL and DVB directly control enteric muscle 
contractions by releasing GABA.  But how can the conventionally inhibitory 
neurotransmitter GABA excite muscles?  With the cloning of expulsion defective gene 
exp-1, the mystery was resolved: exp-1 encodes an excitatory GABA-gated ion channel 
and it is expressed in enteric muscles (Beg and Jorgensen, 2003).  Unlike most other 
ionotropic GABA receptors that are permeable to chloride ions, EXP-1 is mainly 
selective for sodium ions (Beg and Jorgensen, 2003).  Thus EXP-1 is the downstream 
receptor for the expulsion-inducing GABA signals during the defecation cycle. 
 
1.4. Intestines in the Defecation Regulation 
In contrast to the studies on GABAergic neurons, the disclosure of the intestine as 
a regulator of the nematode defecation motor program is less straightforward.  One of the 
first insights into the involvement of the intestine in the defecation regulation came from 
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the study on oscillatory intestinal Ca
2+
 waves during rhythmic defecation cycles (Fig 1C).  
The C. elegans intestine is a tube-like structure that is made up of single-layer epithelial 
cells joined by gap junctions (McGhee, 2007; Peters et al., 2007; Sulston et al., 1983).  
Using Ca
2+
 sensors that detect intracellular Ca
2+
 concentrations in the intestine, several 
groups reported the occurrence of periodic Ca
2+
 spikes in the posterior intestine 
immediately prior to pBoc, the first defecation muscle contraction in the worm (Fig 1C) 
(Dal Santo et al., 1999; Teramoto and Iwasaki, 2006).  Further analysis showed that the 
posterior Ca
2+
 wave propagates anteriorly throughout the intestine, and the timing of Ca
2+
 
peaks at the anterior intestine correlates well with that of aBoc, the second defecation 
muscle contraction (Fig 1C) (Teramoto and Iwasaki, 2006).  Interestingly, an intracellular 
Ca
2+
 channel inositol trisphosphate (IP3) receptor ITR-1 and a gap junction subunit INX-
16 are shown to be required for mediating the Ca
2+
 wave propagation.  In the absence of 
functional ITR-1 or INX-16, the propagation of Ca
2+
 waves in the intestine is slowed 
down or eliminated, resulting in reduced or abolished aBoc and Exp (Dal Santo et al., 
1999; Peters et al., 2007).  This is similar to the observation in the worms where aBoc 
and Exp are disrupted by the intestinal application of IP3 receptor inhibitor heparin 
during the Ca
2+
 wave propagation (Teramoto and Iwasaki, 2006).  Importantly, intestinal 
Ca
2+
 waves persist in the AVL- and DVB-neurons-ablated worms, even though these 
animals exhibit strong aBoc and Exp defects (Teramoto and Iwasaki, 2006).  This 
suggests that the intestinal Ca
2+
 oscillation is not only crucial for the execution of 
defecation related muscle contractions, but it also precedes the AVL and DVB 
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GABAergic neurons controlled muscle contractions, the expulsion, during defecation 
cycles. 
Then how does the intestine, a non-neuronal tissue, regulate neuron-controlled 
cellular processes in C. elegans?  The recent interesting discovery of the intestine as a 
proton gradient generator and the activation of the posterior body wall muscle by H
+
 may 
give us some hints.  Using molecular genetics and physiological approaches, Beg et al. 
showed that the nematode intestine is able to acidify the pseudocoelom (the worm body 
cavity to which body wall muscles are exposed) by pumping protons out of intestinal 
epithelial cells via a Na
+
/H
+
 exchanger (Beg et al., 2008).  The body wall muscles express 
a H
+
 gated ion channel, and when the proton gets to the threshold concentration, it 
activates posterior body wall muscles and triggers pBoc (Beg et al., 2008).  Interestingly, 
the H
+
 gradient is generated in a cyclic pattern that coincides with defecation cycles (Beg 
et al., 2008).  This indicates that the intestine might utilize a diffusible signal to control 
cellular processes in other tissues.  This hypothesis is further supported by the 
observation that Ca
2+
 oscillations are normally associated with electric excitation and 
exocytosis events in excitable cells (such as neurons).  In the following chapter (Chapter 
2), I am going to present evidence to show that this is indeed the case. 
 
1.5. aex Genes in the Defecation Regulation 
To understand the molecular basis of the defecation behavior, in 1990 James 
Thomas performed a mutagenesis screen using the chemical mutagen ethyl methane 
sulfonate (EMS) to look for mutant worms that had altered defecation motor programs 
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(Thomas, 1990).  He identified a variety of defecation mutants that either have one or 
more coordinated muscle contractions missing or have the cycle time altered (Fig 2).  
Based on the specific muscle contractions affected by the mutation, the defecation 
mutants were classified into 4 groups: pbo mutants, which have weak or missing pBoc; 
abo mutants, which have defective aBoc; exp mutants, which have normal pBoc and 
aBoc but frequently miss Exp; and aex mutants, which have defective aBoc and Exp (Fig 
2) (Thomas, 1990).  Other defecation mutants that have either prolonged or shorted 
defecation period are designated as dec mutants, while to a large extent they have the 
three muscle contractions unaffected and intact (Fig 2) (Thomas, 1990).  The subsequent 
studies on these mutated genes have led to discoveries of several novel mechanisms that 
underlie tissue communications and behavior regulation.  This includes the 
aforementioned excitatory GABA ionotropic receptor EXP-1 in regulating enteric muscle 
contractions (Beg and Jorgensen, 2003) and the intestinal Na
+
/H
+
 exchanger PBO-4 in 
establishing the proton gradient that activates posterior body wall muscles (Beg et al., 
2008).  As an additional example, the intestinal IP3 receptor ITR-1 is encoded by dec-4, 
and the extended defecation period in the itr-1/dec-4 mutant results from the frequent 
absence of Ca
2+
 waves in the intestine (Dal Santo et al., 1999).  Together, these studies 
show that molecular genetics are a powerful means to dissect not only the molecular basis 
but also the cellular basis underlying behaviors. 
Among all the defecation mutants isolated, we are particularly interested in aex 
mutants because the aex animal exhibits aBoc and Exp defects very similar to those of 
AVL- and DVB-GABAergic neuron-killed worms (Liu and Thomas, 1994; McIntire et 
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al., 1993b; Thomas, 1990).  This suggests that by studying these genes, we may be able 
to gain valuable insights into the molecular mechanisms that control GABAergic neuron 
activation during the defecation cycle.  The aex gene family consists of 6 members, from 
aex-1 to aex-6 (Thomas, 1990).  Prior to our studies, only aex-1, aex-3 and aex-6 have 
been cloned and studied in details, while the molecular identities and functions of aex-2, 
aex-4 and aex-5 remained unclear (although there are limited data on aex-5 showing it 
encodes a proprotein convertase).  The aex-1 gene encodes an exocytic factor that is 
homologous to MUNC-13 and evidence suggests it functions in the intestine to regulate 
enteric muscle contractions (i.e. Exp) during the defecation (Doi and Iwasaki, 2002).  In 
contrast, aex-3 and aex-6 encode a guanine exchange factor (GEF) and small GTPase 
RAB-27, respectively, and both are widely expressed in neurons (Iwasaki et al., 1997; 
Mahoney et al., 2006).  Genetic, biochemical and physiological analyses showed that 
AEX-3 acts as an AEX-6/RAB-27 GEF to activate AEX-6/RAB-27, and both proteins 
are required for the normal presynaptic transmission in the nervous system (Iwasaki et 
al., 1997; Mahoney et al., 2006).  Therefore, the studies on these aex genes support the 
notion that both intestines and neurons are involved in executing the defecation motor 
program.  Nevertheless, the signal(s) involved in the neuronal regulation and its 
receptor(s), if there is any, need to be identified.  This prompts us to study the 
uncharacterized or less well characterized aex genes aex-2, aex-4, and aex-5 to see how 
different aex genes may regulate the defecation behavior in a coordinated manner. 
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1.6. Overview of Chapter 2: Intestinal Signaling to GABAergic Neurons Regulates A 
Rhythmic Behavior in Caenorhabditis elegans 
In Chapter 2, we describe our work on aex-2, aex-4 and aex-5 genes and we 
present our model whereby intestinal aex genes regulate GABAergic neuron activation 
during the defecation by controlling the release of intestinal peptidergic signals.  Using 
molecular genetics and cell biology approaches, we demonstrate that aex-4 encodes an 
exocytic protein SNAP25 homologue and it is expressed and functions in the intestine.  
The proprotein convertase AEX-5 functions in the intestine, too; and when expressed in 
the intestine it is secreted into the pseudocoelom in an AEX-4-dependent manner.  
Moreover, we show that aex-2 encodes a G-protein coupled receptor (GPCR) and it is 
expressed and functions in GABAergic neurons to regulate the defecation behavior.  
Epistatic analysis reveals that aex-2 is genetically downstream of intestinal aex-4 and 
aex-5, and the stimulatory G! pathway relays the AEX-2 signal in GABAergic neurons.  
Together, our results provide evidence that the C. elegans intestine functions as an 
endocrine organ to regulate neuronal functions and behaviors. 
 
2. The Modulation of Neuronal Functions 
 
2.1. Neurons and Plasticity 
The nervous system probably is the system that experiences the most dramatic 
changes in morphologies and functions in an organism throughout its life: from massive 
synaptogenesis during early development to the learning and memory triggered synaptic 
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alterations in the adulthood.  To adapt to these changes and to ensure neurons constantly 
generate proper electric signals in response to environmental stimuli, neurons must 
develop mechanisms to stabilize their electric gains (Turrigiano and Nelson, 2000; 
Turrigiano and Nelson, 2004).  This cellular process is known as neural plasticity.  In 
general, the neural plasticity could lie in morphological changes or functional changes in 
the nervous system.  In following sections, I will mainly focus on the plasticity of 
neuronal functions and I will discuss the current understanding of molecules involved in 
modulating synaptic transmission in the nervous system. 
 
2.2. Local and Global Plasticity 
The plasticity that regulates synaptic strength could take place at different spatial 
scales, either locally or globally, and both play important roles in developing and adult 
nervous systems.  One of the extensively studied mechanisms of local plasticity is the 
Hebbian plasticity, where the pre- and postsynaptic partners that are activated together 
get wired together, while a non-correlated activation results in the synaptic depression 
(Fig 3A) (Bi and Poo, 2001; Turrigiano and Nelson, 2000).  In the developing nervous 
system, the Hebbian plasticity plays a fundamental role in shaping neuronal connections.  
This is especially important for higher animals such as mammals, as in these organisms 
the developing neurons frequently over-sprout and innervate incorrect targets (Bi and 
Poo, 2001).  Furthermore, the Hebbian plasticity also forms the basis for long-term 
potentiation (LTP) and long-term depression (LTD), suggesting it is likely involved in 
higher brain functions such as learning and memory (Bi and Poo, 2001).  Therefore, the 
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local plastic regulation of synaptic strength provides an important mechanism to 
selectively refine neural connections during the development and to encode synapse-
specific information in neural networks. 
In contrast to local plasticity, global plasticity involves the global modulation of a 
large number of synapses in neural networks.  One of the well-characterized global 
plastic mechanisms is the homeostatic plasticity, which was first described in neuronal 
cultures where neural activities are constantly elevated or dampened by drug treatments.  
Over prolonged time windows, the homeostatic mechanism scales neural activities in the 
opposite direction to that induced by the drug treatment, and it re-stabilizes the global 
neural firing rate (Fig 3B) (Turrigiano and Nelson, 2004).  Interestingly, careful 
physiological analysis disclosed that the strength of all excitatory synapses on a single 
neuron is modulated in a proportional manner, as the cumulative plot of AMPA type 
glutamate receptor mediated miniature excitatory postsynaptic currents (mEPSC) form a 
continuous shifted distribution (Fig 3B, 3C) (Turrigiano and Nelson, 2004).  These 
observations suggest that the global homeostatic plasticity is important for the nervous 
system development and functions in at least two ways: 1) It helps stabilize neuronal 
gains in specified neural networks.  During neural development, the rapid increase in 
synapse numbers and the selective facilitation of stronger connections by the Hebbian 
plasticity potentially de-stabilize the nervous system.  With the homeostatic mechanism, 
neurons are able to globally scale their synaptic strength in proper directions to 
compensate the change in neuronal gains brought by the synaptogenesis and local 
wirings, ensuring they are in the optimal range to respond to stimuli inputs; 2) It 
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preserves the synaptic codes introduced by the Hebbian plasticity.  With the 
multiplicative scaling during the homeostatic plasticity, neurons are able to maintain the 
differences in synaptic strength that are introduced by the Hebbian mechanism, thus 
making the information storage at synapses possible (Turrigiano and Nelson, 2004). 
To summarize, the nervous system adopts both local and global plastic 
mechanisms to modulate neuronal functions.  While local plasticity (like the Hebbian 
plasticity) selectively shapes synaptic strength and is likely involved in information 
coding, global plasticity (such as the homeostatic plasticity) acts to maintain system 
stability in neural networks.  It is worth noting that people have identified new forms of 
synaptic plasticity in recent years, including synapse-specific homeostatic plasticity and 
anti-homeostatic plasticity in both cultured and physiologically relevant neuronal 
preparations (Carrasco et al., 2007; Kim and Tsien, 2008; Moulder et al., 2006).  
Nevertheless, in terms of local and global mechanisms, based on our understandings so 
far the Hebbian and homeostatic plasticity probably represents two essential and best-
characterized forms of plasticity in the nervous system. 
 
2.3. Molecules Involved in Synaptic Plasticity 
A great variety of molecules have been identified in the past decade to play roles 
in modulating synaptic functions, from voltage-gated ion channels (Beck and Yaari, 
2008; Catterall and Few, 2008; Wang, 2008), ionotropic and metabotropic 
neurotransmitter receptors (Cho and Bashir, 2002; Malinow and Malenka, 2002; 
Turrigiano, 2008), scaffolding proteins (Renner et al., 2008), signaling enzymes (such as 
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kinases and ubiquitin ligases) (Cho and Bashir, 2002; Schwartz, 2003; Wang, 2008), 
transcription factors (Alberini, 2009), to proteins involved in transcriptional and 
translational regulation (Alberini, 2009; Richter and Klann, 2009).  Among them, 
membrane bound molecules and secretory molecules are two types of molecules of great 
interest.  This is mainly because they are able to act non-cell-autonomously on 
neighboring synaptic partners or distant cells to modulate their functions (Fig 4).  In 
addition, since their expressions / secretions are frequently dependent on synaptic 
activities (as discussed below), they provide an important feedback mechanism to 
modulate synaptic strength in both developing and adult nervous systems (Tao and Poo, 
2001).  In following sections, I will briefly review examples of cell adhesion molecules 
as well as secretory molecules that are extensively studied and are established for their 
roles in synaptic plasticity. 
 
2.3.1. Cell Adhesion Molecules in Synaptic Modulations 
2.3.1.1. Cadherins 
Cadherins are a class of cell adhesion molecules that is composed of over 80 
members and is divided into several subfamilies (Yagi and Takeichi, 2000).  The 
extensively studied ‘classic’ cadherins, including N- (neural) and E- (epithelial) 
cadherins, are one of the subclasses that share a common molecular structure including 5 
extracellular tandem repeats, a single transmembrane domain, and a cytoplasmic tail 
(Yagi and Takeichi, 2000).  Cadherins are able to form homophilic complexes in a Ca
2+
 
dependent manner.  In the developing nervous system, N- and E-cadherins are initially 
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diffusely expressed at synapses, whereas in mature synapses they become clustered at 
transmitter-release zones (such as peri-active regions) at apposed synaptic sides (Elste 
and Benson, 2006; Rubio et al., 2005; Uchida et al., 1996).  This suggests that cadherins 
may be involved in modulating synaptic properties, like synaptic plasticity. 
In line with this hypothesis, a collection of studies showed that cadherins are 
involved in modulating synaptic functions and plasticity.  Interestingly, cadherins likely 
function as sensors of synaptic activity, and several lines of evidence suggest that 
cadherins modulate synaptic plasticity through trans-synaptic signaling (Arikkath and 
Reichardt, 2008; Gottmann, 2008; Tai et al., 2008).  The extracellular adhesion domains 
of cadherins bind Ca
2+
 and adopt different conformations based on extracellular Ca
2+
 
concentrations (Boggon et al., 2002; Heupel et al., 2008; Pertz et al., 1999).  At high Ca
2+
 
levels, the adhesive ectodomains form a rigid rod-like structure that is required for trans- 
(on opposite cells) or cis- (on the same cell) cadherin adhesions, whereas low Ca
2+
 
concentrations loosen up adhesive domains and dissociate cadherin dimers (Heupel et al., 
2008; Pertz et al., 1999).  In cultured hippocampal neurons, disrupting N- or E-cadherin 
function by blocking peptides blocks the induction of long-term potentiation (LTP) (Tang 
et al., 1998).  Interestingly, blocking peptides interfere with LTP only when neurons are 
repeatedly depolarized and the extracellular Ca
2+
 is lowered (and presumably cadherins 
are open for peptide binding), while supplementing blocking peptides at resting state or 
after LTP is established has no effects (Tang et al., 1998).  This suggests that cadherins 
are dynamically regulated by synaptic activity, and this may underlie their contributions 
to synaptic plasticity.  Further analyses revealed that cadherins modulate synaptic 
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functions by a trans-synaptic mechanism.  In rat hippocampal cultures and at fly 
neuromuscular junctions, the overexpression or knockout of "-catenin, a cytoplasmic 
signaling protein that interacts with cadherins, at postsynapses induces morphological 
and functional changes in presynaptic sides (Li et al., 2008; Murase et al., 2002).  
Moreover, when the postsynapse is deprived of N-cadherin by using either RNAi-
mediated gene silencing or using an N-cadherin-knockout mice embryonic-stem-cell-
derived neuron line, defects are observed in presynaptic neurotransmissions (Jungling et 
al., 2006; Saglietti et al., 2007).  Together, these observations strongly suggest that 
cadherins modulate synaptic functions and plasticity, and they function through a trans-
synaptic mechanism that is probably mediated through trans-interactions between 
cadherins on apposing synapses. 
N- and E-cadherins probably represent the best-characterized cadherin molecules 
in the cadherin superfamily.  In the nervous system, central neurons also express other 
types of cadherins, while their functional roles in modulating synaptic functions and 
plasticity are less extensively explored (Arikkath and Reichardt, 2008).  As currently 
much is still unknown about the signaling components downstream of cadherins, in the 
near future the focus will be to elucidate the molecular mechanisms underlying cadherin-
mediated changes in synaptic plasticity. 
 
2.3.1.2. Neurexins / Neuroligins 
Neurexins and neuroligins are types of Ca
2+
 dependent cell adhesion molecules.  
In mammals, there are three neurexin genes and at least three (humans have five) 
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neuroligin genes, and both molecular families possess an extracellular domain of varying 
length, a single transmembrane domain, and a single cytoplasmic tail followed by a 
protein-protein interaction PDZ domain-binding site at the C-terminus (Craig and Kang, 
2007; Dalva et al., 2007).  Although limited in numbers of genes, neurexins and 
neuroligins have their transcripts under intensive splicing processing, resulting in a 
surprisingly large number of splice isoforms that may help generate cell specificity for 
their functions (Ichtchenko et al., 1996; Ullrich et al., 1995).  Both neurexins and 
neuroligins are highly enriched in the central nervous system (Ichtchenko et al., 1995; 
Ichtchenko et al., 1996; Ullrich et al., 1995).  Antibody labeling reveals that neurexins 
localize to the presynaptic terminus, consistent with its roles in !-latrotoxin (a component 
in the black widow spider venom) binding and the toxin-induced massive 
neurotransmitter release (Dean et al., 2003; Graf et al., 2004; Ushkaryov et al., 1992).  In 
contrast, neuroligins interact with a battery of postsynaptic density proteins, and 
neuroligin-1 and -2 localize specifically to the excitatory and inhibitory postsynapses, 
respectively (Craig and Kang, 2007; Graf et al., 2004; Song et al., 1999; Varoqueaux et 
al., 2004).  This indicates that neurexins and neuroligins may regulate synaptic 
development and function through trans-synaptic interactions. 
So far, the function of neurexins and neuroligins in synapse formation and 
structure regulation has been extensively studied (Craig and Kang, 2007; Dalva et al., 
2007).  Intriguingly, emerging evidence suggested that neurexins and neuroligins could 
also modulate synaptic functions and plasticity in mature neurons (Gottmann, 2008; 
Huang and Scheiffele, 2008).  In cultured hippocampal slices, overexpressing neuroligin-
 17 
1 in excitatory postsynapses induces alterations in vesicle release probability and short-
term plasticity at presynaptic sides (Futai et al., 2007).  This effect is likely mediated 
through trans-synaptic interactions between neuroligins and neurexins, as blocking 
neurexin functions in the presynapse by a dominant-negative form of neurexin induces 
decreases in the release probability similar to that induced by postsynaptic 
downregulation of neuroligin-1 (Futai et al., 2007).  In addition, overexpression of 
neuroligin-2 at hippocampal inhibitory postsynapses selectively enhances the amplitude 
of miniature inhibitory postsynaptic currents (mIPSC), and this effect appears to depend 
on synaptic activities as the pharmacological blockade of network firing eliminates this 
phenomenon (Chubykin et al., 2007).  Currently, it remains largely unknown how 
neurexins and neuroligins may modulate synaptic transmissions through trans-synaptic 
signaling, and people are actively exploring their downstream molecules.  It would be 
interesting to examine the molecular mechanisms that underlie the neurexin-neuroligin 
mediated synaptic plasticity and see if synaptic activity plays a role in this process. 
 
2.3.1.3. NCAM 
Neural cell adhesion molecule (NCAM) is a member of the immunoglobulin (Ig) 
superfamily that contains variable numbers of extracellular globular cysteine-looped 
domains (Vaughn and Bjorkman, 1996).  In mammals, a single NCAM gene encodes 
three alternatively spliced NCAM isoforms, and they contain five IgG domains as well as 
two fibronectin III (FNIII) domains in the extracellular region, followed by a single 
membrane-spanning region and isoform specific cytoplasmic tails (Cunningham et al., 
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1987; Vaughn and Bjorkman, 1996).  In the developing nervous system, NCAM 
expression is localized to synaptic regions (Aaron and Chesselet, 1989; Szele et al., 1994; 
Uryu et al., 1999).  Overexpressing NCAM in cultured neurons induces preferable 
formation of synapses in transfected cells, and similar phenomenon is observed in wild-
type neurons co-cultured with NCAM
-/-
 cells (Dityatev et al., 2000; Dityatev et al., 2004).  
Thus NCAM likely possesses synaptogenic activities in early developing neurons. 
Other than its role in early synapse development, a number of studies disclosed 
that NCAM actively participates in modulating synaptic functions (Bisaz et al., 2009; 
Dalva et al., 2007).  One well-characterized role of NCAM in synaptic plasticity is its 
involvement in the induction of long-term potentiation (LTP).  Applying antibodies or 
synthetic peptides that block NCAM mediated adhesion blocks LTP formation in 
hippocampal CA1 regions, while the basal transmissions remain unaltered (Luthl et al., 
1994; Ronn et al., 1995).  Consistent with the observations, deletion of NCAM in NCAM 
knockout mice results in impaired LTP induction in hippocampal CA1 and CA3 regions 
(Cremer et al., 1998; Muller et al., 2000).  Interestingly, the modulation of NCAM in 
experimental animals triggers a series of behavioral changes including cognitive 
impairment and emotional alterations (Bisaz et al., 2009).  This suggests that an 
appropriate NCAM level in the nervous system is required for maintaining normal 
behaviors. 
The NCAM molecule undergoes a post-translational modification known as 
polysialylation, with chains of polysialic-acid (PSA) being attached to its glycosol groups 
(Finne et al., 1983).  This is probably the most important modification identified for 
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NCAM, as many lines of evidence suggest that PSA-NCAM is responsible for numerous 
NCAM-mediated effects on synaptic functions (Bisaz et al., 2009; Dalva et al., 2007).  
For example, blocking antibodies that inhibit PSA function or enzymes that remove PSA 
from PSA-NCAM prevent LTP and LTD formation in hippocampus (Becker et al., 1996; 
Muller et al., 1996).  Moreover, when polysialyltransferase, the enzyme that adds PSA to 
NCAM, is deleted, hippocampal regions in knockout mice show specific loss of PSA-
NCAM expressions and both LTP and LTD (but not basal transmissions) are impaired 
(Eckhardt et al., 2000).  As PSA weakens homo- and heterophilic NCAM interactions 
(Rutishauser, 1996), one possible mechanism that may underlie PSA’s function is that 
PSA weakens NCAM mediated synaptic adhesions to allow plastic modifications.  The 
clarification of signaling events that lie downstream of PSA-NCAM mediated synaptic 
plasticity will be the future’s focus. 
 
2.3.1.4. Eph Receptors / Ephrins 
Eph receptors comprise by far the largest known receptor tyrosine kinase (RTK) 
family, with 9 EphA and 5 EphB members identified so far (Flanagan and 
Vanderhaeghen, 1998; Klein, 2009).  All Eph receptors are single membrane-spanning 
molecules, which contain an extracellular region that bares cysteine-rich and fibronectin 
III domains and an intracellular tail that bares the protein tyrosine kinase domain 
(Flanagan and Vanderhaeghen, 1998).  Like Eph receptors, ephrins are all membrane-
associated, while they are classified into A and B subtypes based on the presence of 
either a glycosylphosphatidylinositol (GPI) moiety (ephrinA) or a single transmembrane 
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domain (ephrinB) (Flanagan and Vanderhaeghen, 1998; Klein, 2009).  All Eph receptors 
preferably bind to ephrins of their own class (A to A, B to B), whereas EphA4 serves as 
an exception to bind both ephrinA and ephrinB subclasses (Flanagan and Vanderhaeghen, 
1998).  The high expression level of Eph receptors and ephrins in the developing nervous 
system as well as their localization at the synapse is consistent with their functions in 
synapse development (Buchert et al., 1999; Dalva et al., 2000; Torres et al., 1998). 
One noticeable feature of Ephs and ephrins is their ability to initiate bidirectional 
signaling upon the receptor-ligand binding by triggering signaling events such as tyrosine 
phosphorylation on both cytoplasmic tails (Kullander and Klein, 2002).  In the 
developing nervous system, extensive studies have established functional roles of the 
bidirectional signaling in axon pathfinding, cell boundary formation, and synaptogenesis, 
and multiple lines of evidence suggested that such signaling also underlies the Eph-ephrin 
mediated modulation of synaptic plasticity in mature neurons (Dalva et al., 2007; Klein, 
2009; Kullander and Klein, 2002).  One of the well-studied examples is the hippocampal 
mossy fiber-CA3 connection, where both EphB2 and ephrinB ligands are highly enriched 
at synapses (Armstrong et al., 2006; Grunwald et al., 2001).  When blocking peptides and 
soluble ephrinBs are used to disrupt the postsynaptic EphB2-PDZ protein interactions 
and the cross-synaptic EphB2-ephrinB interactions, respectively, the induction of LTP in 
the presynaptic mossy fibers is prevented (Contractor et al., 2002).  Interestingly, 
removing the cytoplasmic tail from ephrinBs blocks LTP formation in the same region, 
indicating that postsynaptic EphB receptors regulate synaptic plasticity through a 
presynaptic signaling cascade that is dependent on ephrinB cytoplasmic tails (Armstrong 
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et al., 2006).  Similar involvements of Eph and ephrins in synaptic plasticity have also 
been documented in hippocampal CA1 regions, whereas in CA1 ephrinBs act in the 
postsynapse rather than in the presynapse to modulate the plasticity (Grunwald et al., 
2004).  Together, these studies strongly support that Ephs and ephrins play important 
roles during the plastic modulation of synaptic functions, and they likely mediate the 
modulation through a trans-synaptic mechanism.  A careful examination of the molecular 
pathways downstream of the bidirectional Eph-ephrin signaling will shed light onto the 
molecular mechanisms that underlie the trans-synaptic plasticity. 
 
2.3.2. Secreted Molecules in Synaptic Modulations 
2.3.2.1. Neurotrophins 
Neurotrophins are a family of secreted proteins that were originally identified for 
their functions in supporting nerve growth.  The mammals encode at least four 
neurotrophins in the genome, including the founding member nerve growth factor (NGF), 
brain-derived neurotrophic factor (BDNF), neurotrophin-3 (NT-3), and neurotrophin-4/5 
(NT-4/5) (Lewin and Barde, 1996).  In cells, neurotrophins are synthesized as precursors, 
and they are processed by proteolytic cleavage before being secreted as dimers (Lewin 
and Barde, 1996; Seidah et al., 1996).  The expression of neurotrophins is not only 
widely detected in the nervous system, but also in targets of innervating peripheral 
neurons, suggesting a broad impact neurotrophins have on developing nervous systems 
(Lewin and Barde, 1996; Snider, 1994). 
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The involvement of neurotrophins in modulating synaptic functions was first 
proposed by the neurotrophin hypothesis, which states that neurotrophins participate in 
activity-induced modification of synaptic transmissions (Schinder and Poo, 2000).  
Indeed, extensive studies revealed that the expression of neurotrophins in mature neurons 
is regulated by neuronal activities.  In cultured rat hippocampal slices, repeated activation 
of neurons upregulates mRNA levels for both NGF and BDNF, whereas blocking the 
network electric activity by drug treatment or GABA neuron stimulation decreases NGF 
and BDNF transcripts (Ernfors et al., 1991; Gall and Isackson, 1989; Zafra et al., 1991; 
Zafra et al., 1990).  In addition, depolarization triggers the release of BDNF from 
cultured neurons, suggesting BDNF is secreted in an activity-dependent manner (Mowla 
et al., 1999).  The role of neurotrophins in synaptic plasticity is subsequently 
demonstrated by a series of LTP studies in hippocampus.  During LTP induction in 
cultured hippocampal slices, the removal of endogenous BDNF by antibodies or soluble 
TrkB-IgG (TrkB is the BDNF receptor and binds BDNF) impairs LTP formation (Chen 
et al., 1999; Figurov et al., 1996; Kang et al., 1997).  This is supported by genetic studies 
where the deletion of BDNF gene results in disrupted LTP in hippocampus (Korte et al., 
1995; Patterson et al., 1996).  Interestingly, BDNF appears to act as a retrograde trans-
synaptic signal, as its functions on LTP induction are mediated through presynaptic, but 
not postsynaptic, TrkB receptors (Li et al., 1998; Xu et al., 2000).  These studies, together 
with the work on the direct enhancement of presynaptic transmissions by neurotrophins, 
provided a strong support for the neurotrophin hypothesis (Schinder and Poo, 2000).  It 
will be interesting to determine if neurotrophins play a more instructive or a more 
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permissive role in synaptic plasticity by examining their downstream signaling 
components. 
 
2.3.2.2. Nitric Oxide 
Nitric oxide (NO) belongs to a group of membrane permeable molecules that 
include nitric monoxide (NO), carbon monoxide (CO), arachidonic acid (AA), and 
platelet-activating factor (PAF) whose roles in synaptic plasticity has been established or 
suggested by a number of studies (Fitzsimonds and Poo, 1998; Hawkins et al., 1998).  In 
mammals, NO is synthesized from L-arginine by three different NO synthase isoforms 
(i.e. neuronal nNOS, endothelial eNOS, and inducible iNOS), and in the nervous system 
several lines of evidence suggest that NO is released from synthesizing neurons in an 
activity-dependent manner (Dawson and Snyder, 1994; Tao and Poo, 2001).  For 
example, in cerebellar cells, activating NMDA-type glutamate receptors induces a Ca
2+
-
dependent release of NO (Garthwaite et al., 1988; Garthwaite et al., 1989).  In a more 
recent study, antibody staining reveals the localization of nNOS in the postsynaptic 
cytoplasm of excitatory auditory synapses, and the stimulation of neuronal activity elicits 
NO release (Steinert et al., 2008).  The role of NO in modulating synaptic functions has 
been demonstrated by a collection of studies, and the experiments on the hippocampal 
LTP are of the most interest, as these studies strongly suggest NO modulates synaptic 
plasticity through a retrograde mechanism.  In hippocampal cultures, bath application of 
NO scavenger hemoglobin blocks LTP formation in the CA1 region (O'Dell et al., 1991; 
Schuman and Madison, 1991).  The NO generated during LTP appears to be released 
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from postsynapses, as the extracellular application of oxymyoglobin (another NO 
scavenger) inhibits the LTP induction in cultures that are postsynaptically injected with 
NO donors, while it fails to block LTP when NO donors are supplied presynaptically 
(Arancio et al., 1996).  Interestingly, injecting nNOS inhibitors into postsynapses 
specifically prevents LTP, suggesting NO is synthesized in postsynaptic cells and is 
released as a retrograde messenger to modulate presynapses during LTP induction 
(Arancio et al., 1996; O'Dell et al., 1991; Schuman and Madison, 1991).  Together, with 
other studies on CO, AA, and PAF (Fitzsimonds and Poo, 1998), these observations 
strongly suggest that the nervous system utilizes small membrane permeable molecules to 
modulate synaptic functions. 
 
2.3.2.3. Other Diffusible Molecules Involved in Synaptic Modulations 
So far, all the molecules discussed have established or suggested roles in long-
term synaptic plasticity (i.e. LTP / LTD), which is of special interest to neuroscientists as 
LTP / LTD is thought to underlie the information coding process during learning and 
memory.  Nevertheless, synaptic transmission is a delicate cellular process that is under 
precise spatial and temporal regulation.  This means that synaptic modulations require the 
functions of a complex of proteins, which include, but are not limited to, the molecular 
families discussed above.  There are examples of other diffusible factors that are involved 
in modulating synaptic transmissions, including endocannabinoids (Harkany et al., 2008), 
small nucleotides (Barnstable et al., 2004; Pankratov et al., 2009), lipids (Yang and Chen, 
2008), and unexpectedly, reactive oxygen species (ROS) (Kamsler and Segal, 2004).  
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With the fast progressions of scientific researches today, it will not be surprising to see 
more molecular players in the modulation of synaptic transmissions and higher brain 
functions in the near future. 
 
2.4. Open Questions and Hormonal Signaling 
Although great progress has been made in the past decade, many questions still 
remain unanswered in the field of synaptic modulations.  One interesting question that 
needs to be elucidated is: what are the molecules that globally modulate synaptic 
functions?  As discussed earlier, the nervous system has local plasticity and global 
plasticity, both of which need to be tightly regulated.  Within the two types of trans-
synaptic signals discussed, cell adhesion molecules are able to induce non-cell 
autonomous changes in neighboring synapses, thus transmitting information to other 
neurons (Fig 4).  However, due to their associations with the plasma membrane, their 
actions are limited to local neural connections.  Secretory molecules, on the other hand, 
are diffusible in nature and can signal to more distant cells from the releasing site (Fig 4).  
However, as synaptically secreted molecules are often not at high concentrations under 
physiological conditions, and as the extracellular matrix (ECM) frequently immobilizes 
molecules after their secretion, the molecules secreted from a population of neurons are 
unlikely to act on a global scale to affect the whole neural network.  Therefore, the 
nervous system must have adopted other mechanisms to realize the global modulation. 
Three mechanisms, including experience-based stimuli (which activate 
coordinated neural networks), intracellular signaling (such as intracellular Ca
2+
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signaling), and hormonal signaling (which is often carried by the circulation system), are 
likely involved, as all three can transmit signals across a large number of synapses.  
Interestingly, recent studies on several non-neuronal derived hormonal factors suggest 
they likely play roles in modulating synaptic functions and plasticity in central neurons 
(McNay, 2007; Moult and Harvey, 2008).  For example, the adipose cell derived 
hormonal factor leptin is able to cross the blood brain barrier, and the expression of leptin 
receptors is detected in many brain regions including hippocampus (Moult and Harvey, 
2008).  Deleting leptin receptor gene in knockout mice impairs hippocampal LTP and 
LTD induction, whereas supplying leptin to hippocampal slice cultures and live animals 
facilitates LTP formation and memory retention in learning-related tasks (Farr et al., 
2006; Li et al., 2002; Oomura et al., 2006).  Similarly, the 6KD hormone insulin that is 
mainly synthesized in and secreted from pancreatic "-cells can also cross the blood brain 
barrier, and it modulates hippocampal long-term plasticity by acting on insulin receptors, 
whose expressions in many brain regions have been well-characterized (McNay, 2007; 
Moult and Harvey, 2008).  One prominent feature of hormonal signaling mediated by 
circulating hormonal factors is their potential ability to globally modulate nervous system 
functions.  In addition, as many hormonal factors are synthesized in non-neuronal tissues, 
their signaling provides an important approach by which central neurons and peripheral 
tissues can communicate.  This has been well demonstrated by the modulatory effects of 
leptin and insulin on animal behaviors (McNay, 2007; Moult and Harvey, 2008).  In the 
future, the identification of other synaptic modulating hormonal factors will provide 
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additional insights into the nervous system function and its ability to maintain 
homeostasis through plastic modulations. 
 
2.5. The C. elegans Intestine As An Endocrine Organ 
In C. elegans, the intestine serves as an important organ to regulate multiple 
biological processes such as food digestion, defecation, stress response, and host-
pathogen interactions (McGhee, 2007).  Composed of polarized epithelial cells, the 
intestine is involved in intensive cross-membrane trafficking, and a number of exocytic 
and endocytic factors have been shown expressed and functioning in the intestine (Fig 5) 
(Chen et al., 2006; Doi and Iwasaki, 2002; Mahoney et al., 2006; Parker et al., 2009; 
Yamashita et al., 2009).  Interestingly, several recent observations suggest that the 
intestine may secret signals to modulate neuronal functions.  For example, during 
rhythmic defecation cycles, a Ca
2+
 wave is initiated near the posterior end of the intestine 
and it propagates through the intestine (Dal Santo et al., 1999; Teramoto and Iwasaki, 
2006).  Blocking the Ca
2+
 oscillation in the intestine by drugs or by disrupting an 
intestinal gap junction not only prevents the execution of subsequent neuron-controlled 
muscle contractions, but also leads to phenotypes indicative of altered synaptic 
transmissions (Peters et al., 2007; Teramoto and Iwasaki, 2006).  Thus, the C. elegans 
intestine may function as an endocrine organ (the organ that secretes hormonal factors) to 
modulate synaptic functions.  It would be interesting to identify such intestine-derived 
signals, and if there are any, the characterization of their downstream signaling 
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mechanisms will shed light onto our understanding of neuronal plasticity as well as the 
interactions between neurons and non-neuronal tissues in multicellular organisms. 
 
2.6. Overview of Chapter 3: Intestine-Derived Signals Regulate Synaptic Transmissions 
in Caenorhabditis elegans 
In Chapter 3, I present the identification of an intestinal signaling system that 
regulates cholinergic neurotransmissions in the C. elegans.  C. elegans utilizes 
acetylcholine as a neurotransmitter at its neuromuscular junctions (NMJs) to control 
muscle contractions and locomotion-related behaviors.  Using molecular genetics, 
pharmacological, and physiological approaches, we show that the proprotein convertase 
AEX-5 is required in the intestine to maintain normal cholinergic transmissions in the 
nematode.  In addition, we find that the GPCR AEX-2 functions in the GABAergic 
neurons to maintain cholinergic transmission level, and the stimulatory G! pathway is 
genetically downstream of AEX-2.  Interestingly, we find that although both the 
defecation motor program and the cholinergic transmission modulation involve intestinal 
signals and neuronal G-protein pathways, they depend on different downstream 
molecules: while the defecation requires GABA to activate the enteric muscle 
contraction, the modulation of cholinergic transmissions partially depends on 
neuropeptide processing enzymes EGL-3 and EGL-21.  As GABAergic neurons do not 
directly synapse on cholinergic neurons in C. elegans, we speculate that the peptide 
signals act in a hormonal manner on cholinergic neurons.  This suggests that the C. 
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elegans intestine could function as an endocrine organ to control rhythmic behaviors as 
well as to modulate neuronal functions. 
 
3. Synapse Development and Overview of Chapter 4: A Homolog of the LIM Domain 
Focal Adhesion Protein ZYX-1 Regulates Synaptic Development in C. elegans 
Besides the studies on the modulations of behaviors and neuronal functions in C. 
elegans, I have also briefly examined the molecular mechanisms that control synaptic 
development.  As a continuation of Dr. Schaefer’s project on the molecular genetic 
analysis of synaptogenesis in the lab (Schaefer, 2001), I have focused on the early 
development of the C. elegans mechanosensory nervous system.  In Chapter 4, I present 
the preliminary evidence from my work on mechanosensory PLM synapses that supports 
a role of the LIM domain focal adhesion molecule ZYX-1 in the PLM synapse 
development.  We cloned the zyx-1 allele and demonstrated that ZYX-1 is widely 
expressed in neurons and non-neuronal tissues such as muscles and spermatheca.  Using 
time-course imaging analysis of fluorescence labeled PLM neurons, we show that zyx-1 
mutants are able to form synapses during early development, while they fail to maintain 
the synapse to adulthood.  In addition, we demonstrate that ZYX-1 acts cell-
autonomously in mechanosensory neurons to regulate PLM synapse maintenance.  I 
expect the identification of additional molecular players involved in the ZYX-1 signaling 
will shed light onto our understanding of synapse development and the maintenance of 
neuronal functions in mature nervous systems. 
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Figures and figure legends 
Figure 1.  Multiple tissues are involved in regulating the C. elegans defecation behavior.  
A) The C. elegans defecation motor program (DMP) consists of three temporally 
coordinated muscle contractions.  In the schematic diagram, the worm head is to the left, 
and the tail is to the right.  The intestine and the intestinal lumen are labeled in grey and 
black, respectively.  Arrowheads denote GABAergic neurons AVL and DVB that control 
defecation cycles (see text).  In feeding animals, the DMP starts with posterior body-wall 
muscle contractions (pBoc) that push intestinal contents anteriorly.  Around 2-3 seconds 
later, anterior body-wall muscles contract (aBoc), pressurizing intestinal contents at the 
anus region at the posterior intestine.  This is followed almost immediately by enteric 
muscle contractions (EMC) that open the anus and allow the pressurized intestinal 
contents being expulsed from the intestine (Exp).  The whole cycle repeats itself with 
little variance in about 45 seconds.  B) GABAergic neurons AVL and DVB are required 
for the execution of DMP.  The C. elegans GABAergic system consists of 26 GABAergic 
neurons, with GABAergic motor neurons shown in blue, and AVL and DVB shown in 
red.  The magnified view of the posterior intestine shows the axons of DVB and AVL 
(red) and enteric muscles (grey) that control the expulsion.  The neurotransmitter GABA 
excites enteric muscles, which leads to muscle contractions and expulsion (see text).  C) 
The rhythmic intestinal Ca
2+
 oscillations are required for the execution of DMP.  In the 
C. elegans intestine, the timing of calcium spikes (orange) in posterior and anterior 
intestines correlates well with that of pBoc and aBoc, and the disruption of Ca
2+
 wave 
propagation in the intestine eliminates aBoc and expulsion. 
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Figure 1.  Multiple tissues are involved in regulating the C. elegans defecation behavior. 
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Figure 2.  Multiple genes are involved in regulating the C. elegans defecation behavior.  
The mutagenesis screen that looked for altered defecation behaviors in C. elegans has 
identified 5 classes of genes that regulate different steps of DMP.  They are: pbo (for the 
regulation of pBoc), abo (for the regulation of aBoc), exp (for the regulation of 
expulsion), aex (for the regulation of aBoc and Exp), and dec (for the defecation cycle 
abnormal).  The aex mutants share a similar defecation phenotype as the AVL- and DVB-
GABAergic-neuron-killed animals, suggesting a possible link between aex genes and 
GABAergic neuron functions. 
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Figure 3.  Local and global plasticity in the nervous system.  A) The schematic diagram 
showing the Hebbian plasticity that locally modulates neuronal functions.  The dendrites 
and axons are drawn on the apical and basal sides of neurons, respectively, and the 
strength of synaptic connections is represented by the thickness of lines.  Thicker lines 
denote stronger connections.  The insets show the timing of spikes in pre- and 
postsynaptic neurons.  Correlated firings in pre- and postsynaptic compartments 
strengthen the synaptic connections, while non-correlated firings weaken the synaptic 
strength.  B) The schematic diagram showing the global regulation of synaptic strength in 
neuronal cultures where neuronal activities are chronically enhanced or suppressed by 
drug treatments.  Chronic enhancement of neural activities leads to global decrease in the 
amplitudes of miniature excitatory postsynaptic currents (mEPSC), while long-term 
suppression increases mEPSC amplitudes.  One of the possible mechanisms that underlie 
the global synaptic modulation is the regulation of AMPA receptor levels on postsynaptic 
sides, which is depicted in C). 
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Figure 3.  Local and global plasticity in the nervous system. 
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Figure 4.  Trans-synaptic signals and hormonal factors are involved in modulating 
synapse strength in the nervous system.  The schematic diagram shows three types of 
synaptic signals that can modulate synaptic functions through a trans-synaptic 
mechanism: 1) neurotransmitters, which are released from presynaptic terminals and 
function on postsynapses; 2) cell adhesion molecules, which can be expressed on both 
pre- and postsynaptic compartments and regulate synaptic functions from both sides, and 
3) secretory molecules, which can be released from both pre- and postsynaptic 
compartments in an activity-dependent manner, and they can also act on both pre- and 
postsynapses to modulate synaptic functions.  Other than those synaptically generated 
signals, a fourth class of molecules, hormonal factors, can modulate synaptic functions 
from a distance.  Either neurons or non-neuronal cells are able to produce hormonal 
factors, which are released from synthesizing cells and transported by the circulation 
system to their target cells.  This is different from the local regulation by synaptically 
produced signals, and we refer this as endocrine regulation. 
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Figure 4.  Trans-synaptic signals and hormonal factors are involved in modulating 
synapse strength in the nervous system. 
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Figure 5.  The C. elegans intestine is a tube-like organ made up of interconnected single-
layer epithelial cells.  The cells int1 through int9 form the main part of the intestine.  
Anterior to int1, the pharyngeal-intestinal valve cells vpi1 through vpi3 connect int1 to 
the posterior pharyngeal muscle m8.  Posterior to int9, the intestinal-rectal valve cell vir 
connects int9 to the rectal epithelial cells rep through hyp7.  The intestinal lumen runs 
through the middle of the intestinal cells and connects posterior pharynx with anus.  The 
Z2 and Z3 denote germ line cells. 
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Behavior in C. elegans 
 56 
Intestinal Signaling to GABAergic Neurons Regulates a Rhythmic Behavior in C. 
elegans 
Classification: Biological Sciences - Neuroscience 
Timothy R. Mahoney
*†
, Shuo Luo
*†
, Elaine K. Round
‡
, Martin Brauner
§
, Alexander 
Gottschalk
§
, James H. Thomas
‡
, Michael L. Nonet
†¶
 
*
 T.R.M. and S.L. contributed equally to this work 
†
 Department of Anatomy and Neurobiology, Washington University School of 
Medicine, St. Louis, MO 63110 
‡
 Department of Genome Sciences, University of Washington, Seattle, Washington 98195 
§
 Institute for Biochemistry, Department of Biochemistry, Chemistry and Pharmacy, 
Goethe-University Frankfurt, Frankfurt, Germany, D-60439 
¶
 To whom correspondence should be addressed 
Mail:  
Michael L. Nonet 
Department of Anatomy and Neurobiology 
Campus Box 8108 
Washington University School of Medicine  
660 South Euclid Ave  
St. Louis, MO 63110  
Phone: 314-747-1176 
Fax: 314-362-3446 
E-mail:  nonetm@pcg.wustl.edu 
 57 
Abbreviations: DMP: defecation motor program, pBoc: posterior body wall muscle 
contraction, aBoc: anterior body wall muscle contractions, Exp: expulsion, aex: aBoc and 
expulsion defective 
 58 
Abstract 
 The C. elegans defecation motor program (DMP) is a highly coordinated 
rhythmic behavior that requires two GABAergic neurons that synapse onto the enteric 
muscles.  One class of DMP mutants, called aex mutants, exhibits similar defects to those 
caused by the loss of these two neurons.  Here we demonstrate that aex-2 encodes a G-
protein coupled receptor (GPCR) and aex-4 encodes an exocytic SNAP25 homolog.  We 
found that aex-2 functions in the nervous system and activates a Gs! signaling pathway 
to regulate defecation.  aex-4, on the other hand, functions in the intestinal epithelial 
cells.  Furthermore, we show that aex-5, which encodes a pro-protein convertase, 
functions in the intestine to regulate the DMP, and its secretion from the intestine is 
impaired in aex-4 mutants.  Activation of the Gs! GPCR pathway in GABAergic neurons 
can suppress the defecation defect of the intestinal mutants aex-4 and aex-5.  Lastly, we 
demonstrate that activation of GABAergic neurons using the light-gated cation channel 
channelrhodopsin-2 (ChR2) is sufficient to suppress the behavioral defects of aex-2, -4, 
and -5.  These results genetically place intestinal genes aex-4 and aex-5 upstream of 
GABAergic GPCR signaling.  We propose a model whereby the intestinal genes, aex-4 
and aex-5, control the DMP by regulating the secretion of a signal, which activates the 
neuronal receptor aex-2. 
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Introduction 
 The C. elegans defecation motor program (DMP) is a highly coordinated series of 
three muscle contractions that are executed every 45 seconds (Fig. 1A and SI Movie 1).  
The cycle is initiated by a posterior body wall muscle contraction (pBoc), followed 2-3 
seconds later by an anterior body wall muscle contraction (aBoc).  About 1 second after 
the aBoc, enteric muscles contract, thus causing the expulsion of intestinal contents 
(Exp).  Approximately 45 seconds later the process repeats itself with little variability in 
the timing of contractions (Thomas 1990).  A genetic screen for mutants that displayed 
defects in the DMP isolated mutants defective in each of the three muscle contractions, 
known as pbo, abo, and exp (Thomas 1990).  The screen also recovered mutants 
defective in the last two muscle contractions (aBoc and Exp, aex), and mutants defective 
in the cycle periodicity (i.e., longer or shorter than normal DMP cycling times, dec) 
(Thomas 1990).  Molecular studies of these mutants have suggested the behavior is 
orchestrated through the communication between the intestine, GABAergic neurons and 
muscle. 
 The periodicity of the DMP is regulated by the C. elegans intestine, a single-cell 
layer tube of polarized epithelial cells joined by gap junctions (McGhee 2007; Peters, 
Teramoto et al. 2007).  Intestinal Ca
2+
 oscillations with approximately 45-second 
periodicity appear to play a central role in this timing. They consist of a posterior to 
anterior Ca
2+
 wave whose levels peak in the posterior and anterior intestinal cells just 
prior to the pBoc and aBoc contractions, respectively (Dal Santo, Logan et al. 1999; 
Teramoto and Iwasaki 2006; Peters, Teramoto et al. 2007).  Mutations in genes involved 
 60 
in the maintenance of Ca
2+
 oscillations or in the propagation of Ca
2+
 waves between cells 
affect the periodicity of the DMP (Dal Santo, Logan et al. 1999; Teramoto and Iwasaki 
2006; Peters, Teramoto et al. 2007).  These studies suggest that the intestine may control 
the timing of the DMP via Ca
2+
 dependent process, such as Ca
2+
 induced exocytosis. 
Furthermore, Recent work demonstrates that the intestine induces the pBoc by 
releasing protons (through a Na
+
/H
+
 exchanger) onto posterior body wall muscle cells 
(Beg, Ernstrom et al. 2008).  The posterior body wall muscle cells contract in response to 
the change in pH because they express a proton-gated cation channel (Beg, Ernstrom et 
al. 2008). By contrast, the expulsion step of the DMP is regulated by the GABAergic 
neurons AVL and DVB
|| 
(McIntire, Jorgensen et al. 1993; Liu and Thomas 1994).  These 
neurons secret GABA onto enteric muscles that express the excitatory GABA receptor 
EXP-1 and cause them to contract (Beg and Jorgensen 2003). 
 If the intestine is the cycle timer and initiates the pBoc step, and neurons initiate 
the Exp step, then how are the intestinal and neuronal mediated behaviors synchronized? 
It seems likely that studies of aex genes will give some insight into how the AVL and 
DVB neurons are activated, since the behavioral defects of aex mutants are reminiscent 
of animals whose AVL and DVB GABAergic neurons are laser ablated (McIntire, 
Jorgensen et al. 1993; Liu and Thomas 1994).  aex-3 and aex-6 regulate synaptic 
transmission, probably by regulating exocytosis of neurotransmitter: aex-3 is a guanine 
nucleotide exchange factor that regulates Rab small GTPase function, and aex-6 (also 
known as rab-27) is a Rab small GTPase that regulates secretory vesicle exocytosis 
(Iwasaki, Staunton et al. 1997; Mahoney, Liu et al. 2006).  aex-5 encodes a pro-protein 
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convertase, an enzyme that is co-packaged with pro-peptides and processes them to make 
mature secretory molecules (Doi and Iwasaki 2002; Husson, Clynen et al. 2006).  Lastly, 
Doi and Iwasaki (Doi and Iwasaki 2002) demonstrated that aex-1 is a distant homolog of 
the synaptic gene unc-13 (or Munc13) which acts in the intestine to regulate the DMP 
(Doi and Iwasaki 2002).  Thus, prior molecular characterization of aex genes implicates a 
secretory event is in control of aBoc and Exp. 
Here we uncover how the intestinal cells regulate the activity of GABAergic 
neuronal function during the DMP.  We cloned aex-4, which encodes a SNAP25 SNARE 
homolog, and aex-2, which encodes a G-protein coupled receptor (GPCR).  We 
demonstrate that while aex-4 and aex-5 act in the intestine to regulate defecation, aex-2 
functions in GABAergic neurons to control this behavior.  Disruption of aex-4 function 
blocks AEX-5 secretion from the intestine.  Moreover, GABAergic expression of either 
activated adenylyl cyclase or photoactivatable channelrhodopsin rescues the defecation 
defects of aex-2, aex-4 and -5.  We propose a model where intestinal aex genes, aex-4 
and aex-5, regulate secretion of a signal that activates the GPCR aex-2 in AVL and DVB, 
which in turn activates these neurons to complete the DMP. 
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Results 
aex mutants are primarily defective in expulsion and only mildly defective in aBoc 
 In order to better understand how the DMP operates, we carefully characterized 
the defecation defects of each of the aex mutants.  aex mutants are primarily defective in 
the expulsion step (SI Fig. 1 and 2).  Surprisingly, aex mutants have only slightly fewer 
aBoc contractions per defecation cycle than wild type; however, those aBoc contractions 
are usually significantly later in the cycle than in a wild-type DMP (SI Fig. 1 and 2).  
Therefore, the aBoc defects of most aex mutants are relatively mild when compared to 
the expulsion defects.  Most aex mutants have a relatively normal cycle length (or 
period), although aex-5 did exhibit a slightly longer defecation cycle period (SI Fig. 1).  
The normal cycle periodicity suggests these mutants do not have a defect in cycle time 
generation.  Taken together, these results suggest aex mutants are primarily defective in 
the expulsion step. 
aex-4 encodes a SNARE Protein 
 We predicted aex-4 would encode a protein involved in exocytosis, neuropeptide 
production, or neuropeptide signaling, since all other aex strains have mutations in genes 
regulating these pathways (Iwasaki, Staunton et al. 1997; Thacker and Rose 2000; Doi 
and Iwasaki 2002).  By searching the genomic interval in which aex-4 had been mapped 
(Thomas 1990), we identified a candidate gene for the aex-4 locus.  All aex-4 alleles 
sequenced have mutations in the gene T14G12.2, and a 4kb genomic clone of this gene is 
sufficient to rescue the defecation defect of aex-4 (SI Fig. 3 and 4A).  T14G12.2 encodes 
a homolog of the SNARE (soluble N-ethylmaleimide sensitive factor attachment 
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receptor) protein SNAP25 (SI Fig. 3)(Bock, Matern et al. 2001; Kloepper, Kienle et al. 
2007).  These findings implicate aex-4 in exocytosis. 
AEX-4 Regulates the Defecation Motor Program from the Intestine 
 To dissect how AEX-4 regulates defecation behavior, we first determined the 
expression pattern of aex-4 by building a transgenic animal that expresses GFP fused to a 
nuclear localization signal under the aex-4 promoter.  Surprisingly, aex-4 expresses only 
in intestinal cells (Fig. 1B).  To determine the subcellular localization of AEX-4, we built 
a transgene expressing a functional GFP-tagged AEX-4 fusion under its native promoter.  
GFP–tagged AEX-4 localizes along the plasma membrane of intestinal cells (Fig. 1C and 
D).  Therefore, AEX-4 likely acts at the surface of intestinal cells to regulate the DMP. 
We expressed the aex-4 gene under an intestinal, a muscle, and a neuronal 
specific promoter to determine in what tissue aex-4 regulates the DMP.  Intestinal 
expression of aex-4 fully rescues the defecation defects of aex-4 mutant animals (Fig. 2A 
and SI Fig. 4B and C), while muscle and neuronal specific promoters only partially 
rescue the defecation defect of aex-4 mutants (Fig. 2A).   
To verify our tissue specific rescue experiments, we tested whether RNAi of aex-
4 in a strain that is only sensitive to RNAi in the intestine would result in a defecation 
defect (Espelt, Estevez et al. 2005).  Indeed, intestinal-specific RNAi of aex-4 results in a 
strong expulsion defect consistent with aex-4 functioning in the intestine (Fig. 2C).  In 
addition to aex-4, RNAi of aex-5 and aex-6 in the intestinal-specific RNAi strain causes a 
strong expulsion defect.  RNAi of aex-3 causes a moderate expulsion defect similar to 
that of the aex-3 loss of function (SI Fig. 1).  These results are consistent with aex-3, -4, -
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5, and -6 functioning in the intestine.  RNAi of aex-1, in contrast, causes only a mild 
defect in expulsion, although tissue specific rescue experiments suggest aex-1 functions 
in the intestine (Doi and Iwasaki 2002).  We suspect that aex-1 levels were not reduced 
enough in the intestinal-specific RNAi strain since RNAi of aex-1 in wild type strains 
causes a strong expulsion defect (data not shown).  Combined together, these results 
strongly suggest that a cohort of exocytic aex genes including aex-4 all function in the 
intestine to regulate the DMP. 
AEX-5 Regulates the Defecation Motor Program from the Intestine 
aex-5 encodes a pro-protein convertase and was identified in the same screen that 
isolated aex-4 (Thomas 1990; Doi and Iwasaki 2002; Husson, Clynen et al. 2006).  We 
confirmed that the pro-protein convertase gene is mutated in aex-5(sa23) by sequencing 
(lesion is C453W) and by genomic fosmid rescue (SI Fig. 4A).  Since aex-4 likely 
regulates secretion of a signal from the intestine, and pro-protein convertases are 
typically packaged into secretory vesicles (Thacker and Rose 2000), we wished to 
determine whether AEX-5 is secreted from the intestine.  Intestinal specific expression of 
AEX-5 fused to VENUS, a variant of GFP (Nagai, Ibata et al. 2002), fully rescues the 
defecation defects of aex-5 mutant animals, while muscle and neuronal specific 
expression only partially rescues (Fig. 2A and SI Fig. 4B and C).  AEX-5::VENUS is 
secreted from the intestine and subsequently endocytosed by coelomocytes, specialized 
endocytic cells in C. elegans (Fig. 1E-F).  These findings suggest AEX-5 is secreted from 
the intestine where it regulates the DMP. 
AEX-4 Regulates the Secretion of AEX-5 from the Intestine 
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We hypothesized that AEX-4 regulates the secretion of AEX-5 from the intestine.  
To test this, we determined if aex-4 mutants are defective in AEX-5::VENUS secretion.  
Wild type animals that express AEX-5::VENUS in the intestine secrete AEX-5::VENUS, 
which accumulates in coelomocytes.  In contrast, aex-4 mutants accumulate AEX-
5::VENUS in intestinal cells and accumulate significantly less AEX-5::VENUS in 
coelomocytes (Fig. 3 and SI Fig. 5).  There is no defect in the secretion of AEX-
5::VENUS in wild type or aex-2 mutants.  Therefore, AEX-4 likely regulates the 
secretion of AEX-5 from the intestine during the DMP.  These results lead us to the 
question: what receives this signal? 
aex-2 Encodes a G-Protein Coupled Receptor 
We mapped aex-2 to a region on the X chromosome and revealed the gene 
T14B1.2 encodes aex-2.  All sequenced aex-2 alleles have mutations in T14B1.2, and a 
transgene that contains the T14B1.2 gene rescues the aex-2 mutant phenotype (SI Fig. 4A 
and 6).  T14B1.2 encodes a protein that shares homology with the A class of G-protein 
coupled receptors (GPCR), some of which mediate peptide signaling (SI Fig. 6) (Gether 
2000).  When expressing a mCherry tagged aex-2 genomic fusion construct (which fully 
rescues the aex-2 defecation defects), we detected AEX-2::mCherry signal in the nerve 
ring, ventral nerve cord, and in the enteric muscles (Fig. 1G-I).  So unlike aex-4, which is 
exclusively expressed in the intestine, aex-2 is expressed in both neuronal and non-
neuronal tissues. 
aex-2 Regulates the Defecation Motor Program from the Nervous System 
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To determine what tissue aex-2 functions in, we expressed an aex-2 cDNA::GFP 
fusion under a neuronal, a muscular, and an intestinal promoter.  While neuronal 
expression of AEX-2::GFP fully rescues the defecation defects of aex-2 mutants, 
muscular and intestinal aex-2 do not (Fig. 2A).  Consistent with this observation, 
intestinal specific RNAi of aex-2 does not cause a robust defecation defect (Fig. 2C).  
Thus unlike aex-4 and -5, aex-2 acts in neurons to regulate the DMP. 
As previous studies have indicated that the GABAergic neurons AVL and DVB 
are required for expulsion (McIntire, Jorgensen et al. 1993), we analyzed aex-2’s 
expression pattern in various neuronal subtypes.  We co-expressed mCherry protein 
under the aex-2 promoter with the GFP under either an unc-17 (drives expression in 
cholinergic neurons), a glr-1 (drives expression in subsets of interneurons), or an unc-47 
(drives expression in GABAergic neurons) promoter to assess if any of the aex-2 positive 
neurons are co-labeled by these neuronal subtype specific markers.  We found that the 
aex-2 reporter is detected in all three neuronal cell types (Fig. 1J-L and SI Fig. 7).  
Briefly, at least one glutamatergic interneuron (likely AVD), several head and pharyngeal 
cholinergic neurons, and two GABAergic neurons (AVL and DVB) express mCherry 
under the control of the aex-2 promoter (Fig. 1J-L and SI Fig. 7).  None of the ventral 
nerve cord motor neurons (neither cholinergic nor GABAergic) are labeled by Paex-
2::mCherry.  Therefore, aex-2 is expressed in the defecation regulating GABAergic 
neurons (AVL and DVB) as well as other types of non-motor neurons. 
In order to determine which neuronal subtype aex-2 functions in, we expressed an 
aex-2::GFP cDNA fusion under neuronal subtype specific promoters.  GABAergic 
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expression of aex-2 significantly rescues the expulsion defect and partially rescues the 
aBoc defect of aex-2 mutants, while the other two promoters do not (Fig. 2B and SI Fig. 
4B and C).  Taken together, these results suggest that aex-2 acts in GABAergic neurons 
(i.e., AVL and DVB) to control the expulsion, and perhaps the aBoc. 
aex-2 Functions Through the Gsa and Adenylyl Cyclase Signaling Pathway 
As aex-2 encodes a GPCR, we examined which Ga subunit might act downstream 
of the aex-2 receptor signaling.  To determine this, we genetically tested a variety of 
candidate G! subunits for their ability to suppress aex-2 mutant phenotype.  We built 
double mutants between an aex-2 loss-of-function mutant and a gsa-1 (Gs!) gain-of-
function mutant (Schade, Reynolds et al. 2005), and an egl-30 (Gq!) gain-of-function 
mutant (Jansen, Thijssen et al. 1999; Lackner, Nurrish et al. 1999; Miller, Emerson et al. 
1999).  We also built an aex-2 and dgk-1 (which encodes a diacylglycerol kinase) double 
loss-of-function mutant, as dgk-1 normally antagonizes egl-30 signaling and its loss-of-
function phenocopies egl-30 gain-of-function (Jansen, Thijssen et al. 1999; Lackner, 
Nurrish et al. 1999; Miller, Emerson et al. 1999).  Gsa gain-of-function mutation causes 
ectopic expulsion in both wild type and aex-2 mutant animals, and it suppresses the 
expulsion defect in aex-2 mutants (Fig. 4A).  On the other hand, the Gqa pathway mutants 
do not have a strong effect on the aex-2 phenotype (Fig. 4A).  Interestingly, gain-of-
function in gsa-1 does not rescue the aBoc defect (SI Fig. 4B and C).  The irregular 
timing of expulsions in gsa-1 mutants (i.e., some expulsions do not occur at the proper 
time, which is 3 seconds after pBoc) may account for the lack of rescue of aBoc in aex-2 
mutants.  To assess if the Gs! rescue is specifically mediated by GABAergic neurons, we 
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tested whether the GABAergic expression of a gain-of-function adenylyl cyclase (acy-1) 
(Saifee 2003), a downstream effector of Gsa, would suppress the defecation defects in 
aex-2 mutants.  Similar to the gsa-1 gain-of-function mutant, over expression of a gain-
of-function acy-1 gene in aex-2 mutants causes ectopic expulsions, and this expression 
significantly rescues the expulsion defects in aex-2 mutants (Fig. 4A).  Taken together, 
these results support a model where the aex-2 GPCR acts in GABAergic neurons to 
regulate the DMP via a downstream Gsa and adenylyl cyclase pathway. 
Neuronal Adenylyl Cyclase Acts Downstream of AEX-4 and AEX-5 to Control 
Defecation 
 While aex-2 acts in AVL and DVB GABAergic neurons, aex-4 and aex-5 
function in the intestine to regulate expulsion.  We wished to determine if aex-2 signaling 
acts downstream of intestinal aex-4 and aex-5.  Since we have not identified the ligand 
for AEX-2, we asked whether gain-of-function mutations in the aex-2 pathway could 
suppress the aex-4 and aex-5 expulsion defects.  GABAergic expression of the gain-of-
function acy-1 gene is sufficient to rescue the expulsion defects seen in aex-4 and aex-5 
mutants (Fig. 4A).  As seen in aex-2 mutants, over expression of gain-of-function acy-1 
in aex-4 and aex-5 mutants also causes ectopic expulsions.  These data suggest that 
GABAergic signaling of aex-2 acts downstream of intestinal signaling of aex-4 and aex-
5. 
Activation of GABAergic Neurons by a Light-Activatable Channel can Bypass the 
Requirement of AEX-2, AEX-4, and AEX-5 for Defecation 
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 We wished to demonstrate that the role of aex-2, aex-4, and aex-5 is to 
specifically activate GABAergic neurons controlling the Exp step.  We used 
channelrhodopsin-2 (ChR2) under a GABAergic promoter to bypass the loss of these aex 
genes.  ChR2, from the green alga Chlamydomonas reinhardtii, is a light-activatable non-
selective cation channel that in the presence of all-trans-retinal will depolarize excitable 
cells (Nagel, Brauner et al. 2005).  We hypothesized that the activation of GABAergic 
neurons using the ChR2 transgene would suppress the behavioral defect of each of the 
aex mutants.  Indeed, activation of ChR2 in GABAergic neurons by brief (~1 second) 
pulses of blue-light ~2 seconds after pBoc is sufficient to completely rescue the expulsion 
defects of aex-2, aex-4, and aex-5 mutants (Fig. 4B and SI Movie 2).  These results 
strongly suggest that aex-2, aex-4, and aex-5 regulate the activity of GABAergic neurons 
AVL and DVB to induce expulsion during the DMP. 
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Discussion 
Several lines of evidence suggest a group of exocytic genes function in the C. 
elegans intestine to control secretion of a signal to regulate the aBoc and expulsion step 
of the DMP.  aex-1, aex-3, aex-4, and aex-6 are each homologous to the genes that 
regulate exocytosis in secretory cells (Doi and Iwasaki 2002; Mahoney, Liu et al. 2006).  
Here we present data that these genes regulate the secretion of a signal from the intestine 
to induce aBoc and expulsion.  This model is further supported by the observation that 
aex-4 mutants prevent the secretion of an intestinal AEX-5::VENUS into the 
pseudocoelom and its subsequent endocytosis by coelomocytes.  Therefore, aex-4 (and 
likely aex-1, aex-3, and aex-6) regulates the secretion of AEX-5, and arguably its 
substrate, from the intestine.  Although our data indicate aex-3 and aex-6 function in 
intestine, it does not exclude the possibility that these genes also function in AVL and 
DVB to regulate the DMP (see SI Fig. 8 for model). 
 The model that the intestine secretes a signal to regulate expulsion prompted us to 
search for the receptor for the signal.  aex-2 encodes a putative GPCR, and our data 
suggest this receptor likely functions in AVL and DVB GABAergic neurons to regulate 
expulsion.  Interestingly, when using either a gain-of-function Gsa or an activated 
adenylyl cyclase that is expressed in GABAergic neurons, we suppressed the expulsion 
defect not only in aex-2, but also in the intestinal aex-4 and aex-5 mutants.  These results 
are consistent with aex-2 encoding the receptor of the intestinal signal and acting 
downstream of intestinal aex genes. 
We speculate that the Gsa and adenylyl cyclase act downstream of aex-2 to excite 
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AVL and DVB during the expulsion.  In support of this model, some gsa-1 loss-of-
function animals, with a mosaic rescuing transgene, were reported to exhibit a defecation 
defect (Korswagen, Park et al. 1997).  We also observe a robust defect in the Exp step in 
these animals (11+/-3%, p<0.0005).  In contrast, acy-1 loss-of-function mutants, with a 
rescuing transgene expressing in muscle (Reynolds, Schade et al. 2005), do not have a 
significant defect in the Exp step (81+/-7%, p>0.05).  This may be due to redundancy of 
the 3 other adenylyl cyclase genes in C. elegans (Bastiani and Mendel 2006) and/or the 
action of other gsa-1 effectors. 
Activation of ChR2 in GABAergic neurons is sufficient to suppress the expulsion 
defects of aex-2, aex-4, and aex-5 mutants.  The aBoc defect of these aex mutants, 
however, was not rescued.  Activation of GABAergic ChR2 causes the worm to become 
paralyzed due to muscle relaxation; therefore it may be difficult to observe the aBoc 
contractions under these conditions.  These findings indicate that the aex genes likely act 
to activate AVL and DVB GABAergic neurons through aex-2. 
Although aex-2 is likely involved in AVL and DVB activation, it remains unclear 
how aex-2 is activated.  As aex-5 encodes a pro-protein convertase and aex-5 mutants are 
defective in neuropeptide production (Husson, Clynen et al. 2006), we suspect aex-2 
encodes a neuropeptide-like receptor.  There are approximately 100 genes in the C. 
elegans genome encoding over 250 peptides (Nathoo, Moeller et al. 2001; Husson, 
Clynen et al. 2005).  The identification of aex-2 ligand(s) will shed new light on our 
understanding of this GPCR’s signaling and the regulation of neuronal functions by non-
neuronal tissues.  
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Several of our observations suggest the expulsion step may be regulated by more 
than one signal.  First, we noticed that activation of ChR2 in either wild type or aex 
mutant animals does not induce ectopic expulsions.   Only temporally correct light-
activation of AVL and DVB rescues the Exp defect of aex-2, -4, and -5.  This observation 
indicates that activation of AVL and DVB (at least via ChR2) is permissive, but not 
completely instructive, to drive the Exp step of the DMP.  Second, while constitutive 
activation of the Gs! pathway causes ectopic expulsions in aex mutants, there is a strong 
tendency for Exp’s to occur at the proper time (~3 seconds after pBoc).  If aex genes 
were the sole connection between the intestinal pacemaker and activation of expulsion, 
then one would expect to see a weaker tendency for Exp’s to occur at the proper time.  
These observations suggest that a second signal may function to regulate the Exp step.  
This signal could, for example, consist of a permissive signal that allows enteric muscles 
to be excited at the right time point in the DMP.  
 Upon first glance, one cannot help notice the similarities between the intestinal 
aex genes and the neuronal secretory apparatus.  SNARE proteins (AEX-4) are thought to 
create a membrane fusion structure at the nerve terminal, with SNARE regulators (AEX-
1) playing a critical role in exocytosis (Sudhof 2004).  Although the precise function of 
Rabs (AEX-6) in exocytosis per se is unclear, they play an important role in synaptic 
transmission (Mahoney, Liu et al. 2006).  Interestingly, while the regulator for AEX-6, 
AEX-3, has a similar defecation phenotype when mutated, the effector of AEX-6, RBF-1, 
does not (Mahoney, Liu et al. 2006).  Perhaps AEX-6, also known as Rab27, functions 
through a novel effector to regulate the DMP.  Given the similarities between the genes 
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involved in the DMP and those involved in synaptic transmission, the C. elegans intestine 
could be seen as an alternative means for investigating the mechanisms governing 
regulated exocytosis and by analogy synaptic transmission.  When one adds on the 
observation that RNAi is highly ineffective in C. elegans neurons (Winston, 
Molodowitch et al. 2002), but very effective in the intestine (Espelt, Estevez et al. 2005), 
the intestine becomes an attractive model for discovering genes and genetic pathways 
regulating exocytosis. 
Our work shows that the intestine may secrete a signal to activate the AVL and 
DVB neurons to induce the DMP (SI Fig. 8).  This might explain why the Ca
2+
 
oscillations are necessary for the timing of the DMP, since excitable cells use increased 
Ca
2+
 to induce secretion.  Our work provides the first explanation of how the intestine 
may regulate this behavior by activating the AVL and DVB neurons. 
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Materials and Methods 
 Refer to SI Text for Materials and Methods 
Behavioral Assay 
For detailed methods refer to SI Text for Materials and Methods.  Briefly, 8-20 
one-day-old adults were scored for 10 defecation cycles (i.e., 10 pBocs).  Statistical 
significance was determined by using unpaired two-tailed student t tests, with unequal 
variance. 
Channelrhodopsin-2 Experiments 
For detailed methods refer to SI Text for Materials and Methods.  Briefly, L4 
larval staged animals were grown in the presence or absence of 500µM all-trans retinal 
(Sigma) overnight at 22°C.  The next day, defecation was scored.  During the DMP 
animals were stimulated with a brief, ~1 second pulse of blue light, ~2 seconds after 
pBoc.  These experiments were performed on a Leica MZ16F fluorescent 
stereomicroscope with an x-Cite 120 excitation light source (EXFO) and a standard GFP 
filter.
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Footnotes 
|| AVL and DVB are not abbreviations; they are the actual names of two specific 
GABAergic neurons in C. elegans (White, Southgate et al. 1986). 
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Figure Legends 
Fig. 1.  aex genes are expressed in both neuronal and non-neuronal tissues of C. elegans.  
(A) Diagram of the C. elegans defecation motor program (DMP).  First, a posterior 
contraction (pBoc) forces the intestinal contents to the anterior end of the worm.  About 3 
seconds later, an anterior contraction (aBoc) forces intestinal contents to the posterior 
end.  Within about 1 second of the aBoc, an enteric muscle contraction in the tail leads to 
excretion of intestinal contents (expulsion).  Arrowheads indicate the location of AVL 
and DVB GABAergic neurons.  (B-D) aex-4 is expressed in the intestine.  (B) GFP 
detected solely in the intestinal nuclei in a transgenic animal that expresses nuclear 
localized GFP under the aex-4 promoter.  (C, D) A functional AEX-4::GFP fusion is 
expressed in intestinal cells and enriched at the cell surface (arrows) (red, auto-
fluorescence).  (C) A confocal slice through the middle of the intestine.  (D) Cell surface 
view of the posterior intestinal cell.  Bright field images are provided for orientation  (E, 
F) Intestinal AEX-5::VENUS (which is driven by the intestinal promoter Pvha-6) is 
secreted from the intestine and taken up by coelomocytes (CC, arrows; red, auto-
fluorescence).  (G-L”) aex-2 is expressed in the GABAergic neurons AVL and DVB as 
well as in enteric muscles.  (G, I) AEX-2::mCherry is detected in the nerve ring (NR, 
arrow), ciliary sensory processes (CA, open arrow), nerve cord (I), and head mesodermal 
cell (HMC, arrow head).  (H) AEX-2::mCherry is expressed in the intestinal muscle (IM, 
arrow) and anal depressor (AD, arrowhead).  (J-L”) mCherry expressed under the aex-2 
promoter is detected in both AVL (J, K, L, arrow) and DVB (J’, K’, L’, arrow) 
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GABAergic neurons.  AEX-2::mCherry signal does not significantly overlap with 
GABAergic GFP in the ventral Nerve cord (J”-L”).  Scale bar, 20µm. 
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Fig. 1.  aex genes are expressed in both neuronal and non-neuronal tissues of C. elegans. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 84 
Fig. 2.  aex-4 and aex-5 function in the intestine, while aex-2 acts in GABAergic neurons 
to regulate defecation.  (A) A neuronal (Prab-3), a muscular (Pmyo-3) and an intestinal 
(Pges-1 or Pvha-6) promoter was used to drive the expression of individual aex genes.  
Intestinal aex-4 and aex-5 fully rescue the aex-4 and aex-5 expulsion defect, respectively, 
and neuronal aex-2 rescues the aex-2 expulsion defect.  Muscular and neuronal 
expressions of aex-4 and aex-5 only partially rescue the aex-4 and aex-5 expulsion defect.  
(B) Punc-47 (GABAergic neurons), but not Punc-17 (cholinergic neurons) or Pglr-1 
(subset of interneurons) expression of aex-2 rescues the aex-2 expulsion defect.  DMP 
function was assayed by observation of 8-20 animals for 10 cycles and plotted as the ratio 
of expulsions to pBocs.  *p<0.05, **p<0.005, ***p<0.0005 significantly different from 
the respective mutant.  +p>0.05 not significantly different from wild type.  (C) Intestinal 
RNAi of aex-4, aex-5, and aex-6 induces strong expulsion defects.  RNAi of aex-3 
induces a moderate defecation defect, while the RNAi on aex-1 and aex-2 induces only 
mild defecation defects.  *p<0.05, **p<0.005, ***p<0.0005 significantly different from 
the vector control RNAi.  Error bars represent standard error of the mean (SEM). 
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Fig. 2.  aex-4 and aex-5 function in the intestine, while aex-2 acts in GABAergic neurons 
to regulate defecation. 
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Fig. 3.  Intestinal aex-4 regulates the secretion of AEX-5.  (A) In aex-4 mutants, the total 
fluorescence, normalized to wild type, of intestinal AEX-5::VENUS in coelomocytes is 
significantly less than wild type.  There is no significant change in coelomocyte 
fluorescence in aex-2 mutants.  ***p<0.0005 significantly different from the respective 
mutant.  +p>0.05 not significantly different from wild type.  Error bars represent SEM. 
(B) Representative photographs of anterior coelomocytes in wild type, aex-2, and aex-4.  
Left image is a Nomarski image.  Right is AEX-5::VENUS fluorescence.  Scale bar, 
5µm. 
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Fig. 3.  Intestinal aex-4 regulates the secretion of AEX-5. 
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Fig. 4.  aex genes likely regulate the defecation through downstream G!s and adenylyl 
cyclase signaling and GABAergic neuron activation.  (A) A gain-of-function allele of G!s 
(gsa-1(ce81)) completely suppresses the expulsion defects in aex-2 mutants.  In contrast, 
a gain-of-function in G!q (egl-30(js126)) and a loss-of-function dgk-1(sy428), which 
phenocopies egl-30 gain-of-function, have only mild effects on the aex-2 expulsion 
defects.  When an activated adenylyl cyclase gene (acy-1(js127)) is specifically expressed 
in the GABAergic neurons, it significantly suppresses the expulsion defects of aex-2, 
aex-4 and aex-5 mutants.  (B) Activation of GABAergic neurons by photoactivatable 
channelrhodopsin-2 (ChR2) suppresses the expulsion defects in aex mutants.  The 
photoactivatable cation channel ChR2 was expressed specifically in GABAergic neurons 
under the Punc-47 promoter in aex-2, aex-4 and aex-5 mutants.  In the presence of all-
trans retinal and blue light activation, the ChR2 fully suppresses the expulsion defects in 
all the aex mutants.  In contrast, in the absence of either all-trans retinal or blue light, the 
ChR2 transgene does not rescue the defecation mutant phenotypes to wild type levels.  
*p<0.05, **p<0.005, ***p<0.0005 significantly different from the respective mutant.  
+p>0.05 not significantly different from wild type.  Error bars represent SEM. 
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Fig. 4.  aex genes likely regulate the defecation through downstream G!s and adenylyl 
cyclase signaling and GABAergic neuron activation. 
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SI Figure Legend 
SI Fig. 1.  aex mutants are primarily defective in expulsion while only mildly defective in 
aBoc.  (A) aex mutants are defective in expulsion.  (B) aex mutants do not have defective 
cycle time length, except for aex-5.  (C) aex mutants have a defect in aBoc frequency.  
(D) aex mutants have defects in the timing of aBoc.  *p<0.05, **p<0.005, ***p<0.0005 
significantly different from wild type.  Error bars represent SEM. 
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SI Fig. 1.  aex mutants are primarily defective in expulsion while only mildly defective in 
aBoc. 
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SI Fig. 2. Behavioral recordings of aex mutants.  Each dot (.) represents 1 second, while 
(p) indicates pBoc, (a) indicates aBoc, and (x) indicates expulsion.  Most aex mutants 
have regular cycle periodicity.  The primary defect is a decrease in the number of 
expulsions.  They also have a decrease in the number of aBoc contractions per cycle and 
have delayed timing of the aBoc contraction.  unc-25(e256) is a loss-of-function mutation 
in a gene required for GABA biosynthesis.  unc-25 mutants do not have a defect in aBoc, 
therefore aBoc is likely regulated by a GABA-independent process.  
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SI Fig. 2. Behavioral recordings of aex mutants. 
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SI Fig. 3.  aex-4 encodes a SNAP25 homolog.  Alignment of AEX-4 (T14G12.2) with 
SNAP25 shows 47% similarity and 15% identity with other SNAP25 genes.  There is 
46% similarity / 23% identity with drosophila SNAP24 (DmSNAP24) and 51% similarity 
/ 19% identity with RIC-4 C. elegans SNAP25 (CeSNAP25).  Mutations in various 
alleles used are indicated.  aex-4(sa22) contains a splice site mutation at S8.  aex-
4(ok614) (also called tag-81(ok614)) contains a deletion marked by a line from S43 past 
the end, which deletes part of a neighboring gene tag-18 (or T14G12.3).  aex-4(n2415) 
encodes a stop codon at E158. 
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SI Fig. 3.  aex-4 encodes a SNAP25 homolog. 
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SI Fig. 4.  Rescue of aex mutants with genomic and fluorescent protein tagged clones and 
rescue of aBoc defects with tissue specific constructs.  (A) AEX-2::mCherry  and AEX-
2::YPet  expressed under the aex-2 promoter are sufficient to rescue aex-2 expulsion 
defect.  A genomic clone of aex-4 and a fosmid containing the aex-5 gene are sufficient 
to rescue their respective mutant phenotypes.  AEX-4::GFP expressed under an aex-4 
promoter is sufficient to rescue aex-4 expulsion defect.  (B) Neuronal (Prab-3) 
expression of aex-2 rescues the decreased frequency of aBoc in aex-2 mutants.  Intestinal 
(Pges-1 or Pvha-6) expression of aex-4 and aex-5 rescues their respective mutants 
decrease in aBoc frequency.  GABAergic expression of aex-2 did not suppress this 
particular aBoc defect of aex-2 mutants  (C) The timing of aBoc is restored by neuronal 
(Prab-3)  or GABAergic (Punc-47) expression of aex-2 in aex-2 mutants.  The aBoc 
timing defects of aex-4 and aex-5 are rescued by intestinal (Pges-1 or Pvha-6) expression 
of these genes.  gsa-1 gain-of-function mutants do not suppress the aBoc defects of aex-2 
mutants (B and C).  *p<0.05, **p<0.005, ***p<0.0005 significantly different from the 
respective mutant.  +p>0.05 not significantly different from wild type.  Error bars 
represent SEM. 
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SI Fig. 4.  Rescue of aex mutants with genomic and fluorescent protein tagged clones and 
rescue of aBoc defects with tissue specific constructs. 
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SI Fig. 5. aex-4 mutants accumulate AEX-5::VENUS in the intestine.  (A) In aex-4 
mutants, the average fluorescence, normalized to aex-2, of intestinal AEX-5::VENUS is 
significantly greater than aex-2 mutants. *p<0.05 significantly different from aex-2. (B) 
Representative photographs of anterior intestinal cells of aex-2 and aex-4 expressing 
AEX-5::VENUS. Scale bar, 5µm. 
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SI Fig. 5. aex-4 mutants accumulate AEX-5::VENUS in the intestine. 
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SI Fig. 6.  aex-2 encodes a GPCR.  The transmembrane domains of AEX-2 (T14B1.2) 
are predicted by the free online tool SMART (http://smart.embl-heidelberg.de/) and 
marked by thick lines.  The changes in specific residues in various aex-2 alleles are 
indicated.  Light grey italic letters mark residues that are conserved in class A GPCRs.  
aex-2(sa21) encodes a stop codon at Y144, aex-2(sa1040) encodes a S174G mutation, 
and aex-2(sa3) encodes an R232Q mutation. 
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SI Fig. 6.  aex-2 encodes a GPCR. 
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SI Fig. 7.  aex-2 is likely expressed in subsets of glutamatergic and cholinergic neurons.  
Fluorescence images show transgenic animals that express (A-C”) mCherry and GLR-
1::GFP under the aex-2 and glutamate receptor glr-1 promoter, respectively, and (D-F”) 
mCherry and GFP under the aex-2 and vesicular acetylcholine transporter unc-17 
promoter, respectively.  The individual panel shows the fluorescence expression in (A-F) 
head ganglia, (A’-F’) tail ganglia, and (A”-F”) ventral nerve cord.  At least one 
glutamatergic interneuron, possibly AVD, and several cholinergic neurons in the head 
and pharynx are co-labeled by Paex-2::mCherry (arrow heads).  Scale bar, 20mm. 
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SI Fig. 7.  aex-2 is likely expressed in subsets of glutamatergic and cholinergic neurons. 
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SI Fig. 8. Model of intestinal to neuronal signaling in the defecation motor program.  
Diagrammed are the posterior and anterior intestinal regions in C. elegans showing the 
position of body wall muscle, enteric muscle, the intestine, and the AVL and DVB 
GABAergic motor neurons.  In the anterior and posterior intestine AEX-1, AEX-3, AEX-
4 and AEX-6 regulate the release of AEX-5 containing vesicles that we propose also 
release the AEX-2 ligand.  The ligand diffuses to activate AVL and DVB via activation 
of G!s !(GSA-1) and adenylyl cyclase (ACY-1) coupled to the GPCR AEX-2.  This in 
turn causes release of GABA onto enteric muscles that are activated via the excitatory 
GABA receptor EXP-1.  Activation of the enteric muscle results in expulsion of gut 
content via the anus. Not depicted are muscle arms of the enteric muscles that contact the 
presynaptic specializations of DVB and perhaps AVL.  The detailed anatomy of these 
structures is available at www.wormatlas.org. 
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SI Fig. 8. Model of Intestinal to neuronal signaling in the defecation motor program. 
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SI Movie 1.  Defecation Motor Program (DMP) movie.  The DMP is described in Fig. 
1A.  rbf-1(js232) was used because these animals move very little when unstimulated. 
 
SI Movie 2.  Activation of channelrhodopsin-2 by blue light suppresses expulsion defects 
in aex-5(sa23).  The first DMP is in the absence of light.  The animal has a clear pBoc 
with no expulsion in the first cycle.  In the subsequent defecation cycle, a brief pulse of 
blue-light following pBoc induces expulsion. 
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SI Materials and Methods 
Growth and Culture of C. elegans and General Methods 
 Caenorhabditis elegans were grown at 22.5°C as described (Wood 1988). 
Standard cloning and molecular biology methods were used, unless otherwise described 
(Sambrook and Russell 2001). 
Strains Used 
 N2(wild type) (Brenner 1974), acy-1(js127) (Saifee 2003), aex-1(sa9) (Thomas 
1990; Doi and Iwasaki 2002), aex-2(sa3) (Thomas 1990), aex-3(js815) (Iwasaki, 
Staunton et al. 1997; Mahoney, Liu et al. 2006), aex-4(n2415), aex-4(sa22), aex-
4(ok614), aex-5(sa23) (Thomas 1990), aex-6(sa24) (Thomas 1990; Mahoney, Liu et al. 
2006), lin-15(n765) zxEx51[Punc-47::chop-2(H134R)::yfp; lin-15
+
], unc-25(e156) (Jin, 
Jorgensen et al. 1999), rde-1(ne219); kbIs7[Pnhx-2::rde-1; rol-6] (Espelt, Estevez et al. 
2005), gsa-1(ce81) (Schade, Reynolds et al. 2005), dgk-1(sy428) (Nurrish, Segalat et al. 
1999; Miller and Rand 2000), egl-30(js126) (Saifee 2003), gsa-1(ce81); aex-2(sa3), dgk-
1(sy428); aex-2(sa3), egl-30(js126) ; aex-2(sa3), rbf-1(js232) (Staunton, Ganetzky et al. 
2001; Mahoney, Liu et al. 2006), unc-119(ed3); jsIs1072[NM2072 (Pvha-6::AEX-
5::VENUS CbUNC-119)], gsa-1(pk75); pkEx270[rol-6(su1006) gsa-1(+)](Korswagen, 
Park et al. 1997), and acy-1(pk1279); ceEx108(myo-3::acy-1) (Reynolds, Schade et al. 
2005). 
aex-4(n2415) jsEx904[NM1427(Paex-4::NLS::GFP) + pRF4(rol-6)], aex-
4(n2415) jsEx905[NM1471(genomic aex-4) + pRF4(rol-6) line1], aex-4(n2415) 
jsEx906[NM1471(genomic aex-4) + pRF4(rol-6) line2], aex-4(n2415) 
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jsEx960[NM1726(Pges-1::aex-4) + pRF4(rol-6) line1], aex-4(n2415) 
jsEx964[NM1726(Pges-1::aex-4) + pRF4(rol-6) line2], aex-4(n2415) 
jsEx961[NM1727(Pmyo-3::aex-4) + pRF4(rol-6) line1], aex-4(n2415) 
jsEx967[NM1727(Pmyo-3::aex-4) + pRF4(rol-6) line2], aex-4(n2415) 
jsEx969[NM1742(Prab-3::aex-4) + pRF4(rol-6) line1], aex-4(n2415) 
jsEx970[NM1742(Prab-3::aex-4) + pRF4(rol-6) line2], aex-4(n2415) 
jsEx987[NM1778(Punc-25::acy-1(js127)) + pRF4(rol-6) line1], aex-4(n2415) 
jsEx994[NM1778(Punc-25::acy-1(js127)) + pRF4(rol-6) line2], aex-4(n2415) 
jsEx1028[NM1609(Paex-4::GFP::aex-4) + pRF4(rol-6) line1], aex-4(n2415 
zxEx51[Punc-47::chop-2(H134R)::yfp; lin-15
+
], aex-4(n2415);  jsIs1072[NM2072 
(Pvha-6::AEX-5::VENUS CbUNC-119)] 
aex-5(sa23) jsEx1057 [WRM068bG11[aex-5 fosmid]; pPD118.25(plet-858::NLS-
GFP); pRF4(rol-6)], aex-5(sa23) jsEx1061[NM2059(Pvha-6::aex-5::VENUS) + 
pRF4(rol-6) line1], aex-5(sa23) jsEx1062[NM2059(Pvha-6::aex-5::VENUS) + 
pRF4(rol-6) line2], aex-5(sa23) jsEx1063[NM2061(Prab-3:: aex-5::VENUS) + 
pRF4(rol-6) line1], aex-5(sa23) jsEx1064[NM2061(Prab-3:: aex-5::VENUS) + 
pRF4(rol-6) line2], aex-5(sa23) jsEx1066[NM2062(Pmyo-3:: aex-5::VENUS) + 
pRF4(rol-6) line1], aex-5(sa23) jsEx1067[NM2062(Pmyo-3:: aex-5::VENUS) + 
pRF4(rol-6) line2], aex-5(sa23) jsEx987[NM1778(Punc-25::acy-1(js127)) + pRF4(rol-6) 
line1], aex-5(sa23) jsEx994[NM1778(Punc-25::acy-1(js127))  + pRF4(rol-6) line2], aex-
5(sa23) zxEx51[Punc-47::chop-2(H134R)::yfp; lin-15
+
], aex-5(sa23);  jsIs1072[NM2072 
(Pvha-6::AEX-5::VENUS CbUNC-119)] 
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aex-2(sa3) jsEx937[NM2099(Paex-2::aex-2::mCherry) + pPD118.33(Pmyo-
2::gfp) line1], aex-2(sa3) jsEx938[NM2099(Paex-2::aex-2::mCherry) + 
pPD118.33(Pmyo-2::gfp) line2], aex-2(sa3) jsEx924[NM2100(Paex-2::aex-2::YPet) + 
pPD118.33(Pmyo-2::gfp) line1], aex-2(sa3) jsEx921[NM2101(Prab-3::aex-2::gfp) + 
pPD118.33(Pmyo-2::gfp) line1], aex-2(sa3) jsEx922[NM2101(Prab-3::aex-2::gfp) + 
pPD118.33(Pmyo-2::gfp) line2], aex-2(sa3) jsEx925[NM2102(Pmyo-3::aex-2::yfp) + 
pPD118.33(Pmyo-2::gfp) line1], aex-2(sa3) jsEx928[NM2102(Pmyo-3::aex-2::yfp) + 
pPD118.33 (Pmyo-2::gfp) line2], aex-2(sa3) jsEx929[NM2103(Pges-1::aex-2::gfp) + 
pPD118.33(Pmyo-2::gfp) line1], aex-2(sa3) jsEx930[NM2103(Pges-1::aex-2::gfp) + 
pPD118.33(Pmyo-2::gfp) line2], nuIs25[Pglr-1::glr-1::gfp] jsEx976[NM1736(Paex-
2::mCherry) line1], oxIs12[Punc-47::gfp] jsEx978[NM1736(Paex-2::mCherry) line1], 
mdIs135[Punc-17::gfp] jsEx977[NM1736(Paex-2::mCherry) line1], aex-2(sa3) 
jsEx999[NM1707(Pglr-1::aex-2::gfp) + pPD118.33(Pmyo-2::gfp) line1], aex-2(sa3) 
jsEx1000[NM1707(Pglr-1::aex-2::gfp) + pPD118.33(Pmyo-2::gfp) line2], aex-2(sa3) 
jsEx1007[NM1841(Punc-17::aex-2::gfp) + pPD118.33(Pmyo-2::gfp) line1], aex-2(sa3) 
jsEx1008[NM1841(Punc-17::aex-2::gfp) + pPD118.33(Pmyo-2::gfp) line2], aex-2(sa3) 
jsEx1003[NM1843(Punc-47::aex-2::gfp) + PD118.33(Pmyo-2::gfp) line1], aex-2(sa3) 
jsEx1004[NM1843(Punc-47::aex-2::gfp) + pPD118.33(Pmyo-2::gfp) line2], aex-2(sa3) 
jsEx1026[NM1778(Punc-25::acy-1(js127)) + pPD118.33(Pmyo-2::gfp) line1], aex-
2(sa3) jsEx1027[NM1778(Punc-25::acy-1(js127)) + pPD118.33(Pmyo-2::gfp) line2], 
aex-2(sa3); zxEx51[Punc-47::chop-2(H134R)::yfp; lin-15
+
], aex-2(sa3);  
jsIs1072[NM2072 (Pvha-6::AEX-5::VENUS CbUNC-119)] 
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Promoters used in this study 
 Neuronal (Prab-3, rab-3 promoter) (Nonet, Staunton et al. 1997), intestinal (Pges-
1, ges-1 promoter) (Marshall and McGhee 2001), intestinal (Pvha-6, vha-6 promoter) 
(Oka, Toyomura et al. 2001), muscle (Pmyo-3, myo-3 promoter) (Okkema, Harrison et al. 
1993), cholinergic neurons (Punc-17, unc-17 promoter) (Sieburth, Ch'ng et al. 2005), 
subsets of interneurons (Pglr-1, glr-1 promoter) (Hart, Sims et al. 1995; Maricq, Peckol 
et al. 1995), GABAergic neurons (Punc-47, unc-47 promoter) (McIntire, Reimer et al. 
1997), and GABAergic neurons (Punc-25, unc-25 promoter) (Jin, Jorgensen et al. 1999).  
Paex-4 and Paex-2 (aex-4 and aex-2 promoters) are described in this study (see below for 
details). 
Transgenic Animals 
 Transgenic animals were generated as previously described (Mello, Kramer et al. 
1991).  Briefly, QIAGEN (Valencia, CA) purified plasmids (5-50ng/µl) were coinjected 
with either 150ng/µl pRF4 (rol-6 dominant marker) or 5ng/µl pPD118.33 (myo-2::GFP a 
gift of A. Fire) and 100ng/µl pBluescript into wild type or mutant animals.  Transgenic 
progeny were identified in the following generation by the presence of the dominant rol-6 
or myo-2::GFP marker,. unc-119(ed3); jsIs1072 [NM2072 (Pvha-6::AEX-5::VENUS 
CbUNC-119)] was created by ballistic transformation of unc-119(ed3) using standard 
methods (Praitis, Casey et al. 2001). 
Generation of the C. elegans strain expressing ChR2 in GABAergic neurons 
The punc-47::chop-2(H134R)::yfp construct was generated by amplifying a 1.44 
kb genomic fragment upstream of the unc-47 start codon via PCR, using primers 5’-
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CCCCGCAAGCTTGTTGTCATCACTTCAAACTTTTCAATG-3’ and 5’-
CCCCGCTGATCACTGTAATGAAATAAATGTGACGCTGT-3’.  AfterHindIII/BclI 
cleavage, the fragment was ligated into a pmec-4::chop-2(H134R)::yfp vector (Nagel, 
Brauner et al. 2005), where pmec-4 was removed using HindIII and BamHI. punc-
47::chop-2(H134R)::yfp was injected together with a lin-15 rescuing construct into lin-
15(n765ts) animals at a concentration of 80 ng/ml each, to yield strain ZX416 (lin-
15(n765ts); zxEx51[punc-47::chop-2(H134R)::yfp; lin-15
+
]). 
Plasmid Construction 
NM1427- aex-4 promoter driving GFP tagged to a nuclear localization signal.  A 1.1kbp 
aex-4 promoter was amplified in a PCR from wild type genomic DNA using 
oligonucleotides 5’-CAACGTTCTAGAACTCCAGCGAACATCAAGCTAC-3’ and 5’- 
CTAGTGCCCGGGTGAATCAATGGTTTTTCTAGCCAT-3’ digested with XbaI and 
XmaI, and inserted into XbaI-XmaI pPD95.70 (A. Fire). 
 
NM1471- genomic clone of aex-4 containing promoter, coding region, and 3’UTR.  A 
4kbp aex-4 genomic sequence was amplified in a PCR from wild type genomic DNA 
using oligonucleotides 5’-GAACGTCCCGGGACTCCAGCGAACATCAAGCTAC-3’ 
and 5’-CTCTATGGGCCCCATCGCTACTTCTACTCTTTCTC-3’ digested with XmaI 
and ApaI, and inserted into XmaI-ApaI pBluescript KS(-). 
 
NM1526- genomic clone of aex-4 containing promoter, N-terminal multiple cloning site, 
coding region, and 3’UTR.  Performed quick change PCR reaction of NM1427 using 
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oligonucleotides 5’- 
GTTTCATCAAAAATCAAAAAATTGCAAAACCTAGGTTAATTAATCCATGG 
ATGGCTAGAAAAACCATTGATTCGTAAG-3’ and 5’- 
CTTACGAATCAATGGTTTTTCTAGCCATCCATGGATTAATTAACCTAGGT 
TTTGCAATTTTTTGATTTTTGATGAAAC 
-3’ digested with DpnI and transformed into DH5! chemically competent cells. 
 
NM1609- aex-4 promoter driving eGFP fused to the N-terminus of aex-4 coding region.  
A 700bp eGFP sequence was amplified in a PCR from NM1090(pRAB100) using 
oligonucleotides 5’-CATGTCCCTAGGATGGTGAGCAAGGGCGAGGAG-3’ and 5’-
GAATCCATGGTCCGCGGCCGTCCTTGTACAG-3’ digested with AvrII and NcoI, 
and inserted into AvrII-NcoI NM1526. 
 
NM1404- ges-1 (intestinal) promoter driving eGFP.  A 2.1kbp ges-1 promoter was 
amplified in a PCR from wild type genomic DNA using oligonucleotides 5’-
TAACCCGGGAATCGCATTTCAAACTG-3’ and 5’-
TAACCATGGTCATCTGAATTCAAAGATAAG-3’ digested with XmaI and NcoI, and 
inserted into XmaI-NcoI NM1019 (Mahoney, Liu et al. 2006). 
 
NM1726- ges-1 (intestinal) promoter driving aex-4 coding region. A 2.1kbp ges-1 
promoter was amplified in a PCR from wild type genomic DNA using oligonucleotides 
5’-TAACCCGGGAATCGCATTTCAAACTG-3’ and 5’-
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TAACCATGGCATCTGAATTCAAAGATAAG-3’ digested with XmaI and NcoI, and 
inserted into XmaI-NcoI NM1526. 
 
NM1727- myo-3 (muscle) promoter driving aex-4 coding region. A 2.6kbp myo-3 
promoter was amplified in a PCR from wild type genomic DNA using oligonucleotides 
5’-GAATGGATCCTCTGTTTTCGTTAATTTTGAATTTTG-3’ and 5’-
GATTTCCCATGGCATTTCTAGATGGATCTAGTGGTCGTG-3’ digested with 
BamHI and NcoI, and inserted into BamHI-NcoI NM1526. 
 
NM1742- rab-3 (neuronal) promoter driving aex-4 coding region. A 1.2kbp rab-3 
promoter was amplified in a PCR from wild type genomic DNA using oligonucleotides 
5’-CTGCAGCCCGGGGGATCTTCAGATGGGAGCAGTG-3’ and 5’-
GTGGCGACCCATGGCATCTGAAAATAGGGCTACTGTAG-3’ digested with XmaI 
and NcoI, and inserted into XmaI-NcoI NM1526. 
 
NM1610- ges-1 (intestinal) promoter driving GFP with an N-terminal multiple cloning 
site.  Performed quick change PCR reaction of NM1404 using oligonucleotides 5’-
CATATCTTATCTTTGAATTCAGCCTAGGTGGTACCACTCGAGATGACCAT 
GGTGAGCAAGGGCGAG-3’ and 5’-
CTCGCCCTTGCTCACCATGGTCATCTCGAGTGGTACCACCTAGGCTGAAT 
TCAAAGATAAGATATG-3’ digested with DpnI and transformed into DH5! 
chemically competent cells.  Resulting clone (NM1528) had mutations in GFP.  A 1.1kbp 
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sequence containing GFP and the rim3’ UTR was amplified in a PCR from 
NM1090(pRAB100) using oligonucleotides 5’-
CTAGCACTCGAGATGACCATGGTGAGCAAGGGCGAGGAG-3’ and 5’- 
CAGCTATGACCATGATTACGCCAAGCGCGCAATTAAC-3’ digested with XhoI 
and BssHI, and inserted into XhoI-BssHI NM1528. The reading frame was shifted just 
before the GFP ATG (CCTAGGTGGTACCACTCGAGATGACC was converted to 
CCTAGGTGGTACCACTCGAGCATGACC) during the subcloning of the new GFP, 
which adds a C before the ATG of GFP and after the XhoI site shifting the reading frame 
1+. 
 
NM1728- ges-1 (intestinal) promoter driving aex-5 cDNA fused to out-of-frame GFP.  A 
1.6kbp sequence containing AEX-5 cDNA was amplified in a PCR using 
oligonucleotides 5’-
CTCCAACCTAGGATGAAATTAATTTTCCTGCTTTTGCTTTTTG-3’ and 5’- 
GTGAAGCTCGAGTATGACATTGTTCCCACCACTTTGAAC-3’ digested with AvrII 
and XhoI, and inserted into AvrII-XhoI NM1610.  The resulting clone (NM1728) has a 
base pair deletion that causes GFP to be out of frame.  The following sequence 
TCATACTCGAGGATGA was converted TCTACTCGAGGATGA. 
 
NM1977- ges-1 (intestinal) promoter driving aex-5 cDNA fused to VENUS. A 900bp 
sequence containing the VENUS variant of GFP with artificial introns was amplified in a 
PCR from NM1358(pRab3VENUSrim3’) using oligonucleotides 5’-
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GAGAGTCTCGAGTAATGAGTAAAGGAGAAGAAC-3’ and 5’- 
GATCTACCGCGGCTATTTGTATAGTTCATCCATGCCAAG-3’ digested with XhoI 
and SacII, and inserted into XhoI-SacII NM1728. 
 
NM2059- vha-6 (intestinal) promoter driving aex-5 cDNA fused to VENUS. A 1.2kbp 
vha-6 promoter was amplified in a PCR from wild type genomic DNA using 
oligonucleotides 5’-GTCGATCCCGGGCATGTACCTTTATAG-3’ and 5’- 
GTCAGTCCTAGGGGGTAGGTTTTAG-3’ digested with XmaI and AvrII, and inserted 
into XmaI-AvrII NM1977. 
 
NM2061- rab-3 (neuronal) promoter driving aex-5 cDNA fused to VENUS. A 1.2kbp 
rab-3 promoter was amplified in a PCR from wild type genomic DNA using 
oligonucleotides 5’-CTGCAGCCCGGGGGATCTTCAGATGGGAGCAGTG-3’ and 5’-
TCAGCACCTAGGCTGAAAATAGGGCTACTGTAG-3’ digested with XmaI and 
AvrII, and inserted into XmaI-AvrII NM2059. 
 
NM2062- myo-3 (muscle) promoter driving aex-5 cDNA fused to VENUS. A 2.5kbp 
myo-3 promoter was amplified in a PCR from wild type genomic DNA using 
oligonucleotides 5’-GAATACCGGTTCTGTTTTCGTTAATTTTGAATTTTG-3’ and 
5’-GATTTCGCTAGCTTCTAGATGGATCTAGTGGTCGTG-3’ digested with AgeI 
and NheI, and inserted into XmaI-AvrII NM2059. 
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NM2099- genomic clone of aex-2 containing promoter, coding region, mCherry at the 
C’-terminus of coding region, and 3’UTR.  A homologous recombination method was 
used to construct aex-2 genomic plasmid (Warming, Costantino et al. 2005).  Briefly, 
fosmid T14B1.2 containing aex-2 sequence was transformed into recombineering strain 
SW102.  A galK gene was inserted into the C’-terminus of aex-2 coding region with 
following oligonucleotides: forward 
GACGAGCATCTGAAAGGCCGCCGGAGCACACCCCCTTACGGTGTGATATGCC
TGTTGACAATTAATCATCGGCA, reverse 
CATTTTTTCCACAAGTTTTACTTACATACATTGCGAATTACTACGATCTATCAG
CACTGTCCTGCTCCTT.  The galK gene was subsequently replaced by mCherry gene 
by homologous recombination with following oligonucleotides: forward 
GACGAGCATCTGAAAGGCCGCCGGAGCACACCCCCTTACGGTGTGATATGAT
GGTGAGCAAGGGCGAGGAG, reverse 
CATTTTTTCCACAAGTTTTACTTACATACATTGCGAATTACTACGATCTACTTG
TACAGCTCGTCCATGCC.  In the final step, the whole fragment that contains aex-2 
promoter, aex-2 coding sequence, mCherry coding sequence and 3’-UTR was gap 
repaired into an Amp containing vector backbone using oligonucleotides forward 
CATTGATCTGCCGCATGATGAAGTACCAAGTCTGAATGATGAAGAATTTCATT
CGTTATGCATTATGGGTAC and reverse 
AATCAAACGACATTAACGATTTCTCAAAAAAAAAAAACTTTAGGAAAACATA
CCAATCTAAGTCTGTGCTCC. 
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NM2100- genomic clone of aex-2 containing promoter, coding region, YPet at the C’-
terminus of coding region, and 3’UTR.  NM2100 was constructed similarly to NM2099, 
except that the following oligonucleotides were used to replace galK with YPet rather 
than mCherry: forward, 
GACGAGCATCTGAAAGGCCGCCGGAGCACACCCCCTTACGGTGTGATATG 
ATGTCTAAAGGTGAAGAATTATTC, reverse 
CATTTTTTCCACAAGTTTTACTTACATACATTGCGAATTACTACGATCTA 
TTTGTACAATTCATTCATACCC. 
 
NM2101- rab-3 (neuronal) promoter driving aex-2 cDNA fused to GFP at the C’-
terminus.  The 1kb aex-2 cDNA was amplified using oligonucleotides 5’- 
AAGTCAGGATCCTCCACCATGAACTCAACGGACATTATTG-3’ and 5’- 
ACTCATACTAGTCATATCACACCGTAAGGG-3’.  The GFP containing vector 
backbone was amplified from the plasmid NM1019 (prab3GFPrim3') using 
oligonucleotides 5’-ACTCATACTAGTATGGCACCGGTCGCCAC-3’ and 5’- 
AAGTCAGGATCCCTGAAAATAGGGCTACTGTAG-3’.  The PCR fragments were 
purified, digested with BamHI and SpeI and ligated. 
 
NM2102- myo-3 (muscular) promoter driving aex-2 cDNA fused to YFP at the C’-
terminus.  The 1kb aex-2 cDNA was amplified using oligonucleotides 5’- 
AAGTCAGCTAGCTCCACCATGAACTCAACGGACATTATTG -3’ and 5’- 
ACTCATAGGCCTCATATCACACCGTAAGGG -3’.  The YFP containing vector 
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backbone was amplified from the plasmid NM783 (pPD132.112, Pmyo-3::YFP, A. Fire) 
using oligonucleotides 5’- ACTCATAGGCCTATGACTGCTCCAAAGAAGA -3’ and 
5’ -AAGTCAGCTAGCTTTTTCTGAGCTCGGTACC -3’.  The PCR fragments were 
purified, digested with NheI and StuI and ligated. 
 
NM2103- ges-1 (intestinal) promoter driving aex-2 cDNA fused to GFP at the C’-
terminus.  The 1kb aex-2 cDNA was amplified using oligonucleotides 5’- 
AAGTCAGGATCCTCCACCATGAACTCAACGGACATTATTG -3’ and 5’- 
ACTCATACTAGTCATATCACACCGTAAGGG -3’.  The GFP containing vector 
backbone was amplified from the plasmid NM1019 (Prab3GFPrim3’) using 
oligonucleotides 5’- ACTCATACTAGTATGACCATGGTGAGCAAG -3’ and 5’ - 
AAGTCAGGATCCCTGAATTCAAAGATAAGATATG -3’.  The PCR fragments were 
purified, digested with BamHI and SpeI and ligated. 
 
NM1736- 10kb aex-2 promoter driving mCherry cDNA.  The vector backbone was 
amplified from the plasmid NM1019 (prab3GFPrim3’) using oligonucleotides 5’- 
AACGCGCCGAGGGCCGCCACTCCACCGGCGGCATGGACGAGCTGTACAAGT
AAGCCGCGGATAACAAATTTCATA -3’ and 5’- 
AATCAAACGACATTAACGATTTCTCAAAAAAAAAAAACTTTAGGAAAACATA
CCAATCTAAGTCTGTGCTCC -3’.  The final plasmid was made by gap repair from 
the intermediate fosmid T14B1.2 that contains mCherry::aex-2. 
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NM1707- glr-1 (subsets of interneurons) promoter driving aex-2 cDNA fused to GFP at 
the C’-terminus.  The 2.5kb glr-1 promoter was amplified using oligonucleotides 5’- 
GAAGTCCCCGGGCGTGCTCTGAAAATTCTTTTAT -3’ and 5’- 
TACAGTGGATCCTGTGAATGTGTCAGATTGGG -3’.  Then the PCR product and 
plasmid NM 2101 (Prab-3::aex-2::gfp) were digested with XmaI and BamHI and ligated. 
 
NM1841- unc-17 (cholinergic) promoter driving aex-2 cDNA fused to GFP at the C’-
terminus.  The 3.5kb unc-17 promoter was amplified using oligonucleotides 5’- 
TAGAAGTCCCCGGGTAGACCCAAAATGGTCCAAAA -3’ and 5’- 
TACAGTGGATCCCTCTCTCTCTCCCCCTG -3’.  Then the PCR product and plasmid 
NM2101 (Prab-3::aex-2::gfp) were digested with XmaI (partial digest for Punc-17) and 
BamHI and ligated. 
 
NM1843- unc-47 (GABAergic) promoter driving aex-2 cDNA fused to GFP at the C’-
terminus.  The 1.45kb unc-47 promoter was amplified using oligonucleotides 5’- 
TAGAAGTCCCCGGGATGTTGTCATCACTTCAAACTT -3’ and 5’- 
TACAGTGGATCCCTGTAATGAAATAAATGTGACG -3’.  Then the PCR product 
and plasmid NM2101 (Prab-3::aex-2::gfp) were digested with XmaI and BamHI (partial 
digest for Punc-47) and ligated. 
 
NM1778- unc-25 (GABAergic) promoter driving acy-1 (js127, gain of function allele).  
The 1.5kb unc-25 promoter was amplified using oligonucleotides 5’- 
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GAAGTCCCGCGGGCCGAAATTTAAAGCTAGTTT -3’ and 5’- 
TACAGTGGATCCTTTTGGCGGTGAACTGAGC -3’.  Then the PCR product and 
plasmid NM964 pAC5 (psnb-1::acy-1(js127)) with SacII and BamHI and ligated. 
 
NM2072- vha-6 (intestinal) promoter driving aex-5 cDNA fused to VENUS vector 
includes a copy of the C. briggsae unc-119 gene (also called Pvha-6::AEX-5-
VENUScbUNC-119). Plasmid pDONR221-CBunc-119 (which contains a 2.0 kb C. 
briggsae unc-119 gene fragment in pDONR 221, a gift of M. Driscoll) was digested with 
PvuII and XbaI and inserted into SmaI-XbaI NM2059. 
 
Imaging and C. elegans Anatomy 
 All images are shown with the anterior end to the left and dorsal side on the top.  
For a guide to C. elegans anatomy we suggest the following sources (Altun and Hall 
2002-2006; Jorgensen 2005; McGhee 2007).  Images were taken on an Olympus 
FluoView FV500 scanning confocal microscope.  Since the C. elegans intestine has 
higher auto-fluorescence than other tissue, an image was taken in the red channel (RFP 
filter sets) while imaging GFP or VENUS in the intestine in order to distinguish auto-
fluorescence from fluorescent protein signal.  Images were analyzed using either 
MetaMorph imaging software  or NIH ImageJ and subsequently processed in Adobe 
Photoshop. 
 AEX-5::VENUS images for quantification were taken on an Olymous BX60 with 
using a 60x objective with a 1.25x Optivar.  Images were taken on a Retiga 2000R 12-bit 
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RGB camera (Q-imaging).  Photos were acquired using Openlab software (Improvision), 
and subsequently analyzed using NIH ImageJ.  Regions of interest were selected by 
outlining the two anterior coelomocytes of L4 larval stage animals.  The total amount of 
fluorescence was determined by subtracting background fluorescence from the integrated 
density (which is the total amount of fluorescence in a given area).  The normalized 
fluorescence was determined by dividing each value by the average wild type 
fluorescence. AEX-5::VENUS accumulation in the intestine was determined by imagin 
the anterior intestinal cells.  Average fluorescene, with background subtraction, was 
determined using NIH ImageJ. Statistical significance was determined by using unpaired 
two-tailed student t tests, with unequal variance. 
  
RNAi experiments 
 The RNAi experiments were performed based on a modified feeding protocol 
(Espelt, Estevez et al. 2005).  Briefly, bacterial strains that express double stranded RNA 
targeting individual aex genes were inoculated from single colonies on freshly streaked 
plates and allowed to grow to O.D.600>1.0.  About 50ml of the liquid culture was spotted 
onto each well of 24 well plates, which was supplemented with 100mg/ml Ampicillin and 
1mM isopropyl-beta-D-thiogalactopyranoside (IPTG), and the plates were incubated at 
RT for 12 hours to induce double stranded RNA expression.  Two L4 intestinal RNAi-
sensitive animals (rde-1(ne219); kbIs7[Pnhx-2::rde-1]) (Espelt, Estevez et al. 2005) were 
then picked onto each well and allowed to give progeny at 22°C.  Two to three days later, 
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8 F1 young adults per well were scored for their expulsion defects. Statistical significance 
was determined by using unpaired two-tailed student t tests, with unequal variance. 
Behavioral Assay 
 Defecation was assayed as previously described (Thomas 1990).  Briefly, the 10 
cycles of the defecation motor program of 8-20 one-day old (24hrs after the L4 larval 
stage) adults was observed on a dissecting stereomicroscope.  Expulsions were recorded 
at all times, this included release events and ectopic expulsions seen in some gain-of-
function mutants.  When appropriate defecation cycles were recorded using the program 
Etho Java event recording software as described in (Thomas 1990).  Statistical 
significance was determined by using unpaired two-tailed student t tests, with unequal 
variance. 
Channelrhodopsin-2 Experiments 
 The assay was modified from (Nagel, Brauner et al. 2005).  NGM agar plates 
were spotted with OP50 bacterial cultures with or without 500µM all-trans retinal 
(Sigma). 10 animals expressing the zxEx51 transgene were picked onto the 500µM all-
trans retinal spotted plates and grown overnight at 22°C.  Young adult animals were 
observed on a Leica MZ16F fluorescent stereomicroscope with an x-Cite 120 excitation 
light source (EXFO).  The defecation motor program was recorded for 5 cycles in the 
absence of blue light.  The next 10 cycles were recorded with a brief (1-5 sec) pulse of 
blue light (using a standard GFP filter) just after (about 1-3 sec) the pBoc contraction.  5 
more cycles were recorded in the absence of blue light.  We did not detect a significant 
difference between expulsion frequencies recorded before the blue light activation 
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procedure and the expulsion frequencies recorded after the blue light activation 
procedure.  The blue light flashes were repeated on zxEx51 positive animals in the 
absence of all-trans retinal with no noticeable change in the frequency of expulsions from 
mutant strains, demonstrating the specificity of the activation of ChR2.  Blue light was 
not left on as this generally left the zxEx51 positive animals paralyzed.  Blue light on wild 
type worms caused an increase in locomotion and sometimes inhibited defecation.  
Statistical significance was determined by using unpaired two-tailed student t tests, with 
unequal variance. 
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Abstract 
The ability of animals to modulate their behaviors based on environmental cues 
critically depends on the modulation of nervous system functions.  Here we describe a 
pathway whereby C. elegans intestinal epithelial cells secret a signal(s) to regulate 
cholinergic synaptic transmission.  Using genetic and pharmacological analyses, we 
demonstrate that the prohormone converting enzyme AEX-5 modulates cholinergic 
transmission from the intestine.  The intestine derived signals appear to act on 
GABAergic neurons through AEX-2, a G-protein coupled receptor that is coupled with 
downstream Gs! and adenylate cyclase signaling.  Interestingly, the AEX-5/AEX-2 
signaling has been previously shown to control the rhythmic defecation motor program 
by activating GABA release from GABAergic neurons.  In contrast, we find that for the 
modulation cholinergic transmission, AEX-5/AEX-2 depends at least partially on 
neuronal peptide signals, while GABA is dispensable for the process.  We further show 
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that in the absence of food, the decrease in the defecation frequency of C. elegans is 
accompanied by reduced cholinergic transmission, and such decrease in cholinergic 
transmission is not seen when the adenylate cyclase is activated in GABAergic neurons.  
We hypothesize that the C. elegans intestine coordinates the rhythmic behavior and 
neuronal functions by controlling the secretion of neural modulatory signals. 
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Introduction 
The proper modulation of synaptic strength is essential for the nervous system 
function and neuronal plasticity.  At central synapses, the modulation of synaptic strength 
involves alterations in pre- and/or postsynapses, and many lines of evidence suggest that 
trans-synaptic secretory molecules play important roles in inducing and coordinating pre- 
and postsynaptic changes.  For example, at ‘silent’ hippocampal synapses, activation of 
the postsynapse by glutamate neurotransmission triggers the insertion of AMPA type 
glutamate receptors into the postsynaptic site (Durand et al., 1996; Isaac et al., 1995; 
Renger et al., 2001).  In contrast, at hippocampal and cerebellar synapses, depolarization 
of postsynaptic neurons induces the release of endocannabinoids that acts on presynaptic 
cannabinoid receptors, resulting in presynaptic suppression (Alger and Pitler, 1995; 
Kreitzer and Regehr, 2001a; Kreitzer and Regehr, 2001b; Wilson and Nicoll, 2001).  
Interestingly, increasing evidence suggests that such synaptic modulatory signals are also 
present in non-neuronal tissues, and they may modulate neuronal functions through a 
secretory pathway.  For example, at fly neuromuscular junctions (NMJs), the exocytic 
protein synaptotagmin 4 (Syt 4) functions in the muscle to regulate the induction of 
presynaptic plasticity (Yoshihara et al., 2005).  Similarly, a C. elegans Munc-13 
homologue protein AEX-1 is expressed in muscles, and it functions in the muscle to 
maintain normal synaptic transmission (Doi and Iwasaki, 2002).  These observations 
imply an interesting interaction between neuronal and non-neuronal tissues.  However, as 
so far our knowledge on the regulation of neuronal functions by non-neuronal tissues is 
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still limited, in many situations the identities of such elusive secretory molecules and 
their signaling mechanisms underlying the synaptic modulation remain unknown. 
The C. elegans intestine serves as an important organ to regulate multiple 
biological processes in the nematode such as food digestion, defecation, stress response, 
and host-pathogen interactions (McGhee, 2007).  Composed of polarized epithelial cells, 
the intestine is involved in intensive cross-membrane trafficking, and a number of 
exocytic and endocytic factors have been shown expressed and functioning in the 
intestine (Chen et al., 2006; Doi and Iwasaki, 2002; Mahoney et al., 2006a; Parker et al., 
2009; Yamashita et al., 2009).  Interestingly, several recent observations suggest that the 
intestine may secret signals to modulate neuronal functions.  For example, during 
rhythmic defecation cycles, a Ca2+ wave is initiated near the posterior end of the intestine 
and it propagates through the intestine (Dal Santo et al., 1999; Teramoto and Iwasaki, 
2006).  Blocking the Ca2+ oscillation in the intestine by drugs or by disrupting an 
intestinal gap junction not only prevents the execution of subsequent neuron-controlled 
muscle contractions, but also leads to phenotypes indicative of altered synaptic 
transmissions (Peters et al., 2007; Teramoto and Iwasaki, 2006).  Thus, the C. elegans 
intestine may function as an endocrine organ to modulate synaptic functions.  It would be 
interesting to identify the molecules that are involved in synaptic modulations from the 
intestine. 
Here we report the identification of a peptidergic pathway that acts in the intestine 
to modulate cholinergic transmissions in C. elegans.  We find that the prohormone 
converting enzyme AEX-5 is required in the intestine to maintain normal cholinergic 
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functions.  To our surprise, GABAergic neurons appear to be downstream of the 
intestinal signal, as epistatic analysis genetically places GABAergic GPCR AEX-2 
downstream of AEX-5.  The stimulatory Gs! subunit and adenylate cyclase are involved 
in relaying AEX-2 signals, and the activation of adenylate cyclase in GABAergic neurons 
specifically suppresses aex-2 and aex-5 cholinergic defects.  Previously, we have shown 
that AEX-5/2 signaling acts on GABAergic neurons to activate enteric muscle 
contractions, a defecation process that depends on neurotransmitter GABA (Mahoney et 
al., 2008).  We show here that GABA is dispensable for modulating cholinergic 
functions, while two neuronal prohormone processing enzymes, EGL-3 and EGL-21, are 
required at least in part downstream of AEX-2.  Interestingly, the stimulation of worm 
defecation by expressing an IP3 receptor in the intestine also enhances its aldicarb 
sensitivity, a phenotype indicative of enhanced cholinergic transmissions.  Such 
enhancement is not observed when the functional AEX-5 is absent.  Together, our results 
support a model where the C. elegans intestine acts as an endocrine organ to coordinate 
the synaptic transmission and the defecation motor program by secreting neural 
modulatory signals. 
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Results 
aex-5 mutants are resistant to cholinesterase inhibitor aldicarb 
We have previously shown that the prohormone converting enzyme AEX-5 
functions in the intestine to regulate GABAergic functions during the defecation 
(Mahoney et al., 2008).  As intestine may also modulates cholinergic functions, we 
decided to examine if AEX-5 is involved in such modulatory signaling from the intestine.  
We used aldicarb-induced paralysis assays to assess the status of cholinergic transmission 
in aex-5 mutants.  Interestingly, aex-5 worms show delayed paralysis in the presence of 
1mM aldicarb, indicating reduced cholinergic transmissions in these animals (Fig 1A). 
 
aex-5 animals have apparently normal acetylcholine receptor (AchR) surface 
expression and gross neural anatomy 
The altered cholinergic transmissions seen in aex-5 animals could be caused by a 
combination of changes in presynaptic structures, functions, and postsynaptic receptors.  
To distinguish between these possibilities, we performed levamisole assays on aex-5 
animals.  Levamisole is an acetylcholine receptor (AChR) agonist that paralyzes worm by 
causing muscle over-contractions.  In the presence of 200µM levamisole, aex-5 worms 
are paralyzed in a way comparable to wild type animals, while the acetylcholine receptor 
unc-29 mutant remains completely resistant to the treatment (Fig 1B).  This suggests that 
the surface expression of postsynaptic AChRs in aex-5 worms remains generally 
unaffected.  To assess whether aex-5 mutants might exhibit cholinergic defects as a result 
of a general alteration in presynaptic structures, we performed RAB-3 (a synaptic vesicle 
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protein) and RIM (a presynaptic active-zone protein) immunostaining.  We failed to 
detect any noticeable changes in general synaptic organizations in aex-5 animals (Fig 1C, 
1D).  Together, these results suggest that the altered cholinergic transmission in aex-5 
animals likely results from reduced presynaptic functions. 
 
aex-5 mutation does not affect presynaptic UNC-13 accumulations or glutamate 
receptor expressions in command interneurons 
Several groups have previously managed to correlate synaptic activities with the 
synaptic localization of a specific UNC-13 isoform (a presynaptic vesicle priming 
protein) at presynaptic neurons (Doi and Iwasaki, 2002; Metz et al., 2007; Nurrish et al., 
1999).  To assess if AEX-5 directly regulates presynaptic functions, we crossed aex-5 
mutants into a UNC-13S::GFP expressing line and examined UNC-13S::GFP levels in 
the mutant dorsal cord, a region consisting of mainly neuromuscular synapses.  As shown 
in Fig 2A-2C, both the wild type and aex-5 dorsal cords exhibit comparable UNC-
13S::GFP expressions, and the quantification of puncta numbers and puncta intensities 
reveals no significant difference (Fig 2A-2C).  This suggests that AEX-5 does not affect 
cholinergic transmission by directly modulating presynaptic UNC-13 localizations.  We 
then asked if the mutation in aex-5 affects the ability of cholinergic motor neurons to 
receive input from presynaptic command interneurons.  Both C. elegans command 
interneurons and motor neurons express ionotropic glutamate receptors (Brockie et al., 
2001).  We examined the expression of a glutamate receptor GLR-1 in aex-5 animals 
using a GLR-1::GFP line, as GLR-1 is known to function in regulating locomotion (Hart 
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et al., 1995; Maricq et al., 1995; Zheng et al., 1999).  As shown in Fig 2D-2E, we failed 
to detect any significant changes in GLR-1::GFP puncta number and intensity in aex-5 
mutants.  This suggests that the interneuron-motor neuron circuits in aex-5 mutants are 
roughly normal at least in terms of their ability to receive inputs through GLR-1 
receptors. 
 
AEX-5 acts in the intestine to regulate synaptic transmission 
To assess where AEX-5 acts to regulate synaptic transmission, we directed the 
expression of AEX-5::VENUS fusion proteins to neurons (Prab-3 driven), muscles 
(Pmyo-3 driven), or intestines (Pvha-6 driven) and examined which expression rescues 
aex-5 defects.  As shown in Fig 3A, intestinal expression of AEX-5::VENUS fully 
restores the aldicarb sensitivity in aex-5 mutants (Fig 3A).  In comparison, neuronal and 
muscular AEX-5::VENUS also confers noticeable rescue activities, which could be 
caused by leaky expressions of AEX-5 under high expression levels or by the ubiquitous 
presence of AEX-5 in multiple tissues (Fig 3A).  To figure out if AEX-5 is required only 
in the intestine for its function, we performed intestine-specific aex-5 gene silencing 
using a transgenic line that is sensitive to RNAi only in the intestine (Espelt et al., 2005).  
As shown in Fig 3B, intestine specific knockdown of aex-5 expression induces strong 
aldicarb resistance comparable to that observed in aex-5 mutants.  As a control, the 
intestine knockdown of aex-2 (a neuronal GPCR) and other aex genes do not have similar 
effects (Fig 3B and data not shown).  This suggests that AEX-5 is required in the 
intestine to maintain normal synaptic functions.  Interestingly, consistent with our 
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previous findings, the intestinal RNAi of aex-5 also induces strong defecation defects 
(Mahoney et al., 2008).  This suggests that AEX-5 may regulate multiple aspects of 
neuronal functions from the intestine. 
 
The GPCR AEX-2 regulates cholinergic functions from GABAergic neurons 
Our previous study has shown that AEX-5 genetically acts on the neuronal GPCR 
AEX-2 to regulate defecation motor program in C. elegans (Mahoney et al., 2008).  We 
then asked if AEX-2 is also involved in regulating cholinergic functions by performing 
aldicarb assays on the aex-2 mutant.  As shown in Fig 1A, aex-2 mutants are resistant to 
1mM aldicarb treatment, suggesting a reduced cholinergic transmission in these animals.  
Using levamisole assays and RAB-3/RIM immunohistochemistry, we found no obvious 
changes in postsynaptic AChR levels or presynaptic organizations in aex-2 animals, 
suggesting AEX-2 mainly affects the efficacy of presynaptic transmissions (Fig 1B, 1C, 
1D).  Interestingly, like aex-5 animals, aex-2 mutants are normal in both UNC-13S::GFP 
and GLR-1::GFP expressions in nerve cords (Fig 2A-2E).  These results support the 
notion that like AEX-5, AEX-2 modulates cholinergic functions through an indirect 
action on presynaptic cholinergic neurons. 
The expression of AEX-2 has been previously detected in cholinergic neurons, 
GABAergic neurons, command interneurons, and enteric muscles (Mahoney et al., 2008).  
To assess where AEX-2 acts to regulate synaptic transmission, we then directed the 
expression of AEX-2::GFP fusion proteins to neurons (Prab-3 driven), muscles (Pmyo-3 
driven), or intestines (Pges-1 driven) and examined which expression rescues aex-2 
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defects.  As shown in Fig 4A, neuronal expression of AEX-2::GFP fully restores the 
aldicarb sensitivity in aex-2 mutants, while muscular and intestinal expressions do not, 
suggesting AEX-2 acts in neurons to regulate cholinergic function (Fig 4A).  To further 
assess what neurons may underlie AEX-2’s functions, we directed AEX-2::GFP 
expressions specifically to cholinergic neurons (Punc-17 driven), GABAergic neurons 
(Punc-47 driven), or subsets of command interneurons (Pglr-1 driven), and we examined 
their rescue activities on aex-2 mutants.  To our surprise, GABAergic expression of 
AEX-2::GFP best restores the aldicarb sensitivity in aex-2 animals, while the cholinergic 
expression confers a partial rescue (Fig 4B).  The expression of AEX-2 in interneurons 
fails to rescue aldicarb phenotypes (Fig 4B).  In conclusion, these results suggest that 
AEX-2 mainly acts through GABAergic neurons to modulate synaptic transmissions, 
whereas we cannot fully rule out an involvement of cholinergic expression in AEX-2 
mediated functions. 
 
Gs!  pathway is genetically downstream of AEX-2 and AEX-5 signaling 
We next examined which G! pathway may be involved in AEX-2 mediated 
synaptic modulations.  We have previously shown that AEX-2 genetically acts on the 
stimulatory Gs! pathway (but not on Gq! or Go! pathways) to regulate defecation 
behaviors, and a Gs! gain-of-function allele fully rescues defecation defects in both aex-
2 and aex-5 mutants (Mahoney et al., 2008).  To find out if Gs! acts downstream of 
AEX-2 to modulate cholinergic functions, we constructed aex-2; gsa-1(gf) double 
mutants and examined the mutant for its aldicarb sensitivity.  As shown in Fig 5A, both 
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gsa-1(gf) and aex-2; gsa-1(gf) animals exhibit similar level of hypersensitivity to 1mM 
aldicarb treatment, suggesting Gs! is downstream of AEX-2 (Fig 5A).  In addition, aex-
5; gsa-1(gf) animals also show similar level of aldicarb hypersensitivity as gsa-1(gf) 
mutants (Fig 5A).  This indicates that the Gs! pathway likely acts downstream of AEX-2 
and AEX-5 to regulate synaptic transmissions. 
One caveat of the above experiments is that over-activating Gs! non-specifically 
(Gs! is widely expressed in C. elegans) may lead to non-specific suppression of synaptic 
transmission phenotypes.  To address this issue, we made a transgenic line that 
specifically expresses an activated Gs! pathway component adenylate cyclase ACY-1 in 
GABAergic neurons using an unc-25 promoter.  We tested the aldicarb sensitivity of the 
transgenic line in both wild type and aex-2/aex-5 mutant backgrounds.  As shown in Fig 
5B, expression of activated ACY-1 in GABAergic neurons alone induces robust aldicarb 
hypersensitivity in the transgenic worms (Fig 5B).  Interestingly, when combined with an 
aex-2 or aex-5 mutant background, the transgene strongly suppresses the aldicarb 
resistant phenotype in aex mutants, making them comparable to hypersensitive ACY-1 
transgenic worms (Fig 5B).  This strongly supports the conclusion that the Gs!-adenylate 
cyclase pathway acts downstream of AEX-2 and intestinal AEX-5 to regulate synaptic 
transmissions. 
 
AEX-2 acts at least in part through neural peptide signals to modulate cholinergic 
transmission 
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We then asked what molecules may act downstream of Gs! following AEX-2-
Gs! activation.  We first examined if neurotransmitter GABA is involved, as GABA is 
released from GABAergic neurons to activate defecation behaviors, and disrupting 
GABA synthesis in the nematode leads to defecation defects reminiscent of those 
observed in aex-2 and aex-5 mutants (Beg and Jorgensen, 2003; McIntire et al., 1993).  
We thus performed aldicarb assays on a GABA synthase unc-25 mutant in which GABA 
is depleted.  We found that unlike aex-2 and aex-5 mutants, unc-25 animals are 
hypersensitive to aldicarb treatment, while all of them exhibit similar defecation defects 
(data not shown).  This suggests that GABA is unlikely downstream of AEX-2 mediated 
synaptic modulations. 
We thus considered if neuropeptides could be involved in the AEX-2 downstream 
signaling.  The worm genome encodes four prohormone convertases to process premature 
peptides: KPC-1, EGL-3/ KPC-2, AEX-5/ KPC-3, and BLI-4/KPC-4 (Thacker and Rose, 
2000).  Among KPC-1, EGL-3, and BLI-4, we were especially interested in EGL-3, as 
EGL-3 is broadly expressed in the nervous system, and similar to aex-5, mutations in egl-
3 result in massive peptide processing defects (Husson et al., 2006; Kass et al., 2001).  
We thus performed aldicarb assays on egl-3 mutants to see if cholinergic functions are 
altered in these animals.  As shown in Fig 6A, egl-3 mutants are resistant to 1mM 
aldicarb treatment, suggesting these animals have decreased cholinergic transmissions 
(Fig 6A).  In addition, crossing egl-3 animals into either aex-2 or aex-5 mutants does not 
enhance the aldicarb phenotype.  This indicates that EGL-3 may act in the same genetic 
pathway as AEX-2 and AEX-5 (Fig 6A). 
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We next assessed where EGL-3 acts to regulate cholinergic functions.  For this 
purpose, we drove EGL-3::VENUS expressions in neurons (using Prab-3), muscles 
(using Pmyo-3), or intestines (using Pvha-6) and examined which expression rescues egl-
3 mutant phenotypes.  As shown in Fig 6B, only neuronal expression of EGL-3::VENUS 
completely restores aldicarb sensitivity in egl-3 mutants, indicating EGL-3 functions in 
the nervous system (Fig 6B).  We then further asked if EGL-3 acts in certain neuronal 
subtypes to regulate synaptic transmission by driving EGL-3::VENUS expressions in 
cholinergic neurons (using Punc-17), GABAergic neurons (using Punc-47), or command 
interneurons (using Pglr-1) of egl-3 mutants.  As shown in Table 1, all three expressions 
lead to partial rescues of the aldicarb sensitivity in egl-3 animals (Table 1).  This suggests 
that EGL-3 likely functions broadly in the nervous system rather than in specific neuronal 
subtypes to regulate cholinergic functions. 
We then asked if the AEX-2/Gs! function requires the presence of neuropeptide 
signaling.  For this purpose, we crossed the egl-3 mutant into the GABAergic acy-1(gf) 
transgenic line, and we asked if the absence of neuropeptide processing blocks the acy-
1(gf) induced aldicarb hypersensitivity.  As shown in Fig 6C, GABAergic expression of 
activated ACY-1 induces aldicarb hypersensitivity in transgenic animals (Fig 6C).  In 
contrast, disruption of egl-3 in these worms significantly suppresses ACY-1 induced 
aldicarb hypersensitivity, suggesting the AEX-2/Gs! signaling requires functional EGL-3 
at least in part to regulate cholinergic transmission (Fig 6C).  We further tested if EGL-
21, a carboxypeptidase E broadly expressed in neurons and involved in neuropeptide 
processing, is also required for the AEX-2/Gs! signaling (Jacob and Kaplan, 2003).  
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Consistent with previous findings, egl-21 animals exhibit strong resistance to aldicarb 
treatment, indicating a decreased cholinergic transmission in these animals (Fig 6C).  
Noticeably, EGL-21 dysfunction nearly completely blocks ACY-1 induced aldicarb 
hypersensitivity, suggesting a neuropeptide signaling is required for the AEX-2/Gs! 
function (Fig 6C).  Together, our results genetically place EGL-3 and EGL-21 
downstream of AEX-2/Gs! pathway, and based on the available data they are at least 
partially required for the AEX-2/Gsa mediated synaptic modulations. 
 
The C. elegans intestine likely coordinates the defecation behavior and synaptic 
transmission by secreting neural modulatory signals 
We were curious on the ability of the C. elegans intestine to modulate both 
defecation behaviors and cholinergic functions.  As the secretion of intestinal signals is 
likely triggered by the excitation of intestinal cells (as supported by Ca
2+
 oscillations), 
one working hypothesis is that, the nematode intestine secrets peptidergic signals in an 
activity-dependent manner to coordinately regulate defecation and synaptic transmission.  
If this were true, by modulating intestinal activities, we would expect to see coordinated 
changes in both defecation patterns and cholinergic functions.  For this purpose, we first 
decreased the intestinal activity by starving animals, as food deprivation is known to 
trigger the defecation to cease (Liu and Thomas, 1994).  As shown in Fig 7A, food 
deprivation in wild type young adults significantly reduces defecation frequencies, 
supporting an accompanied decrease in intestinal activities (Fig 7A).  All the defecation-
related muscle contractions are normal in these worms, suggesting they do not have 
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defecation defects (Fig 7B).  Interestingly, the starved animals exhibit strong resistance to 
aldicarb treatment (Fig 7C).  This suggests that they have reduced cholinergic 
transmission when food is scarce and the intestine is in a less active state.  To test if the 
altered aldicarb sensitivity is specific to the GABAergic Gs! pathway, we further 
examined GABAergic acy-1(gf) transgenic animals.  As shown in Fig 7A, starvation 
similarly reduces defecation frequencies in these transgenic worms (Fig 7A).  In contrast, 
GABAergic specific expression of ACY-1(gf) completely suppresses starvation induced 
aldicarb resistance, and transgenic animals remain aldicarb hypersensitive even without 
food (Fig 7C).  This suggests that GABAergic Gs! signaling may lie downstream of 
starvation induced changes to mediate the modulation on synaptic functions.  Together, 
our results show that in C. elegans, both defecation patterns and cholinergic functions 
may rely on intestinal activities, and the nematode intestine likely functions as an 
endocrine organ to modulate multiple aspects of neuronal functions (Fig 8). 
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Discussion 
The identification of neural modulatory signals has long been the focus of 
extensive studies in the neuroscience field, as they are believed to form the molecular 
basis for neural plasticity and normal brain functions.  In this study, we have provided 
evidence that the C. elegans intestine is able to modulate cholinergic functions through a 
prohormone convertase pathway.  Unexpectedly, the intestinal signals appear to act on 
GABAergic neurons, and the GABAergic signaling appears to partially depend on 
neuropeptide processing.  Thus, we propose a novel mechanism through which non-
neuronal tissues modulate neuronal functions via secretory peptides. 
The C. elegans intestine likely uses exocytic proteins to control the secretion of 
AEX-5 and its peptide substrates.  In our previous study, we showed a SNAP25 protein 
AEX-4 functions in the intestine to regulate C. elegans defecation, and it appears to 
regulate the secretion of AEX-5 from the intestine (Mahoney et al., 2008).  Interestingly, 
we constantly detected medium-to-mild level of aldicarb resistance in aex-4 mutants 
using three different aex-4 alleles (data not shown).  As AEX-4 is solely expressed in the 
intestine, this observation further supports an involvement of the C. elegans intestine in 
modulating synaptic functions.  The milder aldicarb phenotype in aex-4 animals 
(compared with aex-5 mutants) also suggests the presence of redundant exocytic factors, 
which is supported by recent identification of an intestinally functioning exocytic factor 
in C. elegans (Yamashita et al., 2009).  Therefore, we propose that the C. elegans 
intestine expresses a set of redundant exocytic factors to regulate the secretion of AEX-5 
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processed peptides.  It would be interesting to identify additional exocytic proteins 
involved in intestine-specific secretions and neuronal modulations. 
It is a bit surprising to see that GABAergic neurons could positively modulate 
cholinergic functions downstream of the intestine.  We propose that neuropeptides may 
act downstream of GABAergic neurons to mediate the modulatory function, and this is 
supported by three observations: 1) Depleting GABA synthesis in C. elegans results in 
aldicarb hypersensitivity, which argues against an involvement of GABA in the 
modulation.  2) Major neuropeptide processing enzymes EGL-3 and EGL-21 are 
expressed and function in neurons.  3) Disrupting EGL-3 and EGL-21 functions strongly 
suppresses aldicarb hypersensitivity induced by GABAergic expression of activated Gs! 
signaling components.  Consistent with the observations, GABAerigc neurons have been 
suggested to process and secret peptides.  This includes AVL and DVB, two GABAergic 
neurons that express AEX-2 and are required for defecation (Li, 2005; Schinkmann and 
Li, 1992).  Therefore, the AEX-2 expressing GABAergic neurons may modulate 
defecation and cholinergic transmission in a coordinated manner through GABA and 
neuropeptides.  As GABAergic neurons do not directly synapse onto cholinergic neurons, 
we propose that the EGL-3/EGL-21 processed neuropeptides act on the cholinergic 
system in a hormonal manner.  Nevertheless, we cannot fully exclude the involvement of 
other factors in the GABAergic neuron-mediated synaptic modulations. 
Several recent studies suggest that non-neuronal tissues can secret small hormonal 
factors to regulate physiological processes and neuronal functions.  One example, leptin, 
is secreted from adipose tissues, and it is shown to regulate food intakes as well as 
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nervous system functions such as learning and memory (Moult and Harvey, 2008).  Thus, 
with the multi-functional modulatory signals, the organism may be able to couple their 
behaviors (such as food intake) with their neuronal functions as a feedback to the 
environment.  Similarly, our identification of a common pathway that underlies the 
controls over defecation and cholinergic transmission in C. elegans suggests it may 
confer survival advantages to the nematode.  For example, in the absence of food, the 
worm may reduce the defecation frequency and cholinergic functions simultaneously by 
secreting fewer intestinal signals (resulting from less intestinal activations), and this will 
allow the animal to increase food retention in the intestine while decreasing energy 
expenditures.  On the other hand, the identification of such dual regulation of the 
defecation and cholinergic transmission by the C. elegans intestine may also facilitate the 
screen for neural modulatory molecules.  As mutations in any components of this 
synaptic modulation pathway may lead to defecation defects at the same time, one could 
simply perform a saturated screen for synaptic transmission mutants by easily scoring 
constipation phenotypes.  This greatly facilitates the screening process.  In the future, it 
will be interesting to use this approach to identify the neuropeptides that are involved in 
synaptic modulations. 
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Materials and methods 
For detailed information on transgenic strains and plasmid clones, see 
supplemental information. 
 
Pharmacological assay 
The time-course analysis of aldicarb or levamisole induced paralysis in C. elegans 
was performed as previously described (Mahoney et al., 2006b).  Briefly, 25-30 L4 stage 
larvae of various genetic backgrounds were picked to fresh OP50 spotted NGM plates 
and allowed to grow at 25°C for overnight.  The young adults were then transferred to 
aldicarb (1mM) or levamisole (200µM) containing plates and the drug-induced paralysis 
was scored as a function of time.  Each set of experiments was repeated at least three 
times independently and the mean value and standard error of mean (SEM) were 
reported. 
 
Immunohistochemistry 
The immunohistochemistry was performed as previously described (Mahoney et 
al., 2006a).  Briefly, worms were collected, washed, and fixed in Bouin fixative.  A 
1:10,000 mouse monoclonal !-RAB-3 antibody and a 1:5,000 chicken polyclonal !-
RIM-1 antibody were used for RAB-3 and RIM-1 immunostaining, respectively.  Fixed 
worms were incubated with primary antibodies at 4°C for overnight, washed, and then 
incubated with appropriate Alexa-conjugated secondary antibodies at 1:1000 dilution at 
RT for 1 hour.  Images were captured by a Retiga 2000R 12-bit RGB camera (Q-
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imaging) on an Olympus BX60 epifluorescence microscope using X60 objective and X1 
optivar, which were then processed in Adobe Photoshop. 
 
Fluorescence imaging and quantification 
The images of UNC-13S::GFP and GLR-1::GFP labeled nerve cords were 
captured under Olympus BX60 epifluorescence microscope as stated above.  For 
fluorescence quantification, a 100µm fragment of dorsal nerve cord anterior to the anus 
(UNC-13S::GFP) or ventral nerve cord posterior to the vulva (GLR-1::GFP) was selected 
and analyzed in NIH ImageJ.  Line scan was performed to identify puncta on the nerve 
cords with a fixed threshold.  For coelomocyte AEX-5::VENUS fluorescence 
quantification, images were taken on an Olympus FluoView FV500 scanning confocal 
microscope.  The total coelomocyte fluorescence was then analyzed and quantified in 
ImageJ as described previously (Mahoney et al., 2008). 
 
RNAi 
The bacterial feeding RNAi was carried out essentially as described before 
(Mahoney et al., 2008).  Briefly, bacterial strains expressing dsRNAs that target various 
aex genes were spotted onto NGM plates supplemented with 1mM IPTG and 100µg/ml 
Ampicillin to induce dsRNA expression.  Twelve hours after the induction, two L4 
intestinal RNAi-sensitive animals were picked onto the plates and were allowed to give 
progenies for two generations.  The L4 larvae of the second generation were picked for 
subsequent aldicarb assay.  The experiment was repeated three times and mean and 
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standard error of mean were reported. 
 
Germ line transformation 
The transgenic lines were constructed using standard germ line transformation 
procedures (Mello et al., 1991).  Typically plasmids were injected at 30ng/µl final 
concentration.  For co-injection marker Pmyo-2::gfp, 5ng/µl final concentration was used, 
while for pRF4 (rol-6) the plasmid was injected at 100ng/µl.  At least two independent 
lines of each injection were analyzed. 
 
Supplemental materials and methods 
Strain maintenance 
All C. elegans strains were maintained on E. coli OP50 spotted NGM plates at RT 
using standard procedures unless otherwise stated (Wood, 1988). 
 
Strains 
N2 (wild type) REF(Brenner, 1974), aex-1(sa9) REF(Doi and Iwasaki, 2002; 
Thomas, 1990), aex-2(sa3) REF(Thomas, 1990), aex-4(n2415), aex-4(sa22), aex-
4(ok614), aex-5(sa23) REF(Thomas, 1990), aex-2(sa3);aex-5(sa23), aex-2(sa3);egl-
3(n150); aex-5(sa23);egl-3(n150), nuIs46[unc-13s::gfp], aex-1(sa9);nuIs46[unc-
13s::gfp], aex-2(sa3);nuIs46[unc-13s::gfp], aex-5(sa23);nuIs46[unc-13s::gfp], 
nuIs25[glr-1::gfp], aex-2(sa3);nuIs25[glr-1::gfp], aex-5(sa23);nuIs25[glr-1::gfp], unc-
25(e156) REF(Jin et al., 1999), egl-3(n150), egl-3(ok979), egl-21(n476), rde-
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1(ne219);kbIs7[Pnhx-2::rde-1; rol-6] REF(Espelt et al., 2005), gsa-1(ce81) REF(Schade 
et al., 2005), gsa-1(ce81);aex-2(sa3), gsa-1(ce81);aex-5(sa23), acy-1(js127) REF(Saifee, 
2003), unc-119(ed3);jsIs1072[NM2072 (Pvha-6::aex-5::Venus Cbunc-119)], acy-
1(pk1279);ceEx108(myo-3::acy-1) REF(Reynolds et al., 2005). 
 
aex-2(sa3) jsEx921[NM2101(Prab-3::aex-2::gfp) + pPD118.33(Pmyo-2::gfp) 
line1], aex-2(sa3) jsEx922[NM2101(Prab-3::aex-2::gfp) + pPD118.33(Pmyo-2::gfp) 
line2], aex-2(sa3) jsEx925[NM2102(Pmyo-3::aex-2::yfp) + pPD118.33(Pmyo-2::gfp) 
line1], aex-2(sa3) jsEx928[NM2102(Pmyo-3::aex-2::yfp) + pPD118.33 (Pmyo-2::gfp) 
line2], aex-2(sa3) jsEx929[NM2103(Pges-1::aex-2::gfp) + pPD118.33(Pmyo-2::gfp) 
line1], aex-2(sa3) jsEx930[NM2103(Pges-1::aex-2::gfp) + pPD118.33(Pmyo-2::gfp) 
line2], aex-2(sa3) jsEx999[NM1707(Pglr-1::aex-2::gfp) + pPD118.33(Pmyo-2::gfp) 
line1], aex-2(sa3) jsEx1000[NM1707(Pglr-1::aex-2::gfp) + pPD118.33(Pmyo-2::gfp) 
line2], aex-2(sa3) jsEx1007[NM1841(Punc-17::aex-2::gfp) + pPD118.33(Pmyo-2::gfp) 
line1], aex-2(sa3) jsEx1008[NM1841(Punc-17::aex-2::gfp) + pPD118.33(Pmyo-2::gfp) 
line2], aex-2(sa3) jsEx1003[NM1843(Punc-47::aex-2::gfp) + PD118.33(Pmyo-2::gfp) 
line1], aex-2(sa3) jsEx1004[NM1843(Punc-47::aex-2::gfp) + pPD118.33(Pmyo-2::gfp) 
line2], aex-2(sa3) jsEx987[NM1778(Punc-25::acy-1(js127)) + pRF4(rol-6) line1], aex-
2(sa3) jsEx987[NM1778(Punc-25::acy-1(js127)) + pRF4(rol-6) line2] 
 
aex-5(sa23) jsEx1061[NM2059(Pvha-6::aex-5::Venus) + pRF4(rol-6) line1], aex-
5(sa23) jsEx1062[NM2059(Pvha-6::aex-5::Venus) + pRF4(rol-6) line2], aex-5(sa23) 
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jsEx1063[NM2061(Prab-3:: aex-5::Venus) + pRF4(rol-6) line1], aex-5(sa23) 
jsEx1064[NM2061(Prab-3:: aex-5::Venus) + pRF4(rol-6) line2], aex-5(sa23) 
jsEx1066[NM2062(Pmyo-3:: aex-5::Venus) + pRF4(rol-6) line1], aex-5(sa23) 
jsEx1067[NM2062(Pmyo-3:: aex-5::Venus) + pRF4(rol-6) line2], aex-5(sa23) 
jsEx987[NM1778(Punc-25::acy-1(js127)) + pRF4(rol-6) line1], aex-5(sa23) 
jsEx994[NM1778(Punc-25::acy-1(js127))  + pRF4(rol-6) line2] 
 
egl-3(n150) jsEx1115[NM2242(Prab-3::egl-3::Venus) + pPD118.33(Pmyo-
2::gfp) line1], egl-3(n150) jsEx1116[NM2242(Prab-3::egl-3::Venus) + 
pPD118.33(Pmyo-2::gfp) line2], egl-3(n150) jsEx1118[NM2248(Pvha-6::egl-3::Venus) 
+ pPD118.33(Pmyo-2::gfp) line1], egl-3(n150) jsEx1119[NM2248(Pvha-6::egl-
3::Venus) + pPD118.33(Pmyo-2::gfp) line2], egl-3(n150) jsEx1121[NM2182(Pmyo-
3::egl-3::yfp) + pPD118.33(Pmyo-2::gfp) line1], egl-3(n150) jsEx1122[NM2182(Pmyo-
3::egl-3::yfp) + pPD118.33(Pmyo-2::gfp) line2], egl-3(n150) jsEx1142[NM2249(Pglr-
1::egl-3::Venus) + pPD118.33(Pmyo-2::gfp) line1], egl-3(n150) 
jsEx1143[NM2249(Pglr-1::egl-3::Venus) + pPD118.33(Pmyo-2::gfp) line2], egl-3(n150) 
jsEx1144[NM2250(Punc-17::egl-3::Venus) + pPD118.33(Pmyo-2::gfp) line1], egl-
3(n150) jsEx1146[NM2250(Punc-17::egl-3::Venus) + pPD118.33(Pmyo-2::gfp) line2], 
egl-3(n150) jsEx1149[NM2251(Punc-25::egl-3::Venus) + pPD118.33(Pmyo-2::gfp) 
line1], egl-3(n150) jsEx1150[NM2251(Punc-25::egl-3::Venus) + pPD118.33(Pmyo-
2::gfp) line2], egl-3(n150) jsEx1152[NM2252(Punc-47::egl-3::Venus) + 
pPD118.33(Pmyo-2::gfp) line1], egl-3(n150) jsEx1153[NM2252(Punc-47::egl-3::Venus) 
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+ pPD118.33(Pmyo-2::gfp) line2], egl-3(n150) jsEx987[NM1778(Punc-25::acy-1(js127)) 
+ pRF4(rol-6) line1], egl-3(ok979) jsEx987[NM1778(Punc-25::acy-1(js127)) + 
pRF4(rol-6) line1], egl-21(n476) jsEx987[NM1778(Punc-25::acy-1(js127)) + pRF4(rol-
6) line1], egl-21(n476) jsEx987[NM1778(Punc-25::acy-1(js127)) + pRF4(rol-6) line2] 
 
DNA constructs 
The construction of following plasmids has been previously described: NM1707, 
NM1778, NM1841, NM1843, NM2059, NM2061, NM2062, NM2101, NM2102, 
NM2103 (Mahoney et al., 2008).  See reference for oligos and detailed cloning 
procedures. 
 
NM2242-egl-3 cDNA fused with Venus at the C-terminus driven by neuronal rab-
3 promoter.  The 2kb full-length egl-3 cDNA was amplified from C. elegans cDNA 
library (kindly provided by Dr. Robert Barstead) using oligos 5’-TAGA AGTC GGA 
TCC ATGAAAAACACACATGTCGACCT-3’ and 5’-TAGA AGTC ACT AGT 
GTGGCTGCGTTTGTGGGCTT-3’.  The PCR product was fully digested by SpeI and 
partially digested by BamHI, with the full length digestion product ligated into BamHI 
and SpeI digested plasmid NM2101 (Prab-3::aex-2::gfp).  The 2kb egl-3 cDNA swapped 
aex-2 coding region, resulting in Prab-3::egl-3::gfp construct.  This plasmid was then 
digested with SpeI and SacII to remove gfp coding region.  The 900bp Venus coding 
region was subsequently amplified from NM1358 (Prab-3::Venus) using oligos 5’- 
TAGA AGTC ACT AGT ATGAGTAAAGGAGAAGAACTTTTC-3’ and 5’- TAGA 
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AGTC CCG CGG CTATTTGTATAGTTCATCCATGCCAAG-3’, digested with SpeI 
and SacII and ligated into above Prab-3::egl-3 vector.  This gave the plasmid Prab-
3::egl-3::Venus. 
 
NM2248-egl-3 cDNA fused with Venus at the C-terminus driven by intestinal 
vha-6 promoter.  An intermediate plasmid NM2244 (Punc-25::egl-3::gfp) was first made 
to facilitate the construction of NM2248 (Pvha-6::egl-3::Venus).  The 1.5kb unc-25 
promoter and 2.0kb full-length egl-3 cDNA were fused together by overlap PCR using 
oligos 5’- TAGA AGTC GCA TGC GCCGAAATTTAAAGCTAGTTTTTTTG-3’, 5’- 
AGGTCGACATGTGTGTTTTTCAT GCT AGC TTTTGGCGGTGAACTGAGCT-3’ 
(amplifying 1.5kb Punc-25) and 5’- AGCTCAGTTCACCGCCAAAA GCT AGC 
ATGAAAAACACACATGTCGACCT-3’, 5’- TAGA AGTC ACT AGT 
GTGGCTGCGTTTGTGGGCTT-3’ (amplifying 2.0kb egl-3 cDNA).  The Punc-
25::egl-3 fusion fragment was digested with SphI and SpeI and ligated with SphI and SpeI 
digested 5.0kb gfp vector backbone amplified from NM1019 (Prab-3::gfp::rim3’) using 
oligos 5’- ACT CAT ACT AGT ATGGCACCGGTCGCCAC-3’ and 5’- TAGA AGTC 
GCA TGC ACTGCTCCCATCTGAAGATC-3’.  The plasmid NM2244 (Punc-25::egl-
3::gfp) was then digested with SphI and NheI to remove Punc-25, followed by ligation 
with SphI (partial) and NheI digested 1.2kb vha-6 intestinal promoter amplified from 
NM1352 (VHA-6mch) using oligos 5’- TCTA CGAT GCA TGC 
GCATGTACCTTTATAGGTGCG-3’, 5’- TCTA CGAT GCT AGC 
GGGTAGGTTTTAGTCGCCCT-3’.  This gives the plasmid NM2247 (Pvha-6::egl-
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3::gfp).  Finally, the gfp in this plasmid was digested out with SpeI and SacII and 
replaced with SpeI and SacII digested 900bp Venus coding sequence, which was 
amplified from NM1358 (Prab-3::Venus) using oligos 5’- TAGA AGTC ACT AGT 
ATGAGTAAAGGAGAAGAACTTTTC-3’ and 5’- TAGA AGTC CCG CGG 
CTATTTGTATAGTTCATCCATGCCAAG-3’.  This gave the plasmid Pvha-6::egl-
3::Venus. 
 
NM2182-egl-3 cDNA fused with yfp at the C-terminus driven by muscular myo-3 
promoter.  The 2kb full-length egl-3 cDNA was amplified from C. elegans cDNA library 
using oligos 5’- TAGA AGTC GCT AGC ATGAAAAACACACATGTCGACCT-3’ and 
5’- TAGA AGTC AGG CCT GTGGCTGCGTTTGTGGGCTT-3’.  The PCR product 
was then digested with NheI and StuI and ligated with NheI, StuI double digested plasmid 
NM2102 (Pmyo-3::aex-2::yfp).  This replaced aex-2 with egl-3 coding sequence and gave 
the plasmid Pmyo-3::egl-3::yfp. 
 
NM2249-egl-3 cDNA fused with Venus at the C-terminus driven by glutamate 
receptor glr-1 promoter.  An intermediated plasmid NM2184 (Pglr-1::egl-3::gfp) was 
first made to facilitate the construction of NM2249 (Pglr-1::egl-3::Venus).  The 2kb full-
length egl-3 cDNA was amplified from the C. elegans cDNA library using oligos 5’-
TAGA AGTC GGA TCC ATGAAAAACACACATGTCGACCT-3’ and 5’-TAGA 
AGTC ACT AGT GTGGCTGCGTTTGTGGGCTT-3’.  The PCR product was fully 
digested by SpeI and partially digested by BamHI, with the full length digestion product 
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ligated into BamHI and SpeI digested plasmid NM1707 (Pglr-1::aex-2::gfp).  The 2kb 
egl-3 cDNA replaced aex-2 coding region, giving NM2184 (Pglr-1::egl-3::gfp).  This 
plasmid was then digested with SpeI and SacII to remove the gfp coding sequence and 
ligated with SpeI and SacII double digested 900bp Venus coding region amplified from 
plasmid NM1358 (Prab-3::Venus) using oligos 5’- TAGA AGTC ACT AGT 
ATGAGTAAAGGAGAAGAACTTTTC-3’ and 5’- TAGA AGTC CCG CGG 
CTATTTGTATAGTTCATCCATGCCAAG-3’.  This gave the plasmid Pglr-1::egl-
3::Venus. 
 
NM2250-egl-3 cDNA fused with Venus at the C-terminus driven by cholinergic 
unc-17 promoter.  An intermediated plasmid NM2185 (Punc-17::egl-3::gfp) was first 
made to facilitate the construction of NM2250 (Punc-17::egl-3::Venus).  The 2kb full-
length egl-3 cDNA was amplified from C. elegans cDNA library using oligos 5’-TAGA 
AGTC GGA TCC ATGAAAAACACACATGTCGACCT-3’ and 5’-TAGA AGTC ACT 
AGT GTGGCTGCGTTTGTGGGCTT-3’.  The PCR product was fully digested by 
SpeI and partially digested by BamHI, with the full length digestion product ligated into 
BamHI and SpeI digested plasmid NM1841 (Punc-17::aex-2::gfp).  The 2kb egl-3 cDNA 
replaced aex-2 coding region, giving NM2185 (Punc-17::egl-3::gfp).  This plasmid was 
then digested with SpeI and SacII to remove the gfp coding sequence and ligated with 
SpeI and SacII double digested 900bp Venus coding region amplified from plasmid 
NM1358 (Prab-3::Venus) using oligos 5’- TAGA AGTC ACT AGT 
ATGAGTAAAGGAGAAGAACTTTTC-3’ and 5’- TAGA AGTC CCG CGG 
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CTATTTGTATAGTTCATCCATGCCAAG-3’.  This gave the plasmid Punc-17::egl-
3::Venus. 
 
NM2251-egl-3 cDNA fused with Venus at the C-terminus driven by GABA 
synthase unc-25 promoter.  An intermediated plasmid NM2244 (Punc-25::egl-3::gfp) 
was first made to facilitate the construction of NM2251 (Punc-25::egl-3::Venus).  The 
1.5kb unc-25 promoter and 2.0kb full-length egl-3 cDNA were fused together by overlap 
PCR using oligos 5’- TAGA AGTC GCA TGC 
GCCGAAATTTAAAGCTAGTTTTTTTG-3’, 5’- AGGTCGACATGTGTGTTTTTCAT 
GCT AGC TTTTGGCGGTGAACTGAGCT-3’ (amplifying 1.5kb Punc-25) and 5’- 
AGCTCAGTTCACCGCCAAAA GCT AGC ATGAAAAACACACATGTCGACCT-3’, 
5’- TAGA AGTC ACT AGT GTGGCTGCGTTTGTGGGCTT-3’ (amplifying 2.0kb 
egl-3 cDNA).  The Punc-25::egl-3 fusion fragment was digested with SphI and SpeI and 
ligated with SphI and SpeI digested 5.0kb gfp vector backbone amplified from NM1019 
(Prab-3::gfp::rim3’) using oligos 5’- ACT CAT ACT AGT 
ATGGCACCGGTCGCCAC-3’ and 5’- TAGA AGTC GCA TGC 
ACTGCTCCCATCTGAAGATC-3’.  The resulting plasmid NM2244 (Punc-25::egl-
3::gfp) was then digested with SpeI and SacII to remove the gfp coding sequence and 
ligated with SpeI and SacII double digested 900bp Venus coding region amplified from 
plasmid NM1358 (Prab-3::Venus) using oligos 5’- TAGA AGTC ACT AGT 
ATGAGTAAAGGAGAAGAACTTTTC-3’ and 5’- TAGA AGTC CCG CGG 
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CTATTTGTATAGTTCATCCATGCCAAG-3’.  This gave the plasmid Punc-25::egl-
3::Venus. 
 
NM2252-egl-3 cDNA fused with Venus at the C-terminus driven by GABAergic 
unc-47 promoter.  An intermediated plasmid NM2245 (Punc-47::egl-3::gfp) was first 
made to facilitate the construction of NM2252 (Punc-47::egl-3::Venus).  The 1.45kb unc-
47 promoter and 2.0kb full-length egl-3 cDNA were fused together by overlap PCR using 
oligos 5’- TAGA AGTC GCA TGC ATGTTGTCATCACTTCAAACTTTTC-3’, 5’- 
AGGTCGACATGTGTGTTTTTCAT GCT AGC 
CTGTAATGAAATAAATGTGACGCTG-3’ (amplifying 1.45kb Punc-47) and 5’- 
CAGCGTCACATTTATTTCATTACAG GCT AGC 
ATGAAAAACACACATGTCGACCT-3’, 5’-TAGA AGTC ACT AGT 
GTGGCTGCGTTTGTGGGCTT-3’ (amplifying 2.0kb egl-3 cDNA).  The Punc-
47::egl-3 fusion fragment was digested with SphI and SpeI and ligated with SphI and SpeI 
digested 5.0kb gfp vector backbone amplified from NM1019 (Prab-3::gfp::rim3’) using 
oligos 5’-ACT CAT ACT AGT ATGGCACCGGTCGCCAC-3’ and 5’-TAGA AGTC 
GCA TGC ACTGCTCCCATCTGAAGATC-3’.  The resulting plasmid NM2245 (Punc-
47::egl-3::gfp) was then digested with SpeI and SacII to remove the gfp coding sequence 
and ligated with SpeI and SacII double digested 900bp Venus coding region amplified 
from plasmid NM1358 (Prab-3::Venus) using oligos 5’- TAGA AGTC ACT AGT 
ATGAGTAAAGGAGAAGAACTTTTC-3’ and 5’- TAGA AGTC CCG CGG 
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CTATTTGTATAGTTCATCCATGCCAAG-3’.  This gave the plasmid Punc-47::egl-
3::Venus. 
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Figure legends 
Figure 1.  aex-2 and aex-5 mutants are defective in presynaptic cholinergic transmission.  
A) Time-course analysis of 1mM aldicarb induced paralysis in aex mutants.  Both aex-2 
and aex-5 animals show enhanced resistance to aldicarb treatment.  B) Time-course 
analysis of 200µM Ach agonist levamisole induced paralysis.  aex-2 and aex-5 mutants 
show similar sensitivity to levamisole as wild type animals.  As a control, AchR mutant 
unc-29(e1072) is completely resistant to levamisole induced paralysis.  C) RAB-3 
antibody staining of wild type and aex animals.  All three lines show comparable staining 
at nerve ring (NR), dorsal nerve cord (DNC), and SAB head cholinergic motor axons 
(SAB).  D) RIM-1 antibody staining of wild type and aex animals.  All three lines show 
comparable staining at nerve ring (NR), dorsal nerve cord (DNC), and ventral nerve cord 
(VNC).  Scale bar, 20µm. 
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Figure 1.  aex-2 and aex-5 mutants are defective in presynaptic cholinergic transmission. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
A B 
C D 
 168 
Figure 2.  aex-2 and aex-5 mutants have normal UNC-13S::GFP and GLR-1::GFP 
expressions in the nerve cords.  A) Fluorescence images of UNC-13S::GFP expressions 
in the dorsal nerve cord of wild type and aex animals.  No obvious changes in the 
expression are seen in the aex mutants.  The cord fluorescence and number of UNC-
13S::GFP puncta are quantified in B) and C), respectively.  D) Fluorescence images of 
GLR-1::GFP expressions the ventral nerve cord of wild type and aex animals.  No 
obvious changes in the expression are seen in the aex mutants.  The number of GLR-
1::GFP puncta is quantified in E).  Scale bar, 20µm. 
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Figure 2. aex-2 and aex-5 mutants have normal UNC-13S::GFP and GLR-1::GFP 
expressions in the nerve cords. 
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Figure 3.  AEX-5 functions in the intestine to regulation synaptic transmission.  A) The 
expression of AEX-5::VENUS in the intestine rescues aldicarb phenotype in the aex-5 
mutant.  In contrast, both neuronal and muscular expressions of AEX-5::VENUS 
partially restores aldicarb sensitivity in aex-5 animals.  B) Intestinal specific RNAi 
mediated knockdown of endogenous AEX-5 expression induces strong resistance of the 
animal to 1mM aldicarb treatment.  As a control, neither AEX-1 nor AEX-2 RNAi affects 
aldicarb sensitivity in the strain. 
 171 
Figure 3. AEX-5 functions in the intestine to regulation synaptic transmission. 
 
 
 
A B 
 172 
Figure 4.  AEX-2 functions in GABAergic neurons to regulate synaptic transmission.  A) 
Neuronal expression of AEX-2::GFP completely restores aldicarb sensitivity in aex-2 
mutants, while muscular and intestinal expressions do not.  B) GABAergic expression of 
AEX-2::GFP restores aldicarb sensitivity in aex-2 mutants.  In contrast, cholinergic 
AEX-2::GFP expression partially rescues aex-2 aldicarb phenotype, while interneuronal 
expression fails to do so. 
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Figure 4.  AEX-2 functions in GABAergic neurons to regulate synaptic transmission. 
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Figure 5.  Gs! pathway acts genetically downstream of AEX-2 and AEX-5.  A) A gain of 
function mutation in the stimulatory G! subunit GSA-1 in C. elegans fully suppresses 
aldicarb phenotypes in aex-2 and aex-5 mutants.  B) The GABAergic expression of an 
activated acy-1(js127) transgene under the GABA synthase gene unc-25 promoter 
sufficiently restores aldicarb sensitivity in both aex-2 and aex-5 animals. 
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Figure 5.  Gs! pathway acts genetically downstream of AEX-2 and AEX-5. 
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Figure 6.  AEX-2 acts at least in part through the neuropeptide signaling.  A) Disruption 
of either aex-2 or aex-5 gene functions in the egl-3 mutant background does not enhance 
the aldicarb resistance.  B) Neuronal expression of EGL-3::VENUS rescues aldicarb 
phenotypes in egl-3 mutants, while muscular or intestinal expressions do not.  C) 
Disrupting peptide processing enzymes EGL-3 or EGL-21 in GABAergic::acy-1(js127, 
gf) transgenic animals significantly blocks activated ACY-1 induced aldicarb 
hypersensitivity, leading to aldicarb resistance in double animals. 
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Figure 6.  AEX-2 acts at least in part through the neuropeptide signaling. 
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Figure 7.  Food deprivation decreases intestinal activity and induces aldicarb resistance. 
A) A 10h starvation of young adult animals results in significant decrease in defecation 
frequency.  Average number of defecation cycles in 5 minutes reduces from 4.7±0.8 to 
1.5±1.1 for N2 animals, and from 4.7±0.9 to 1.1±1.1 for GABA::acy-1(js127, gf) 
animals.  B) The 10h food deprivation does not affect defecation motor program, with 
most of N2 and GABA::acy-1(js127, gf) animals having functional enteric muscle 
contractions (EMC).  Thus they are not defecation defective.  C) Starved wild type 
animals have enhanced resistance to 1mM aldicarb treatment, while GABAergic 
expression of activated ACY-1 completely blocks the starvation-induced aldicarb 
resistance. 
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Figure 7.  Food deprivation decreases intestinal activity and induces aldicarb resistance. 
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Figure 8.  Model.  The C. elegans intestine functions as an endocrine organ to coordinate 
the defecation and synaptic transmission regulation.  The intestinal prohormone 
convertase (not shown) processes peptides (blue circles) that are secreted from the 
intestine (1).  These intestine-derived signals act on GABAergic neurons (purple ellipse), 
which triggers the release of both GABA (small blue circles) and neuropeptides (green 
circles) via the Gs!-adenylate cyclase pathway (not shown) (2).  Subsequently, GABA 
triggers enteric muscle (EM) contractions and defecation (3), while neuropeptides 
facilitate cholinergic transmission (4).  The GABAergic GPCR AEX-2 likely functions as 
a receptor for intestinal peptide signals (not shown).  A) An active intestine.  This results 
in increased (1) and (2), which increases defecation activity (3) and cholinergic 
transmission (4).  B) An inactive intestine.  The reduced (1) and (2) leads to decreased 
defecation activity (3) and cholinergic function (4). 
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Figure 8.  Model.  The C. elegans intestine functions as an endocrine organ to coordinate 
the defecation and synaptic transmission regulation. 
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Table 1.  Expressing EGL-3 in GABAergic neurons, cholinergic neurons or command 
interneurons partially rescues aldicarb phenotypes in egl-3 mutants.  The experiment was 
repeated at least three times and the fraction of worms that remained responsive to touch 
at 180min of the aldicarb assay was calculated and expressed as mean ± SEM. 
 
 
 
 
 
 
 
 
 
 
 
 
N2 3.7%   0.1%
egl-3(n150) 83.7%   6.8%
Pu17::egl3Venus (n=4) 32.9%   12.9% - 71.6%   6.2%
Pglr1::egl3Venus (n=3) 38.9%   5.6% - 63.5%   1.9%
Pu25::egl3Venus (n=4) 50.0%   9.3% - 76.9%   7.7%
Pu47::egl3Venus (n=10) 27.8%   1.9% - 72.5%   0.5%
± 
± 
± ± 
± ± 
± 
± 
± 
± 
Percentage of worms that 
respond to touch at 180min of 
the 1mM aldicarb treatment Strains 
N2 
egl- 150) 
Punc-17::egl-3::Venus (n=4) 
Pglr-1 : -3::Venus ( 3) 
Punc-25::egl-3::Venus (n=4) 
Punc-47::egl-3::Venus (n=10) 
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Abstract 
The proper formation and maintenance of synapses is important for the correct 
wiring of the nervous system.  Using a genetic screen looking for mutants that disrupt 
synaptic protein localization at mechanosensory PLM synapses, we identified sam-6 as a 
gene that regulates synapse development in the nematode C. elegans.  sam-6 encodes a 
cytoskeletal LIM domain protein ZYX-1, a homologue of vertebrate Zyxin that is found 
in focal adhesion complexes and shuttles between the cytoplasm and nucleus.  The C. 
elegans zyx-1 locus encodes two ZYX-1 isoforms, and both are widely expressed in the 
nervous system, muscles, and spermatheca.  Interestingly, the specific disruption of the 
splicing site in ZYX-1 LIM domain-only short isoform results in PLM synaptic defects, 
suggesting that LIM domains are involved in regulating synapse development.  Using 
time-course imaging analysis of synaptic protein localizations, we revealed that zyx-1 
PLM synapses are still be able to form with apparently normal accumulations of 
presynaptic active zone proteins, synaptic vesicle proteins, and mitochondria.  In contrast, 
PLM synapses fail to maintain in adult mutants, suggesting a defect in synapse 
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maintenance versus synaptogenesis.  Tissue specific rescues reveal that ZYX-1 functions 
in mechanosensory neurons to regulate synapse maintenance.  In an attempt to identify 
signal pathways downstream of ZYX-1, we examined several focal adhesion complex 
mutants and MAP kinase mutants, while we did not detect any defects in PLM synapses.  
Together, our results have provided evidence that the synapse maintenance in C. elegans 
PLM mechanosensory neurons involves a nuclear-cytoskeletal shuttling protein ZYX-1. 
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Introduction 
The nervous system is a network made up of a large number of neurons that are 
electrically connected at synapses.  During development, after a synapse is formed and 
stabilized, it needs to be maintained to carry out functions of both pre- and postsynaptic 
cells.  In past few decades, several classes of molecules have been identified as regulators 
of synaptogenesis and synapse maintenance.  Among them, the molecules that regulate 
neuronal cell contact and adhesion are implicated in organizing and maintaining synaptic 
structures.  For example, at Drosophila giant fiber (GF) circuits, the L1-type cell adhesion 
molecules (CAMs) are required for maintaining normal presynaptic structures 
(Godenschwege et al., 2006).  Disruption of L1-CAMs not only destabilizes presynaptic 
organizations, but also leads to decreased synaptic functions (Godenschwege et al., 
2006).  Moreover, the formation and stabilization of synapses also appear to involve 
cadherin molecules, as in the absence of functional cadherins such as cadherin-11, 
cadherin-13 or atypical cadherin flamingo, the neurons develop with either fewer 
synapses or destabilized synapses and axons (Bao et al., 2007; Paradis et al., 2007).  
These observations strongly suggest that cell adhesion molecules play important roles in 
organizing and maintaining synaptic structures.  However, how these molecules act on 
synapses and what are their downstream signaling mechanisms remain not well 
understood. 
The six-cell mechanosensory system of the nematode C. elegans provides a good 
model to study synapse development.  Noticeably, two posteriorly localized 
mechanosensory neurons, PLML and PLMR, send out neuronal processes anteriorly 
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along the body, and two synapses are formed on the ventral nerve cord with the extended 
branches from PLM processes.  The PLM synapses are large in size and separated from 
synapse rich regions, which make them an excellent system to study synapse formation 
and maintenance during development. 
Here, we report the identification of a cytoskeletal protein ZYX-1 that likely acts 
in adhesion complexes to regulate PLM synapse development in C. elegans.  ZYX-1 is a 
LIM domain protein that is conserved in worms and mammals.  The nematode zyx-1 gene 
encodes at least two ZYX-1 isoforms, and the LIM domain-containing short form appears 
to be required for the synaptic development.  We found that ZYX-1 likely regulates both 
synapse formation and maintenance, as zyx-1 young larva form fewer PLM synapses, 
which are apparently normal.  In contrast, adult zyx-1 mutants fail to maintain many of 
the synapses.  ZYX-1 is broadly expressed in neurons and other non-neuronal tissues.  
We showed that ZYX-1 functions autonomously in mechanosensory neurons to regulate 
synapse maintenance.  Interestingly, expression of ZYX-1 in yeast induces yeast cell to 
aggregate, suggesting a role of ZYX-1 in organizing adhesion complexes.  We then 
intended to determine what cell adhesion molecules might be involved in ZYX-1 
functions.  So far, we did not observe any PLM defects in the absence of functional 
integrins or SYG-1/2.  We are currently testing if cadherins are involved in maintaining 
PLM synapses.  Together, our results support a role of a cytoskeletal protein ZYX-1 in 
regulating mechanosensory synapse development. 
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Results 
zyx-1 mutants lack synaptic protein accumulation at PLM synapses 
To identify genes that regulate synapse development in C. elegans, we used a 
transgenic line that specifically expresses GFP fused synaptobrevin in mechanosensory 
neurons.  We performed ethylmethane sulfonate (EMS) mutagenesis using this transgenic 
line, and we recovered sam-6 (which is zyx-1) as a mutant that lacks SNB-1::GFP at the 
PLM synapses.  The SNB-1::GFP nicely labels PLM synapses in wild type animals.  
However, as it is relatively dim and not easy to score under dissection scopes, we then 
used a bright GFP::RAB-3 line (expressed in mechanosensory neurons) to analyze all the 
zyx-1 mutant phenotypes.  We first characterized the GFP::RAB-3 localization in wild 
type and mutant mechanosensory neurons.  As shown in Fig 1A, in wild type animals, 
GFP::RAB-3 labels processes of PLMs and PVM neurons as well as two synaptic patches 
formed by PLM neurons on the ventral cord (Fig 1A, 1A’).  Noticeably, in zyx-1 mutants, 
no PLM synaptic structures are observed, while all the neuronal processes are normally 
labeled by GFP::RAB-3 (Fig 1B).  We found that GFP::RAB-3 signals somehow 
accumulate on distal ends of PLM processes, forming a beads-on-a-thread structure (Fig 
1B, 1B’).  Moreover, the branches sending out by PLM processes are often missing in the 
mutant, while occasionally a branch and a single synaptic patch are observed on the 
ventral cord (Fig 1B’).  Therefore, zyx-1 mutants likely have disrupted PLM synapses.  It 
remains unclear if the missing PLM synapse is caused by abnormalities in synapse 
formation, synapse maintenance, or both. 
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zyx-1 mutants are defective in PLM synapse formation and maintenance 
As the lack of synaptic GFP::RAB-3 accumulation in zyx-1 mutants could be 
caused by disrupted protein trafficking to synaptic sites, we first examined if a synaptic 
structure is still present in zyx-1 mutants by using a transgenic line that expresses 
cytoplasmic RFP in mechanosensory neurons.  As shown in Fig 2A, diffused RFP labels 
both PLM processes and synaptic patches on the ventral cord in wild type animals (Fig 
2A).  In contrast, no RFP is seen at the positions of PLM synapses in zyx-1 animals, 
indicating the lack of synaptic structures in the mutant (Fig 2A).  Therefore, the absence 
of GFP::RAB-3 accumulation at zyx-1 PLM synapses is unlikely resulted from defective 
protein trafficking. 
We then performed time-course analysis of GFP::RAB-3 localization at both wild 
type and mutant PLM synapses to see if ZYX-1 regulates synapse formation or 
maintenance.  As shown in Fig 2B, both wild type and mutant PLM neurons have 
extended PLM processes in newly hatched L1 animals (0h).  At 22.5°C, wild type PLM 
processes start extending branches towards the ventral cord at around 2 hours (2h).  The 
appearance of GFP::RAB-3 at synapses slightly lags behind the branch extension, and at 
4 hours significant fractions (38.6 ± 3.6%) of PLM processes have GFP::RAB-3 labeled 
synapses on the ventral nerve cord (4h) (Fig 2B, 2C).  By the time of 8 hours, about 95% 
(95 ± 0%) of wild type PLM neurons have formed bright GFP::RAB-3 patches at 
synaptic sites (8h), which keep growing in size in developing larva until animals get to 
adulthood (Fig 2B, 2C, 8h-48h).  Surprisingly, zyx-1 mutants are still able to form PLM 
synapses as revealed by GFP::RAB-3 accumulations, while they have significantly 
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slowed synapse formation compared with wild type animals.  As shown in Fig 2B, the 
first PLM synapse is not seen on the mutant ventral cord until 4 hours after hatch (Fig 
2B).  After that, the fractions of PLM processes with formed synapses increase slowly, 
and by 24 hours only 46.2 ± 3.8% of mutant PLM neurons have formed synapses on the 
ventral cord (Fig 2C).  Intriguingly, after this developmental time point (24h), zyx-1 
mutants seem to start losing PLM synapses.  This is revealed by the decrease in the 
GFP::RAB-3 labeled synaptic puncta, and by the time of young adults (48h) only 25.0 ± 
2.5% of mutant PLM processes still maintain synapses on the ventral cord (Fig 2C).  
Accompanied with the decrease in synaptic numbers, there is an increase in the 
GFP::RAB-3 accumulation on mutant PLM processes, which form beads like structures 
(Fig 2A).  Therefore, our results indicate that while ZYX-1 regulates synapse formation, 
it is also required to maintain synapses in the developing mechanosensory system. 
The PLM synapses formed in zyx-1 mutants are smaller and less structurally 
complicated compared with wild type PLM synapses.  To examine if the mutant PLM 
synapse have proper localization of synaptic proteins, we crossed the mutant into 
transgenic lines that express either a mitochondria localized GFP or an active zone 
protein RIM-1::GFP in mechanosensory neurons.  As shown in Fig 2B’ and 2B”, both 
mitochondria GFP and RIM-1::GFP are localized to PLM synapses in zyx-1 animals (Fig 
2B’, 2B”).  Interestingly, the GFP intensities of these synaptic markers are generally 
lower than those in wild type animals, indicating a decrease in the synapse size, 
complexity, or both, in zyx-1 animals.  We concluded that PLM synapses in mutants 
accumulate proper synaptic proteins at lower intensities. 
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zyx-1 encodes a focal adhesion LIM domain protein that is widely expressed in the 
nervous system 
We mapped the original sam-6 mutant to chromosome II and we demonstrated 
that it is zyx-1.  In C. elegans, zyx-1 encodes a focal adhesion LIM domain protein that 
shares homology with vertebrate zyxin, which has been found in cytoplasmic part of the 
focal adhesion complex (Wang and Gilmore, 2003) (Fig 3A).  The zyx-1 locus produces 
at least five transcripts, and they encode in total two ZYX-1 isoforms, a short form and a 
long form, in the nematode (Fig 3A).  ZYX-1 contains three highly conserved C-terminal 
LIM domains (Fig 3A).  Interestingly, a splice site mutation in the transcript of ZYX-1 
short form that contains only C-terminal LIM domains disrupts PLM synapse 
development, suggesting that LIM domains are specifically required for PLM synapse 
formation and maintenance. 
We then analyzed ZYX-1 expressions using rescuing ZYX-1 genomic constructs 
with either mCherry (a RFP variant) or GFP fused to the N- and C-terminus of ZYX-1, 
respectively.  In the animals co-injected with the two constructs, the N-terminal mCherry 
labels only the long form of ZYX-1 protein, while C-terminal GFP labels all ZYX-1 
isoforms, which we thought would help identify isoform specific ZYX-1 expression 
patterns.  As shown in Fig 3B, ZYX-1::GFP is widely detected in neurons, muscles, and 
spermatheca (a structure where oocytes get fertilized by stored sperms).  In the nervous 
system, the ZYX-1::GFP strongly labels cell bodies and axons of many neurons in the 
head ganglia, the ventral cord, and the tail ganglia, and we were unable to distinguish 
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between a nuclear and cytoplasmic localization of ZYX-1::GFP under such over-
expression conditions (Fig 3B).  In comparison, the expression of mCherry::ZYX-1 is 
pretty similar to that of ZYX-1::GFP, while it is much weaker in the intensity (Fig 3B).  
This suggests that the long form ZYX-1 is expressed at relatively low levels in C. 
elegans.  Interestingly, despite its broad expressions, zyx-1 animals show no noticeable 
defects in locomotion and other behaviors such as egg laying and mating.  This suggests 
that either a long form ZYX-1 is required for these cellular functions, or there are 
redundant proteins that compensate the reduction-of-function of ZYX-1 in zyx-1 mutants.  
We concluded that ZYX-1 is a broadly expressed protein with its long form maintained at 
relatively low levels in C. elegans. 
 
ZYX-1 functions autonomously in mechanosensory neurons to regulate PLM 
synapse development 
To assess where ZYX-1 functions to regulate PLM synapse development, we 
directed the expression of ZYX-1::GFP fusion proteins to mechanosensory neurons 
(driven by Pmec-7), subset of command interneurons (driven by Pglr-1), or muscles 
(driven by Pmyo-3) and examined which expression rescues PLM synapse defects.  At 
PLM synapses, the presynaptic mechanosensory PLM neurons mainly synapse onto 
command interneurons AVA, AVD, AVE, and PVC, all of which express GLR-1 (Hart et 
al., 1995; Maricq et al., 1995).  Therefore, by driving ZYX-1::GFP expression in 
mechanosensory neurons or command interneurons, we expected to distinguish a 
presynaptic versus a postsynaptic involvement of ZYX-1 in PLM synapse development.  
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As shown in Fig 4A, expression of ZYX-1::GFP in mechanosensory neurons 
significantly restores GFP::RAB-3 accumulation at PLM synapses in zyx-1 mutants (Fig 
4A).  In contrast, glutamatergic or muscular expressions of ZYX-1::GFP do no rescue 
mutant PLM phenotypes, suggesting ZYX-1 acts presynaptically to regulate synapse 
development (Fig 4A).  We then assessed if a short form of ZYX-1 is sufficient to restore 
PLM synapse development.  For this purpose, we expressed either N- or C-terminal half 
of full-length ZYX-1 in mechanosensory neurons.  As shown in Fig 4c, the expression of 
ZYX-1 C-terminal tandem LIM domains is sufficient to restore PLM synapses in zyx-1 
mutants, while the N-terminal ZYX-1 fails to rescue (Fig 4B).  This indicates that the 
LIM domains of ZYX-1 are important for ZYX-1 functions.  Together, our results 
suggest a cell autonomous role of ZYX-1 in regulating mechanosensory synapse 
development. 
 
Intention to identify the interactions between ZYX-1 and other cell adhesion and 
signaling molecules 
In vertebrates, the ZYX-1 homologue protein zyxin is found in focal adhesion 
complexes.  It interacts with various integrins, actin binding proteins, and signaling 
molecules, and it is implicated in regulating cell adhesion, motility and gene transcription 
(Wang and Gilmore, 2003).  Therefore, to assess if the C. elegans ZYX-1 functions in 
any of the adhesion complexes or signal pathways, we examined a series of mutants that 
are defective in integrins, focal adhesion proteins, IgG superfamily molecules, or 
signaling kinases to see if they have disrupted synapse development.  The results are 
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summarized in Table 1.  As shown in the table, we failed to detect significant defects in 
PLM synapse development in any of the mutants.  Also we noticed that although 
mutations in the p38 MAP kinase pathway (dlk-1, mkk-4, pmk-3) suppress PLM synaptic 
defects in rpm-1 mutants (Nakata et al., 2005 and data not shown), they do not suppress 
the synaptic defects in zyx-1 animals (Table 1).  Therefore, these molecules are unlikely 
to be involved in ZYX-1’s functions. 
We next performed a yeast two-hybrid screen to look for interacting proteins for 
the ZYX-1 LIM domains.  As the LIM domains are suggested in PLM synapse 
development, we thought their interacting proteins might be involved in ZYX-1 
functions.  We recovered around 20 candidate molecules from the screen.  Some of the 
candidates encode mitosis/meiosis related molecules, while the others are unannotated.  
We were able to get mutant alleles for five of the candidates, i.e. C44B9.2(tm3522), 
F29G6.3(tm3495), zfp-1(ok554), div-1(or148), and atn-1(ok84), and we examined their 
PLM synapses.  We failed to detect any defects in the PLM synapse development in the 
mutants examined (data not shown).  We will need to wait for more available mutants to 
determine if the remaining candidate molecules are involved in regulating PLM synapse 
development. 
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Discussion 
Previous studies have established a role for cell adhesion molecules in regulating 
synapse development, while how they transmit the signals inside the cell remains not well 
understood.  Here we provide evidence that a C. elegans focal adhesion protein ZYX-1 
may act in adhesive complexes to regulate synapse formation and maintenance in 
mechanosensory neurons.  ZYX-1 is widely expressed in neurons, and it functions cell-
autonomously in mechanosensory neurons to regulate PLM synapse development.  
Interestingly, the C-terminal LIM domains are important for ZYX-1 functions, suggesting 
that ZYX-1 may regulate synapse development via LIM domain mediated protein 
interactions.  Our results provide a possible link between the synaptic regulatory cell 
adhesion molecules and their cytoplasmic signaling. 
ZYX-1 is a conserved focal adhesion protein that contains a putative N-terminal 
actin binding domain and three C-terminal LIM domains.  In vertebrates, the vertebrate 
homologue of ZYX-1 has been implicated in actin dynamics, and it is actively involved 
in the regulation of cell adhesion, motility, and mechanotransduction (Hirata et al., 2008; 
Wang and Gilmore, 2003).  Interestingly, several lines of evidence suggest that the ZYX-
1 homologue is able to shuttle between focal adhesion sites and nucleus in vertebrates 
(Nix and Beckerle, 1997; Nix et al., 2001).  This suggests that the C. elegans ZYX-1 may 
regulates PLM synapse development by a similar mechanism, where it modulates gene 
transcriptions during early PLM neuron development.  Unfortunately, we were unable to 
detect a nuclear accumulation of ZYX-1 in mechanosensory neurons using either a multi-
copy mCherry::zyx-1::gfp transgenic line or a single-copy integrated line (Fig 3 and data 
 196 
not shown).  Thus, it is likely that ZYX-1 mainly localizes to the cytoplasm.  As in 
vertebrates, the mutation in the putative nuclear export signal (NES) in zyxin induces 
nuclear localization of the protein, it will be interesting to determine if there is a similar 
NES in the C. elegans ZYX-1, and if there is, whether deleting the sequence leads to 
ZYX-1 nuclear accumulation. 
We have tried several ways to identify proteins that may act together with ZYX-1 
in regulating synapse development.  In summary, we have examined three types of 
molecules, while so far we did not detect any functions of them in regulating PLM 
synapse development: 1) Cell adhesion complex molecules.  These include integrins, 
focal adhesion proteins UNC-97 and UNC-98, and IgG superfamily proteins SYG-1 and 
SYG-2 that have been shown to regulate HSN synapse development (Shen et al., 2004); 
2) Signaling molecules.  These include p38 MAP kinase pathway components DLK-1, 
MKK-4, PMK-3, which have been shown to regulate PLM and GABAerigc synapse 
development (Nakata et al., 2005); 3) ZYX-1 LIM domain interacting proteins.  These 
include an actin binding protein, a zinc finger protein, a cell division protein, and two 
unannotated proteins (Table 2).  As a result, we think ZYX-1 may depend on other 
classes of molecules to carry out its functions.  One of the sets of molecules we are 
currently looking at are cadherins/catenins, as evidence suggests that the vertebrate zyxin 
and N-cadherin/catenins are present in a complex (Lee et al., 2004).  This leads us to 
examine PLM synapse development in available cadherin/catenin mutants.  If there are 
any defects detected, we will test the interactions of cadherins/catenins with the ZYX-1 
pathway using genetic and biochemical approaches.  Also we are trying to characterize 
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more mutants of LIM domain interacting proteins, as some of them might be available in 
the near future.  Together, the characterization of ZYX-1 pathway and the involved 
proteins will eventually lead to a better understanding on the molecular mechanisms that 
underlie synapse development. 
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Materials and methods 
Strain maintenance 
All C. elegans strains were maintained on E. coli OP50 spotted NGM plates at RT 
using standard procedures unless otherwise stated (Wood, 1988). 
 
Strains 
N2 (wild type) REF (Brenner, 1974), sam-6(js417), zyx-1(gk190), syg-1(ky652), 
syg-2(ky671), ina-1(gm144), ina-1(gm39), pat-3(st564);mwEx31[pat-3(Y804F),sur-
5::gfp], pat-4(st551);zpEx225[gfp::pat-4(S334A);rol-6], unc-97(su10), unc-98(su130), 
mkk-4(ok1545), pmk-3(ok169), C44B9.2(tm3522), F29G6.3(tm3495), zfp-1(ok554), div-
1(or148), atn-1(ok84), jsIs821[Pmec-7::gfp::rab-3,Cbrunc-119], jsIs973[Pmec-
7::mrfp,Cbrunc-119], jsIs608[Pmec7::mtgfp; pJM23(lin-15)], jsEx448[Pmec-7::rim-
1::gfp;pJM23(lin-15)];lin-15(n765) 
 
jsIs821;jsIs973, jsIs608;jsIs973, jsEx448;jsIs973, sam-6(js417);jsIs821;jsIs973, 
sam-6(js417);jsIs608;jsIs973, sam-6(js417);jsEx448;jsIs973, zyx-
1(gk190);jsIs821;jsIs973, zyx-1(gk190);jsIs608;jsIs973, zyx-1(gk190);jsEx448;jsIs973, 
syg-1(ky652);jsIs821, syg-2(ky671);jsIs821, ina-1(gm144);jsIs821, ina-1(gm39);jsIs821, 
pat-3(st564);jsIs973;mwEx31, pat-4(st551);jsIs821;zpEx225, unc-97(su110);jsIs821, 
jsIs973;unc-98(su130), mkk-4(ok1545);jsIs821, zyx-1(gk190);mkk-4(ok1545);jsIs821, 
pmk-3(ok169);jsIs821, zyx-1(gk190);pmk-3(ok169);jsIs821, C44B9.2(tm3522);jsIs821, 
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F29G6.3(tm3495);jsIs821, zfp-1(ok554);jsIs821, div-1(or148);jsIs821, atn-
1(ok84);jsIs821 
 
jsEx1013[NM1860(mcherry::zyx-1), NM1874(zyx-1::gfp)], sam-
6(js417);jsEx1015[NM1934(Pmec-7::zyx-1(fl)::gfp) + pPD118.33(Pmyo-2::gfp) line1], 
sam-6(js417);jsEx1017[NM1934(Pmec-7::zyx-1(fl)::gfp) + pPD118.33(Pmyo-2::gfp) 
line2], sam-6(js417);jsEx1020[NM1938(Pglr-1::zyx-1(fl)::gfp) + pPD118.33(Pmyo-
2::gfp) line1], sam-6(js417);jsEx1021[NM1938(Pglr-1::zyx-1(fl)::gfp) + 
pPD118.33(Pmyo-2::gfp) line2], sam-6(js417);jsEx1024[NM1941(Pmyo-3::zyx-
1(fl)::yfp) + pPD118.33(Pmyo-2::gfp) line1], sam-6(js417);jsEx1025[NM1941(Pmyo-
3::zyx-1(fl)::yfp) + pPD118.33(Pmyo-2::gfp) line2], sam-
6(js417);jsEx1043[NM2004(Pmec-7::gfp::zyx-1(aa 1-293)) + pPD118.33(Pmyo-2::gfp) 
line1], sam-6(js417);jsEx1044[NM2004(Pmec-7::gfp::zyx-1(aa 1-293)) + 
pPD118.33(Pmyo-2::gfp) line2], sam-6(js417);jsEx1047[NM2006(Pmec-7::gfp::zyx-1(aa 
294-603)) + pPD118.33(Pmyo-2::gfp) line1], sam-6(js417);jsEx1048[NM2006(Pmec-
7::gfp::zyx-1(aa 294-603)) + pPD118.33(Pmyo-2::gfp) line2] 
 
Constructs 
NM1860-zyx-1 genomic construct with mCherry fused at the N-terminus. A 
recombineering pipeline protocol has been adapted to make the mCherry::zyx-1 fusion 
plasmid (Sarov et al., 2006).  Briefly, a 1.8kb KanRmch fragment was amplified from the 
plasmid NM1849 pR6KKanRmch using oligos 5’ - 
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CGTGCTCGCTCCTTCAGCACTATTCCAGACTCGGCATCCGCTACTGATCTGAA
TTCTGAAGTTCCTATTCTCT - 3’ and 5’- 
CTTACGGATGGGAGTAGAGGGGGTGGTGGAGGCGGAGGCGGGGGTCCCATC
TTGTACAGCTCGTCCATGC - 3’.  The PCR product was digested with DpnI to 
remove the template plasmid, followed by electroporation into the cells containing zyx-1 
fosmids.  After recombination, the KanR was removed by anhydrotetracycline treatment, 
and the mCherry::zyx-1 fragment was gap repaired into an Amp vector backbone using 
oligos 5’-  
AAATAAAAAAATAGAAAAATACTTGAAAAATATTGAAAAAGATTTTAAAAA
TACAATTCGTTATGCATTATGGGTAC - 3' and 5’ - 
TACAAATTCGGCAAATCGACAACTTGCCGGTTTGCCGGAAACTATCAATTTAC
CAATCTAAGTCTGTGCTCC - 3'.  This gave the plasmid mCherry::zyx-1. 
 
NM1874- zyx-1 genomic construct with gfp fused at the C-terminus. A 
recombineering pipeline protocol has been adapted to make the zyx-1::gfp fusion 
plasmid.  Briefly, a 1.8kb GFPKanR fragment was amplified from the plasmid NM1835 
pR6KGFP using oligos 5’ - 
TGCTCTGCAAGACCTGTAATGGAAACCGGCTCCGCGTGGTCAGCTCCACGAG
CTCAGGAGGTAGCGGCA - 3’ and 5’- 
GAAGAAAAACGGATGGGGGGAATGGAAATTGTTGACTGATGGCTCGCTTAAC
CGGCAGATCGTCAGTCAG - 3’.  The PCR product was digested with DpnI to remove 
the template plasmid, followed by electroporation into the cells containing zyx-1 fosmids.  
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After recombination, the KanR was removed by anhydrotetracycline treatment, and the 
zyx-1::gfp fragment was gap repaired into an Amp vector backbone using oligos 5’- 
AAATAAAAAAATAGAAAAATACTTGAAAAATATTGAAAAAGATTTTAAAAA
TACAATTCGTTATGCATTATGGGTAC - 3' and 5’ - 
TACAAATTCGGCAAATCGACAACTTGCCGGTTTGCCGGAAACTATCAATTTAC
CAATCTAAGTCTGTGCTCC - 3'.  This gave the plasmid zyx-1::gfp. 
 
NM1934-zyx-1 full-length cDNA with gfp fused at the C-terminus expressed 
under the mechanosensory specific mec-7 promoter.  The full-length zyx-1 cDNA was 
amplified from the cDNA clone yk1054c6 using oligos 5’- TGAC ACGT GGA TCC 
ATGGGACCCCCGCCTCCG - 3' and 5’- TGAC ACGT CGG TAC CAA 
CGTGGAGCTGACCACGCGG - 3’.  Both the PCR product and the plasmid NM776 
pPD117.01 (Pmec-7::gfp) were digested with BamHI and KpnI, and the digestion 
products were gel purified, ligated, and transformed into DH5! competent cells.  This 
gave the plasmid Pmec-7::zyx-1(fl)::gfp. 
 
NM1938-zyx-1 full-length cDNA with gfp fused at the C-terminus expressed 
under the glr-1 promoter.  The full-length zyx-1 cDNA was amplified from the cDNA 
clone yk1054c6 using oligos 5’- TGAC ACGT GGA TCC ATGGGACCCCCGCCTCCG 
- 3’ and 5’- TGAC ACGT ACT AGT CGTGGAGCTGACCACGCGG - 3’.  Both the 
PCR product and the plasmid NM1707 Pglr-1::aex-2::gfp were digested with BamHI and 
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SpeI, and the digestion products were gel purified, ligated, and transformed into DH5! 
competent cells.  This gave the plasmid Pglr-1::zyx-1(fl)::gfp. 
 
NM1941-zyx-1 full-length cDNA with yfp fused at the C-terminus expressed 
under the muscle specific myo-3 promoter.  The zyx-1 full-length cDNA was amplified 
from the cDNA clone yk1054c6 using oligos 5’- TGAC ACGT GCT AGC 
ATGGGACCCCCGCCTCCG - 3’ and 5’- TGAC ACGT AGG CCT 
CGTGGAGCTGACCACGCGG - 3’.  Both the PCR product and the plasmid NM2102 
Pmyo-3::aex-2::yfp were digested with NheI and StuI, and the digestion products were 
gel purified, ligated, and transformed into DH5! competent cells.  This gave the plasmid 
Pmyo-3::zyx-1(fl)::yfp. 
 
NM2004-zyx-1 N-terminal (aa 1-293) cDNA fragment fused with gfp at the N-
terminus under the mechanosensory specific mec-7 promoter.  The gfp::zyx-1(aa 1-293) 
fragment was amplified with overlap PCR using oligos 5’- TGAC ACGT GGT ACC 
ATGAGTAAAGGAGAAGAACTTTTC - 3’, 5’- 
CGGAGGCGGGGGTCCCATCTTGTATGGCCGGCTAGCGA - 3’ (for gfp 
amplification, from the plasmid NM776 pPD117.01), and 5’- 
TCGCTAGCCGGCCATACAAGATGGGACCCCCGCCTCCG - 3’, 5’- TGAC ACGT 
GAT ATC TATCGTTGATAAAGATCTGGTGGT - 3’ (for zyx-1(aa 1-293) 
amplification from the zyx-1 cDNA clone yk1054c6).  Both the PCR product and the 
plasmid NM445 pPD96.41 were digested with KpnI and EcoRV, and the digestion 
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products were gel purified, ligated, and transformed into DH5! competent cells.  This 
gave the plasmid Pmec-7::gfp::zyx-1(aa 1-293). 
 
NM2006-zyx-1 C-terminal (aa 294-603) cDNA fragment fused with gfp at the N-
terminus under the mechanosensory specific mec-7 promoter.  The gfp::zyx-1(aa 294-
603) fragment was amplified with overlap PCR using oligos 5’- TGAC ACGT GGT 
ACC ATGAGTAAAGGAGAAGAACTTTTC - 3’, 5’- 
GGAAAGTTCTTGCTTGAGTCATCTTGTATGGCCGGCTAGCGA - 3’ (for gfp 
amplification, from the plasmid NM776 pPD117.01), and 5’- 
TCGCTAGCCGGCCATACAAGATGACTCAAGCAAGAACTTTCC - 3’, 5’- TGAC 
ACGT GAT ATC TTACGTGGAGCTGACCACGC - 3’ (for zyx-1(aa 294-603) 
amplification from the zyx-1 cDNA clone yk1054c6).  Both the PCR product and the 
plasmid NM445 pPD96.41 were digested with KpnI and EcoRV, and the digestion 
products were gel purified, ligated, and transformed into DH5! competent cells.  This 
gave the plasmid Pmec-7::gfp::zyx-1(aa 294-603). 
 
Cloning of zyx-1 
We mapped sam-6 to a 190kb region on chromosome II using single nucleotide 
polymorphism (SNP) analysis.  Subsequent germ line transformation experiments 
revealed that fosmid 17Bb03 fully restores GFP::RAB-3 localization at PLM synapses in 
sam-6 mutants.  Using a candidate gene approach, we verified that sam-6 is zyx-1 based 
on following observations: 1) zyx-1 mutants do not complement sam-6 mutants; 2) 
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sequencing of sam-6 allele reveals mutation in zyx-1 locus; 3) a zyx-1 mutant allele gk190 
exhibits defective PLM synapse phenotypes that resemble sam-6 animals, and 4) A zyx-1 
plasmid is able to rescue both sam-6 and zyx-1 mutant phenotypes.  Thus, we concluded 
that sam-6 encodes ZYX-1. 
 
Fluorescence imaging and time-course analysis 
The images of fluorescence labeled mechanosensory neuronal processes were 
captured by a Retiga 2000R 12-bit RGB camera (Q-imaging) under an Olympus BX60 
epifluorescence microscope using X60 objective and X1 optivar, which were then 
processed in Adobe Photoshop.  For the time-course imaging of mechanosensory 
GFP::RAB-3, RFP, MITO::GFP and RIM::GFP, the eggs of appropriate fluorescent lines 
were collected and allowed to hatch at RT, and about 20 L1 larvae were picked at various 
time points after the hatch to analyze the fluorescence protein expression and localization 
at PLM synapses.  The quantification was calculated by dividing the numbers of 
branching or synapse-bearing PLM processes with the total numbers of PLM processes 
scored.  These experiments were repeated twice, and mean values and stand error of 
mean (SEM) were reported. 
 
Germ line transformation 
The transgenic lines were constructed using standard germ line transformation 
procedures (Mello et al., 1991).  All the ZYX-1 rescue plasmids were injected at the final 
concentration of 30ng/µl, while the co-injection marker Pmyo-2::gfp and the plasmid 
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vector pcDNA3 were injected at 5ng/µl and 100ng/µl, respectively.  At least two 
independent transgenic lines of each injection were analyzed for the rescue of PLM 
synapse development phenotypes. 
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Figures and figure legends 
Figure 1.  PLM synapses are missing in zyx-1 mutants.  A) The GFP::RAB-3 expressed 
by the jsIs821 transgene labels mechanosensory neurons PLM and PVM in an L4 animal.  
Two PLM synaptic patches are localized on the ventral nerve cord.  A’) GFP::RAB-3 
labeled PLM processes and synapses in a young adult wild type animal.  B) PLM 
synapses are absent in young adult zyx-1 mutants.  Instead, the RAB-3 signal accumulates 
on PLM processes, forming beads like structures (arrow heads).  B’) Another example of 
zyx-1 mutant animal bearing one PLM synapse (asterisk) on the ventral cord.  Scale bar, 
20µm. 
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Figure 1.  PLM synapses are missing in zyx-1 mutants. 
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Figure 2.  zyx-1 mutants have defects in synapse formation and maintenance.  A) A zyx-1 
mutant with mechanosensory neurons double labeled by GFP::RAB-3 and cytoplasmic 
mRFP.  No mRFP signals are detected at PLM synapses in the mutant, indicating a lack 
of synaptic structures.  B-B”) Time-course imaging of PLM synapse development in wild 
type and zyx-1 animals.  The mechanosensory processes and synapses are double labeled 
by either GFP::RAB-3 (B), Mito::GFP (B’), or RIM-1::GFP (B”) and cytoplasmic mRFP.  
Red color denotes intensity saturations.  The fractions of PLM processes that have sent 
out branches or formed synapses at various time points after hatch are quantified in C).  
Scale bar, 20µm. 
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Figure 2.  zyx-1 mutants have defects in synapse formation and maintenance. 
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Figure 2.  zyx-1 mutants have defects in synapse formation and maintenance. 
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Figure 2.  zyx-1 mutants have defects in synapse formation and maintenance. 
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Figure 3.  zyx-1 encodes a focal adhesion LIM domain protein and is widely expressed in 
the nervous system and muscles.  A) Gene structure of zyx-1.  The zyx-1 locus is located 
on the C. elegans chromosome II and encodes at least five different transcripts.  Two 
isoforms of ZYX-1 protein, a long form and a short form, are predicted.  Blue boxes, 
coding exons; gray boxes, non-coding exons; black lines, introns.  Similar to its 
vertebrate homologue, the C. elegans ZYX-1 is predicted to have three LIM domains at 
the C-terminus.  B) The MCHERRY::ZYX-1 and ZYX-1::GFP genomic fusion proteins 
are widely expressed in the nervous system and muscles.  M, muscle; NR, nerve ring; 
VNC, ventral nerve cord; SP, spermatheca.  ZYX-1 signals label muscle nuclei 
(asterisks).  Due to high expression levels, the subcellular localization of ZYX-1 in 
neurons is not clearly distinguished.  Scale bar, 40µm. 
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Figure 3.  zyx-1 encodes a focal adhesion LIM domain protein and is widely expressed in 
the nervous system and muscles. 
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Figure 4.  ZYX-1 functions autonomously in mechanosensory neurons to regulate PLM 
synapse development.  The percentage of rescued animals with 2 PLM synapses, 1 PLM 
synapse, and no PLM synapses are quantified.  A) Expression of full length ZYX-1 
cDNA in presynaptic mechanosensory neurons significantly rescues zyx-1 mutant 
phenotype, while muscular or interneuronal expressions do not.  B) Expression of ZYX-1 
LIM domains in mechanosensory neurons significantly rescues zyx-1 mutant phenotypes.  
The error bars represent standard deviation (SD). 
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Figure 4.  ZYX-1 functions autonomously in mechanosensory neurons to regulate PLM 
synapse development. 
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Table 1.  Test of candidate molecules that may regulate PLM synapse development.  
None of the genes examined have significant roles in PLM synapse formation or 
maintenance. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Genotype N Two patches One patch 
 
 
No patches 
Wild type 29 97% 3% 0% 
zyx-1(js417) 50 0% 8% 92% 
zyx-1;mkk-4 128 15.6% 22.7% 61.7% 
zyx-1;pmk-3 128 7.0% 16.4% 76.6% 
zyx-1;dlk-1 55 14.5% 9.1% 76.4% 
unc-97(su110)     
unc-98(su130) 12 66.7% 33.3% 0% 
ina-1(gm39) 25 100% 0% 0% 
ina-1(gm144) 50 96% 2% 2% 
pat-3;[pat-
3(Y804F)] 79 74.7% 17.7% 7.6% 
pat-4;[pat-
4(S334A)::gfp] 90 87.8% 7.8% 4.4% 
syg-1(ky652) 48 96% 4% 0% 
syg-2(ky671) 34 97% 3% 0% 
syd-1(ju2); syd-
2(ju487) 41 88% 12% 0% 
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Chapter 5 
 
Concluding Remarks 
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When Sydney Brenner first settled on Caenorhabditis elegans as a genetic model 
about half a century ago, his goal was to ultimately use this organism to unravel the 
mysteries of the nervous system.  Realizing that the animal only has a limited number of 
neurons, he proposed the complete circuitry of the nervous system could be determined 
by serial-section electron microscopy, and based on this it is possible to dissect the roles 
of every single gene involved in neural development and function (Riddle et al., 1997).  
With White and his colleagues’ efforts, the first part of Brenner’s proposal had already 
come true 20 years before.  Now with many new technologies not available at old days 
(RNAi, for example), people are making rapid progresses towards realizing the second 
part of the proposal. 
My dissertation presented here has added another example of the power of C. 
elegans as a model organism to study nervous system function.  In this dissertation, I 
have described the identification of intestinal peptide-related signals, and they likely 
function as modulators of multiple aspects of neural functions, such as defecation and 
synaptic transmission.  Several lines of evidence in mammals have demonstrated that 
small peptides and hormones can modulate nervous system functions (Moult and Harvey, 
2008).  Interestingly, as a small organism as C. elegans, its genome contains over 100 
identified peptide genes that encode over 250 peptides (Li, 2005).  Evidence suggests that 
the peptides, together with their processing enzymes (proprotein convertases, PC), are 
present in many neuronal classes across the nematode nervous system, and they could be 
potentially co-released with conventional neurotransmitters (Li, 2005; Li et al., 1999).  
On the other hand, the C. elegans intestine is likely the largest endocrine organ in the 
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animal.  With both the PC (i.e. AEX-5) and peptides present in this organ, the intestine 
likely plays an important role in modulating other neuronal functions.  In the future, it 
will be interesting to adopt efficient genetic approach (such as RNAi) to disrupt intestinal 
peptide expressions to see what other neuronal phenotypes could occur.  If there is any, 
by scoring one easily observable phenotype (such as defecation), one may be able to 
identify molecules, such as peptides, peptide-processing enzymes, and peptide-release 
related exocytic factors that are involved in the nervous system function.  The C. elegans 
intestine will serve as a powerful start point to demystify genes involved in neural 
function, and this, together with other studies, will ultimately help people move towards 
realizing what Brenner had proposed when he first adopted this small organism. 
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